REGISTER RAKA ZA SLOVENIJO CANCER REGISTRY OF SLOVENIA EPIDEMIOLOGIJA IN REGISTER RAKA EPIDEMIOLOGY AND CANCER REGISTRY Poročilo RR št. 45 Report No. 45 LJUBLJANA 2006 INCIDENCA RAKA V SLOVENIJI CANCER INCIDENCE IN SLOVENIA ISSN 1318-2471 REGISTER RAKA ZA SLOVENIJO CANCER REGISTRY OF SLOVENIA EPIDEMIOLOGIJA IN REGISTER RAKA EPIDEMIOLOGY AND CANCER REGISTRY Poročilo RR št. 45 Report No. 45 LJUBLJANA 2006 INCIDENCA RAKA V SLOVENIJI CANCER INCIDENCE IN SLOVENIA ISSN 1318-2471 Uredniški odbor / Editorial Board Maja Primic Žakelj, glavna urednica / editor-in-chief Matej Bračko Marko Hočevar Vera Pompe–Kirn Primož Strojan Vesna Zadnik Branko Zakotnik Tina Žagar Osebje Registra raka / Staff of the Cancer Registry Maja Primic Žakelj, vodja / head Barbara Babuder Mojca Brus Andrej Kirn Andrej Krašovec Neža Milčič Nataša Robek Fani Škrlec Nataša Šturm Tina Žagar, mlada raziskovalka / junior researcher Računalniška obdelava / EDP analysis Jurij Modic Vesna Zadnik Tina Žagar Oblikovanje / Design Monika Fink-Serša Studio N, studio za oblikovanje in grafično pripravo Priprava za tisk in tisk / Typesetting and printing Studio N, studio za oblikovanje in grafično pripravo Izdal / Published by Onkološki inštitut Ljubljana / Insitute of Oncology Ljubljana, Slovenia Direktor / Director Zvonimir Rudolf Naslov / Correspondence to Maja Primic Žakelj Onkološki inštitut / Institute of Oncology Zaloška c. 2, 1001 Ljubljana, p.p. 2217, Slovenia Telefon / Phone: + 386 (1) 5879 563 E-pošta / E-mail: register@onko-i.si Spletna stran / Web site: http://www.onko-i.si/sl/dejavnosti/epidemiologija_in_registri_raka/registri_raka/register_raka_za_slovenijo/ http://www.onkoi.si/en/sectors_of_the_institute_of_oncology/epidemiology_and_cancer_registries/cancer_registries/can- cer_registry_of_slovenia/ Nasvet za citiranje / Recommended reference Incidenca raka v Sloveniji 2003. Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2006. Cancer incidence in Slovenia 2003. Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2006. Vse pravice pridržane. All rights reserved. VSEBINSKO KAZALO / CONTENTS Stran / Page Uvod in pojasnila Introduction and Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Tabela A Breme raka - Slovenija 2003 Table A Cancer burden - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Tabela B Prevalenca glede na obdobje opazovanja - Slovenija, 31. 12. 2003 Table B Prevalence by period of observation - Slovenia, December 31, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Tabela C Stabilnost podatkov - število in odstotek novih primerov raka, prijavljenih po izdaji letnega poročila, po obdobju - Slovenija, 1965-2002 Table C Data stability - number and percentage of new cases reported after the publication of annual reports, by time period - Slovenia, 1965-2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Tabela D Opazovana in napovedana incidenca raka v Sloveniji v obdobju 1994-2006 Table D Observed and predicted cancer incidence in Slovenia in the period1994-2006 . . . . . . . . . . . . . . . . . . . . . . . . 17 Slike / Figures 1 Najpogostejše rakave bolezni po spolu - Slovenija 2003 The leading cancer sites by sex - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 2 Odstotni delež vseh rakov po starostnih skupinah in spolu - Slovenija 2003 Percentage distribution of all cancer sites by age groups and sex - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 3 Najpogostejše rakave bolezni po starostnih skupinah in spolu - Slovenija 2000-2003 The leading cancer sites by age groups and sex - Slovenia 2000-2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 4 Groba in kumulativna letna incidenca vseh rakov po spolu - Slovenija 1950-2003 Crude and cumulative annual cancer incidence; all sites by sex - Slovenia 1950-2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 5 Groba letna incidenca izbranih rakov po spolu - Slovenija 1950-2003 Crude annual cancer incidence by selected primary sites and sex - Slovenia 1950-2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 6 Glava in vrat - moški Head and neck - males . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 7 Glava in vrat - ženske Head and neck - females . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 8 Želodec - moški Stomach - males . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 9 Želodec - ženske Stomach - females . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 10 Maligni melanom - moškI Malignant melanoma - males . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 11 Maligni melanom - ženske Malignant melanoma - females . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 12 Relativno 5-letno preživetje bolnikov z izbranimi raki po spolu, zbolelih v letih 1998-2002 in 1993-1997 Five year relative survival for selected cancer sites by sex in periods 1998-2002 and 1993-1997 . . . . . . . . . . . . . . . . . . . . . 30 Cancer Incidence in Slovenia 2003 3 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabele / Tables 1 Prebivalstvo Slovenije po starosti in spolu na dan 30. junija 2003 Population of Slovenia by age and sex on June 30, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 2 Prebivalstvo Slovenije po statističnih regijah po spolu na dan 30. junija 2003 Population of Slovenia by statistical regions by sex on June 30, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 3 Število novih primerov raka, število in odstotek mikroskopsko potrjenih primerov, število in odstotek primerov, ugotovljenih z drugimi preiskavami in število in odstotek registriranih samo iz zdravniških poročil o vzroku smrti, po lokaciji in spolu - Slovenija 2003 Total number of new cancer cases, number and percentage of microscopically confirmed cases, number and percentage of cases confirmed by other investigations, and number and percentage of cases registered from death certificates only, by site and sex - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 4a Število novih primerov raka po lokaciji (MKB-10), spolu in starosti - Slovenija 2003 Number of new cancer cases by primary site (ICD-10), sex, and age - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 4b Število novih primerov raka po lokaciji (MKB-8), spolu in starosti - Slovenija 2003 Number of new cancer cases by primary site (ICD-8), sex, and age - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 5 Incidenca raka na 100.000 prebivalcev po spolu in starosti ter kumulativna stopnja (KS) po lokaciji - Slovenija 2003 Cancer incidence per 100.000 population by sex and age, and cumulative rate (CR) by site - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 6a Število novih primerov raka po statističnih regijah, po najpogostejših lokacijah in spolu - Slovenija 2003 Number of new cancer cases by statistical regions, by most frequent sites and sex - Slovenia 2003 . . . . . . . . . . . . . . 54 6b Starostno standardizirana incidenca raka po statističnih regijah, po najpogostejših lokacijah in spolu - Slovenija 2003 Age standardised cancer incidence rate by statistical regions, by most frequent sites and sex - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 7 Število histološko (in citološko) potrjenih novih primerov raka - po histološki vrsti in lokaciji - Slovenija 2003 Number of histologically (and cytologically) confirmed new cancer cases by histologic type and site - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 8 Število primerov ne-Hodgkinovih limfomov po lokaciji, spolu in starosti Slovenija 2003 Total number of non-Hodgkin's malignant lymphomas by site, sex, and age - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . 65 9 Število novih primerov raka po bolnišnicah ugotovitve diagnoze ter število in odstotek primerov, napotenih na Onkološki inštitut Ljubljana (OI) - Slovenija 2003 Number of new cancer cases diagnosed by reporting hospitals, and number and percentage of cases referred to the Institute of Oncology Ljubljana (IO) - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . 66 10 Število in odstotek novih primerov raka (brez registriranih samo iz zdravniških poročil o vzroku smrti) po stadiju, lokaciji in spolu - Slovenija 2003 Number and percentage of new cancer cases (without cases registered from death certificates only) by stage, site and sex - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68 11 Število umrlih za rakom po lokaciji, spolu in starosti - Slovenija 2003 Number of cancer deaths by site, sex and age - Slovenia 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72 12 Število vseh živih bolnikov z rakom po spolu in izbrani primarni lokaciji - Slovenija, 31. 12. 2003 Prevalence of cancer patients by sex and selected primary site - Slovenia, December 31, 2003 . . . . . . . . . . . . . . . . . . . . 77 Izbor publikacij / Selected publications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 4 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 5 UVOD Register raka za Slovenijo (Register) je eden najstarejših populacijski registrov v Evropi. Ustanovljen je bil leta 1950 na Onkološkem inštitutu v Ljubljani kot posebna služba za zbi- ranje in obdelavo podatkov o incidenci raka in preživetju bolnikov z rakom. Pred letom 1950 so bili populacijski registri raka le v Hamburgu, na Danskem in v Veliki Britaniji. Od ustanovitve do leta 1975 je Register vodila pokojna profe- sorica dr. Božena Ravnihar, dologoletna direk- torica Onkološkega inštituta. Njeno delo je nato prevzela profesorica dr. Vera Pompe Kirn, ki je do leta 2003 skrbela za nadaljnjo uveljav- ljanje Registra v domačem in mednarodnem merilu. Tega leta je Onološki inštitut dobil nov statut, ki je združil Register z Enoto za epidemi- ologijo v enotno službo Epidemiologija in regi- stri raka. V njej so poleg Registra še bolnišnič- ni register Onkološkega inštituta, oddelek za epidemiologijo, kjer tečejo epidemiološke raz- iskave, in na novo ustanovljeni Register orga- niziranega presejanja za raka materničnega vratu (ZORA), kjer je tudi koordinacija državnega programa presejanja za raka materničnega vratu. Prijavljanje raka je že od ustanovitve Registra v Republiki Sloveniji obvezno in zakonsko pred- pisano (Ur. l. SRS, št. 10/50, št. 29/50, št. 14/65, št. 1/80, št. 45/82, št. 42/85; Ur. l. RS, št. 9/92 in št. 65/00). Zbrani podatki so podlaga za oce- njevanje bremena rakavih bolezni v državi, za načrtovanje in ocenjevanje onkološkega varstva na področju primarne in sekundarne preventive, diagnostike, zdravljenja in rehabili- tacije, za načrtovanje zmogljivosti in sredstev, ki so potrebni za obvladovanje rakavih bolezni (osebje, medicinska oprema, posteljne zmog- ljivosti), ter za klinične in epidemiološke razis- kave v Sloveniji in v sklopu širših mednarodnih raziskav. Populacijski register raka opravičuje svoj obstoj, če se zbrani podatki tudi redno obdelujejo, objavljajo in uporabljajo. Ena izmed stalnih oblik vračanja obdelanih informacij so letna poročila. Ker je virov informacij več, je čas, potreben za dokončanje zbirke, povezavo in objavo podatkov pri nas in po svetu daljši, obi- čajno 2 do 3 leta. Sedanje poročilo prikazuje INTRODUCTION The Cancer Registry of Slovenia (Registry) is one of the oldest population based registries in Europe. It was founded in 1950 at the Institute of Oncology in Ljubljana as a special service for collecting and processing data on cancer inci- dence and cancer patients’ survival. Before 1950, population based registries existed only in Hamburg, Denmark and in Great Britain. From its foundation and untill 1975, the Registry was headed by the late Professor Božena Ravnihar who was also director general of the Institute of Oncology for almost 20 years. At the registry she was succeeded by Professor Vera Pompe-Kirn, who carried on her work until 2003 and con- tributed a lot to the further development of the Registry as well as its promotion and recognition at the national and international level. In 2003, a new Statue was adopted by the Institute that enacted the merghing of the registry and Epide- miology Unit in a single service, Epidemiology and Cancer Registry. The new service comprises, besides Cancer Registry of Slovenia, also the hospital-based Cancer Registry of the Institute of Oncology, Epidemiology Unit for epidemiologic studies and the newly established Cervical Cancer Screening Registry, a unit that is in charge of coordinating the nationally organised cervical cancer screening programme. Notification of cancer has been compulsory in Slovenia since the foundation of the Registry and prescribed by law (Official Gazette of SRS, No. 10/50, No. 29/50, No. 14/65, No. 1/80, No. 45/82, No. 42/85; Official Gazette of RS , No. 9/92 and No. 65/00). The data collected serve as the basis for assessing the cancer burden in the country, for programming and evaluating pri- mary prevention, diagnosis, treatment and rehabilitation, planning facilities and funding needed for cancer control (personnel, equip- ment and hospital capacities) as well as for clinical and epidemiological research in Slovenia and in international multicentric studies. The existence of a population-based cancer registry is justified only by regular processing, publishing and using the data collected. The Registry’s Annual Reports are one of the regular ways of disseminating information. Because of a variety of data sources, data collection, their Onkološki inštitut Ljubljana, Register raka za Slovenijo 6 Incidenca raka v Sloveniji 2003 podatke o novih primerih, registriranih v letu 2003. Za osnovno informacijo o tem, kakšno incidenco pričakujemo leta 2006, dodajamo s posebno statistično metodo ocenjeno napo- ved za leto 2006. Register je prva letna poročila izdajal že v letih 1953-57 za leta 1951-55. Prva analiza podatkov za leto 1950 je bila objavljena v Zdravstvenem vestniku leta 1951. Podatki za leta 1957-71 so bili objavljani v periodičnih publikacijah Svetovne zdravstvene organizacije Epidemiological and Vital Statistics in v World Health Statistics Report. Od leta 1965 so bili podatki spet redno objavljani v posebnih letnih poročilih z naslo- vom Rak v Sloveniji (1965-77) in Incidenca raka v Sloveniji (1978-2002), in sicer v slovenskem in angleškem jeziku. Za vsebino publikacije skrbi uredniški odbor, v katerem smo zbrani specia- listi raznih vej onkologije. Glede na želje in pri- pombe uporabnikov letna poročila iz leta v leto dopolnjujemo, vendar skrbimo tudi za to, da so objavljeni podatki iz leta v leto primerljivi. Incidenca raka je po svetu zelo različna, za ra- ziskovanje teh razlik pa so ključni kakovostni podatki. Prav zato so bili in so naši podatki o incidenci raka zanimivi tudi za svet. Leta 1957 je izšlo prvo obsežnejše poročilo za leta 1950-55 v angleščini. Podatke za leta 1956-60, 1961-65, 1968-72, 1973-76, 1978-81, 1982-87, 1988-92 in 1993-97 so objavili tudi v vseh osmih zvezkih knjige Cancer Incidence in Five Continents, ki jo izdaja Mednarodna agencija za raziskova- nje raka. Podatki o incidenci in umrljivosti za rakom so vključeni tudi v mednarodne poda- tkovne baze EUROCIM, GLOBOCAN, ACCIS, preživetje slovenskih bolnikov pa je obdelano v mednarodnih študijah EUROCARE II in EURO- CARE III. Zbrane podatke v Registru obdelujemo in pojasnjujemo v skladu s trenutno perečo pro- blematiko v Sloveniji, z lastnim raziskovalnim programom in s predlogi uporabnikov. Izsledke objavljamo v člankih v domačem in tujem stro- kovnem in poljudnem tisku. Med najpomemb- nejšimi so tri knjige: Zemljevidi incidence raka v Sloveniji 1978-1987, Preživetje bolnikov z rakom v Sloveniji 1963-1990 in Preživetje bolni- kov z rakom v Sloveniji 1983-1997. Seznam dru- gih pomembnejših del, objavljenih v zadnjih petih letih, je v dodatku na koncu poročila. linking and publication is rather time consum- ing (with us and elsewhere) and usually takes two to three years. As preliminary information on expected incidence in 2006, predicted num- bers and rates are presented in this report. The first annual reports of the Registry for the period 1951-55 were issued during the years 1953-57. The first data analysis for the year 1950 was published in Zdravstveni vestnik in 1951. The data for the period 1957-71 were appearing in the periodicals Epidemiological and Vital Statistics Report and World Health Statistics Report, both edited by World Health Organization. From 1965 onwards, the data have been appearing regularly in special bi-lingual (Slovene-English) annual reports, first entitled Cancer in Slovenia (1965-77), and then Cancer Incidence in Slovenia (1978-2000). The editorial board, responsible for the contents of the report, consists of experts of different specialties in oncology. Our endeavours have always been directed towards further improvement of these publications, by taking into account as much the requests and comments of the users as the comparability of the data from year to year. There are great differences in cancer incidence among different populations and to evaluate them, good quality data are needed from dif- ferent parts of the world. That is why our data on cancer incidence have always been interesting also for professional public abroad. In 1957, the first comprehensive report, covering the period 1950-55, was issued in English under the title Cancer in Slovenia 1955. The data for the peri- ods 1956-60, 1961-65, 1968-72, 1973-76, 1978-81, 1982-87, 1988-92 and 1993-97 were published in all eight volumes of the Cancer Incidence in Five Continents issued by International Agency for Research on Cancer. The data on cancer incidence and mortality for the years 1983-99 were also included in international databases EUROCIM, GLOBOCAN, ACCIS. The survival of Slovenian cancer patients is included into and analysed by the international studies EUROCARE II and EUROCARE III. The data collected have been processed in accordance with the current problems in Slovenia, as well as with respect to our research program and suggestions from our users. These data are published in national and foreign medical Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 7 Letošnje poročilo je v celoti dostopno v elektron- ski obliki na spletni strani Onkološkega inštituta http://www.onko-i.si/sl/dejavnosti/epidemiolo- gi ja_in_registr i_raka/registr i_raka/regi- ster_raka_za_slovenijo/ GRADIVO IN METODE Osnovni vir podatkov so prijavnice rakave bolezni. Registru jih pošiljajo iz vseh bolnišnic in diagnostičnih centrov v Sloveniji, iz ordinacij osnovnega zdravstvenega varstva pa le izje- moma, če bolnik ni napoten na nadaljnje pre- iskave in/ali zdravljenje. Dodatni vir podatkov so zdravniška poročila o vzroku smrti in obduk- cijski zapisniki z diagnozo maligne bolezni. Zbiranje podatkov za to letno poročilo smo zaključili 31. marca 2006. Zanesljivost podatkov osvetljujeta dva kazalca: odstotni delež mikroskopsko (histološko ali cito- loško) potrjenih primerov in odstotni delež raka, registriranega samo iz zdravniških poročil o vzroku smrti (tabela 3). Majhen delež primerov, prijavljenih po izdaji letnega poročila v raznih časovnih obdobjih, kaže, da do izdaje poroči- la registriramo večino novih primerov raka. Ta delež je stabilen in kaže na popolnost poda- tkov (tabela C). Od leta 1993 je obvezno prijavljanje sprememb materničnega vratu, označenih kot CIN III (šifra 219 po 8. reviziji MKB), dotlej pa so se registrirale le spremembe, označene v tabelah s šifro 234.0 (karcinom in situ). Primerjava s podatki za obdo- bje 1961-92 tako ni možna. Po 10. reviziji MKB so vse intraepiteljiske spremembe materničnega vratu uvrščene v šifro D06. Od leta 1995 registri- ramo tudi prijavljene intraepitelijske karcinome mehurja in maligne melanome Clark I. Za razvrščanje neoplazem po lokacijah Register od leta 1997 uporablja 10. revizijo Mednarodne klasifikacije bolezni, poškodb in vzrokov smrti, do takrat pa je uporabljal osmo. Za vse, ki želijo primerjati podatke iz prejšnjih poročil, je dodana tabela 4b. Klasifikaciji različ- no uvrščata bolezni med maligne, zato število novih primerov raka po obeh klasifikacijah ni enako. literature and as publications for lay readers. Among the most important are three special publications: Atlas of Cancer Incidence in Slovenia 1978-1987, Cancer Patients’ Survival in Slovenia 1963-1990 and Cancer Patients’ Survival in Slovenia 1983-1997. The list of other relevant publications is at the end of this report. The current annual report is available in pdf format on website of the Institute of Oncology: http://www.onkoi.si/en/sectors_of_the_insti- tute_of_oncology/epidemiology_and_can- cer_registries/cancer_registries/cancer_reg- istry_of_slovenia/ MATERIAL AND METHODS The main sources of data are notifications gathered from all hospitals and diagnostic centres in Slovenia, exceptionally also from pri- mary health care centres in case the patient was not referred for further diagnostic investi- gations. This information is completed by death certificates and autopsy protocols stating cancer diagnosis. The collection of data for the current report was completed on March 31, 2006. The reliability of information can be assessed by two parameters: the percentage of microscop- ically (histologically or cytologically) confirmed cases and by the percentage of cancer cases registered on the basis of death certificates only (Table 3). The small and stable proportion of cases registered after the publication of annual reports shows that the majority of cases are reported to the Registry by the time of the publication of annual reports and that the registration is complete (Table C). In 1993, compulsory registration of all cervical intraepithelial dysplasias classified as CIN III was introduced (code 219 according to ICD-8). Till then, only carcinoma in situ (code 234.0) was registered. Thus, the comparison with the data for the period 1961-1992 is not possible. According to ICD-10, all cervical intraepithelial neoplasms (in situ and CIN III) are coded as D06. Since 1995, the number of all reported intraepithelial carcinomas of the bladder and all malignant melanomas Clark I have been registered. Onkološki inštitut Ljubljana, Register raka za Slovenijo 8 Incidenca raka v Sloveniji 2003 Prav pri uvrščanju med maligne bolezni je treba opozoriti še na klasifikacijo za morfologi- jo neoplazem, za katero uporabljamo morfolo- ški del Mednarodne klasifikacije bolezni za onkologijo, od poročila za leto 2001 tretjo izda- jo. V tej izdaji je spet nekaj sprememb, tudi kate- re histološke vrste sodijo med maligne. Po tretji reviziji so med maligne uvrščene kronične mie- loproliferativne bolezni in mielodisplastični sin- dromi (sedaj v topografski šifri C96.7). V skladu z novimi pravili tudi mejno malignih ovarijskih tumorjev ne uvrščamo več v kategorijo C56, pač pa v D39.1. Opozarjamo še, da so v tabeli 7 histološke vrste razvrščene po tretji reviziji morfološkega dela Mednarodne klasifikacije bolezni za onkologijo in združene v drugačne skupine kot v poročilih za leto 2000 in leta pred njim. V tabeli 6 smo doslej prikazovali podatke po devetih zdravstvenih regijah. V skladu z Uredbo o standardni klasifikaciji teritorialnih enot - SKTE, ki predpisuje sistematiko členitve ozemlja Slovenije na enajstih ravneh, smo se odločili, da v tej tabeli in zemljevidih uporabimo raven SKTE-3, 12 statističnih regij. Po potrebi pa poda- tke lahko še vedno posredujemo do ravni upra- vnih enot. Za napoved incidence v letu 2006 je uporablje- na metoda po Dybi in Hakulinenu, ki je primer- na za oceno incidence v krajšem časovnem obdobju, saj upošteva samo obdobje diagno- ze in starost; pri napovedih za daljša časovna obdobja je treba upoštevati tudi vpliv rojstne kohorte. Since 1997, cancer sites are coded according to the 10th revision of the International Statistical Classification of Diseases and Related health Problems (ICD-10); before, the 8th revision was used (ICD-8). As in earlier reports, Table 4b con- tains also the data coded according to the 8th revision in order to allow the comparison with the earlier reports. There are differences in cod- ing neoplasms as malignant or benign accord- ing to both classifications, so, according to the two classifications, the number of new cancer cases is not equal. When classifying tumours as malignant, the behaviour digit of the morphology code of the third edition of International Classification of Diseases for Oncology is used in the current annual report. In this edition, some changes were introduced in terms of morphology and behaviour code. According to this classifica- tion, chronic myeloproliferative disorders and myelodisplastic syndromes are classified as malignant (topography code C96.7), while ovarian tumours of borderline malignancy are currently coded as D39.1 (and not C56). It should be noted that in Table 7 the morphology codes are grouped in new categories and are adapted to the third revision of morphology part of International Classification of Diseases for Oncology. Till this report, the data in Table 6 have been presented by 9 health regions. The new law on regional division of Slovenia introduced the sys- tem of eleven levels, and health regions are not official units. So, 12 statistical regions have been chosen to present the data in Table 6 and on the maps. The method by Dyba and Hakulinen was used for predictions. It is suitable for predictions in shorter time period, taking into account period of diagnosis and age structure of population. For long-term predictions the cohort effect should be included also. Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 9 DEFINICIJE Incidenca pomeni število vseh v enem koledar- skem letu na novo ugotovljenih primerov raka v točno določeni populaciji. V incidenco ne šte- jemo novih primarnih rakov parnega organa iste lokacije, če je bila histološka vrsta obeh rakov, npr. leve in desne dojke, enaka. Prav tako v incidenco ne štejemo novega pojava raka iste histološke vrste na istem organu, npr. multi- ple lezije v debelem črevesu. V incidenco so vključeni primeri bolezni bolnikov s stalnim biva- liščem na območju Republike Slovenije, ne glede na to, kje so bili ti bolniki zdravljeni. Prevalenca je število vseh živih bolnikov z rakom na določen datum ne glede na leto diagnoze. Groba incidenčna stopnja je število novih pri- merov na 100.000 oseb opazovane populacije, starostno specifična stopnja pove to relativno število v posamezni petletni starostni skupini. Če analiziramo incidenco v daljšem časovnem obdobju (če se starostna struktura prebivalstva v času spreminja) ali če primerjamo incidenco med populacijami z različno starostno strukturo, je potrebo uporabiti eno od metod starostne standardizacije. Starostno standardizirana stop- nja je teoretična incidenčna stopnja, pri kateri predpostavimo, da je starostna struktura opa- zovane populacije enaka starostni strukturi v standardni populaciji. V tabeli 6b je za primer- javo incidenčnih stopenj med slovenskimi stati- stičnimi regijami uporabljena neposredna metoda starostne standardizacije; standard je starostna struktura prebivalcev Slovenije ob popisu leta 2002. Kumulativna incidenčna stopnja (v zadnjem stolpcu tabele 5) je petkratna vsota starostno specifičnih incidenc na 100 prebivalcev posa- meznih petletnih starostnih skupin do 74. leta starosti. Je neposredna, na dejansko populacijo posamezne petletne starostne skupine standar- dizirana incidenca ali približek kumulativnemu tveganju. Kumulativno tveganje je verjetnost posamezni- ka, da zboli za rakom v izbranem starostnem obdobju, npr. do 74. leta starosti (če, seveda, ne umre prej zaradi drugih vzrokov). Kumulativno stopnjo računamo na 100 in jo izražamo v DEFINITIONS Incidence is the number of newly diagnosed cancer cases in a defined population, reported to the Registry for a given calendar year. New primary cancers of the same histology in paired organs, e. g. on the left and right breast, are not comprised in the incidence figures, neither are any new cancers of the same histology appearing in the same organ, e.g. multiple lesions of the colon. The incidence includes only the data on patients with permanent resi- dence in Slovenia, regardless of the place of treatment. Prevalence is the number of all surviving cancer patients, irrespective of the year of diagnosis. Crude incidence rate is the number of new cases per 100.000 population, while the age specific rate expresses this relative number in an individual five-year age group. When analysing the incidence rate within longer time period (if the age structure of population changes) or comparing the incidence between populations with different age struc- ture, age standardisation is needed to adjust the rate for the effect of age. The age-stan- dardised rate is a theoretical incidence rate assuming that the age structure in the observed population is the same as in the stan- dard population. In Table 6b, direct age stan- dardisation with Slovenian population from the 2002 census as standard is used for the com- parison of incidence rates between health regions, controlling for differences in their age composition. The cumulative incidence rate (the last col- umn in Table 5) is five times the sum of the age- specific incidence rates per 100 population, calculated over five-year age groups up to the age of 74 years. It is a directly age-standardized rate with the same population size in each age group, or as an approximation to the cumula- tive risk. The cumulative risk is the risk an individual would have of developing the disease in ques- tion during a certain age period if no other causes of death were in operation. The cumu- lative rate is expressed per hundred (per cent). Onkološki inštitut Ljubljana, Register raka za Slovenijo 10 Incidenca raka v Sloveniji 2003 odstotkih. Kumulativna stopnja raka dojk pri ženskah 7,2/100 pomeni, npr., da bo verjetno 7,2 % deklic, rojenih leta 2003 (ali ena od 14) do 75. leta starosti zbolelo za rakom dojk. Kumulativno incidenčno stopnjo smo uporabi- li za prikaz časovnega trenda incidence, kot je za Slovenijo prikazan na spodnjem delu slike 4. Primerjava oblike krivulj grobih in kumulativnih stopenj na sliki 4 kaže, da povečevanja inci- dence raka ne moremo pripisati le staranju prebivalstva RS, ampak da k temu prispevajo še drugi nevarnostni dejavniki. Kumulativne stopnje smo uporabili tudi pri zemljevidih. Relativno preživetje pomeni razmerje med opazovanim preživetjem proučevane skupine in preživetjem, ki bi ga pričakovali pri enako stari skupini istega spola v slovenski populaciji. Je približek preživetja bolnikov v primeru, da bi upoštevali kot vzrok smrti samo izbranega raka. Metoda je natančneje opisana v knjigi Preživetje bolnikov z rakom v Sloveniji 1983-1997. POJASNILA Tabeli A in B in Slika 1 prikazujejo osnovne podatke o bremenu raka v Sloveniji: število vseh zbolelih in umrlih za rakom v letu 2003, pre- valenco in najpogostejše rakave bolezni po spolu. Sliki 2 in 3 opozarjata na različno breme raka v raznih življenjskih obdobjih. Rak je skoraj izjema pri mladih do 19 let; če pa zbolijo, najpogoste- je za levkemijo. Manj kot 3 % vseh rakov je med 20. in 34. letom starosti, ko je pri moških najpo- gostejši rak mod, pri ženskah pa rak maternič- nega vratu. Pljučni rak pri moških in rak dojk pri ženskah sta na prvem mestu med 35. in 69. letom starosti, po 70. letu pa pri moških vodi rak prostate, pri ženskah pa kožni rak. Več kot tri četrtine vseh rakov je pri bolnikih, starejših od 50 let. Sliki 4 in 5 kažeta trende incidence vseh in izbranih rakov po spolu. Pri grafičnih prikazih so v eno skupino združeni rak debelega črevesa in danke in v drugo rak ust, žrela in grla (glava in vrat). Thus, the cumulative rate (0-74) of 7.2/100 for breast cancer in females means that 7.2% of women (each 14th woman) are expected to develop breast cancer by their age of 75. The cumulative rate was used to present the incidence time trend in the lower part of Figure 4. The comparison of the curves of crude inci- dence per 100.000 population and cumulative incidence rates in Figure 4 indicates that the increasing cancer incidence rate in both sexes cannot be attributed only to the aging of pop- ulation, but also to additional risk factors. Cumulative rate is used also in cancer maps. Relative survival is the ratio of the observed actual survival and the survival that is, in the observation period, expected in general pop- ulation of Slovenia with respect to age and sex. It is approximation of cancer cause specific survival. The method is explained in more detail in the publication Cancer Patients’ Survival in Slovenia 1983-1997. COMMENTS Tables A and B and Figure 1 present the basic data on cancer burden in Slovenia: the num- ber of new, deceased and prevalent cancer patients in 2003 and the most frequent cancer sites by sex. Figures 2 and 3 point to the different proportion of cancer in different age groups; cancer is more an exception till the age of 19, with leukaemia being the most frequent cancer. Less than 3 percent of all cancer is in the age group 20-34, where the most frequent is testic- ular cancer in males and cervical in females. Lung in males and breast in females are the most frequent cancer sites in the age group 35- 69; after the ahe of 70, in males prostate is the most frequent cancer site while skin in females. Figures 4 and 5 show the incidence trends for all and selected cancers by sex. In graphical presentations, colon and rectal cancers are grouped in one category as colorectal, as well as oral, pharyngeal and laryngeal cancers as head and neck. Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 11 Na slikah 6 do 11 so zemljevidi incidence rakov glave in vratu, želodca in malignega melano- ma v letih 1999-2003 po statističnih regijah. Poleg zemljevidov grobe in kumulativne inci- denčne stopnje prikazujemo še trend incidence po stadijih ob diagnozi in starostno specifično incidenco. Slika 12 prikazuje relativno 5-letno preživetje bolnikov z vsemi in izbranimi raki, zbolelih v letih 1998-2002. Za primerjavo so dodani podatki o bolnikih, zbolelih v letih 1993-1997, kot so bili objavljeni v knjigi Preživetje bolnikov z rakom v Sloveniji 1983-1997. Pri moških se je skupno pre- živetje povečalo za 9 %, delno tudi na račun boljšega prijavljanja raka prostate nižjih stadijev, ki imajo boljšo prognozo, saj je pri tej bolezni preživetje navidezno večje kar za 21 %. Za 9 % boljše preživetje bolnikov z rakom debelega črevesa in za 8 % boljše preživetje bolnikov z rakom danke je gotovo realno, posledica bolj- šega odkrivanja, večje kakovosti zdravljenja in več sistemskega zdravljenja. Pri ženskah je skupno preživetje večje za 6 %. Tudi pri njih je za 9 % boljše preživetje pri bolnicah z rakom debelega črevesa, za 8 % pa se je izboljšalo preživetje bolnic z rakom dojk. Tabele prikazujejo podatke o prebivalcih in incidenci raka v Sloveniji leta 2003 po spolu, sta- rosti, lokaciji, histološki vrsti in stadiju bolezni ob diagnozi, o incidenci po statističnih regijah ter podatke o številu novih primerov raka, ugotov- ljenih v tem letu po posameznih bolnišnicah, število smrti za rakom po spolu, starosti in loka- ciji ter prevalenco najpogostejših rakov. Tabela 3 je letos prenovljena in so v njej tudi podatki, ki so bili doslej prikazani v tabeli 3 in bivši tabeli 7. Z novo tabelo 3 prikazujemo, na kakšen način je bila postavljena diagnoza regi- striranim novim primerom raka. Od 9997 leta 2003 na novo registriranih primerov raka je bila pri 93 % diagnoza potrjena mikroskopsko (histološko ali citološko), pri 6 % z drugimi prei- skavami, 1 % primerov pa smo registrirali samo na osnovi zdravniškega poročila o vzroku smrti. Ta zadnji odstotek, ki je že več let podoben, kaže bolnike, ki verjetno zaradi starosti ali na- predovale bolezni niso bili zdravljeni v bolnišni- ci. Kakšna je bila morfološka slika malignomov pri 9294 primerih, pri katerih je bila diagnoza potrjena mikroskopsko, kaže sedanja tabela 7. Figures 6-11, maps on incidence of head and neck and stomach cancer as well as malig- nant melanoma by statistical regions are pre- sented. Along with the maps on crude and cumulative rates in the years 1999-2003, trends in incidence by stage and age specific rates are presented. In figure 12, five-year relative survival of all and selected cancer sites in patients diagnosed in 1998-2002 is presented along with the same survival in patients, diagnosed in 1993-1997 (as presented in the publication Cancer Patients’ Survival in Slovenia 1983-1997). In all male can- cer patients the relative five-year survival increased for 9 %, partially also due to better registration of prostate cancer cases with less advanced stage at diagnosis, who have better prognosis. In these patients the five-year relative survival increased for 21 %. Nine-percent better five-year relative survival of colon cancer patients and 8 % increase in survival in rectal cancer patients is real, reflecting earlier diag- nosis and better surgical and medical oncolo- gy treatment. In all female cancer patients the five-year relative survival increased for 6 %. In colon cancer patients the relative survival increased for 9 % and in breast cancer patients for 8 %. Tables show the data on population and on cancer incidence in Slovenia in 2003 by sex, age, primary site, histology, stage of the disease at diagnosis, on the incidence in the individual statistical regions, and on new cancer cases diagnosed in the current year in different hos- pitals in Slovenia, on deaths and on preva- lence of most frequent cancer sites. This year, Table 3 is new and presents data that have been till last year separated in table 3 and table 7. It shows data on basis of diagno- sis of new cancer cases that were registered in 2003. From 9997 new cancer cases, in 93 % the diagnosis was confirmed microscopically (by histology or cytology), in 6 % with other investi- gations and 1 % was registered from death certificate only. This letter percentage has been similar for several years and represents those patients that, due to advanced age or disease have not been treated in the hospital. The morphology of tumours in 9294 cases, diagnosed microscopically, is presented in Table 7. In this table, cases confirmed by histol- ogy (90%) and by cytology only (10%) are pre- sented separately. In Table 4b, the diagnoses are coded according to the 8th revision of International Classification of Diseases. According to this classification, 9926 new cancer cases were registered. The dif- ference of 71 cases is due to new morphology classification of the third revision of International Classification of Diseases for Oncology. Table 5 shows crude and age specific inci- dence rate per 100.000 population and cumu- lative rate per 100. For calculation of crude rate, the Slovenian population on June 30, 2003 was used. In Table 6a, the number of new cases of all and selected cancer sites by different statistical regions is presented. These numbers are impor- tant for planning health care facilities. The age standardised rates in Table 6b indicate that the majority of the differences are due to different age structure of population in these regions. Age distribution of extranodal and nodal sites of non-Hodgkin malignant lymphomas is pre- sented in Table 8. Owing to a small number of extranodal sites, only the absolute numbers are given. From Table 9 it is evident, in which hospitals cancer cases are diagnosed. Observations of many years show that half of the patients diag- nosed or initially treated in regional hospitals are later on referred to the Institute of Oncology Ljubljana. A simplified definition of stages at diagnosis is presented in Table 10. The simplified definition is based on all investigation methods, including surgery. In case the patient was not treated before death, the autopsy record is considered as well. The simplified stage definition is used because, in cancer notification forms, the data on stage according to TNM Classification System are often lacking. However in solid tumours, the simplified stage definition often fol- lows the TNM Classification. Localised stage includes all cancers where the tumour has been classified as T1 and T2 (except in breast, malignant melanoma and thyroid cancer, where T3 is also included, and uterine cervix, uterine corpus and sarcomas, where T1 only is V njej so posebej primeri, ki so potrjeni histolo- ško (90 %) in tisti, ki so bili potrjeni samo citolo- ško (10 %). Po 8. reviziji MKB, po kateri so raki razvrščeni v tabeli 4b, je novih primerov raka 9926. Razlika za 71 primerov je posledica novega razvršča- nja neoplazem glede na tretjo izdajo morfolo- škega dela Mednarodne klasifikacije bolezni za onkologijo. Tabela 5 prikazuje grobo in starostno specifič- no incidenčno stopnjo na 100.000 prebivalcev ter kumulativno stopnjo na 100. Število vseh novih primerov raka iz leta 2003 je preraču- nano na število prebivalcev R Slovenije na dan 30. junija 2003. V tabeli 6a je število novih primerov vseh in izbranih rakov prikazano po statističnih regijah. Te številke so pomembne za načrtovanje zdravstvenih zmogljivosti. V tabeli 6b starostno standardizirana incidenca kaže, da so razlike med regijami tudi posledica različnega deleža starejših. Tabela 8 kaže starostno porazdelitev ekstrano- dalnih in nodalnih lokacij ne-Hodgkinovih malignih limfomov. Ker je število ekstranodalnih lokacij majhno, so prikazane le absolutne šte- vilke. Iz tabele 9 je razvidno, kje vse bolnikom posta- vijo diagnozo. Tako kot že vrsto let, polovica od vseh bolnikov z rakom, ki jim diagnozo postavijo v slovenskih bolnišnicah ali jih tam tudi začnejo zdraviti, v nadaljnjem poteku bolezni pride na posvet ali na zdravljenje na Onkološki inštitut. Tabela 10 prikazuje porazdelitev bolnikov po stadiju, v katerem je bila bolezen odkrita. Upora- bljena je poenostavljena opredelitev stadijev, ki upošteva vse preiskovalne metode, vključno operacijo; če bolnik ni bil poprej zdravljen, tudi obdukcijo. Uporabljamo in navajamo jo zato, ker so podatki o stadiju bolezni po klasifikaciji TNM na prijavnicah pogosto pomanjkljivi. Poenostavljena opredelitev stadijev pri solidnih tumorjih praviloma sledi klasifikaciji TNM. V omejeni stadij je razvrščena bolezen, kjer je tumor označen kot Tl in T2 (razen pri dojki, malignem melanomu in ščitnici, kjer so vključeni tudi tumorji T3, in materničnem vratu, telesu in sarkomih, kjer so vključeni le tumorji T1) in pri kateri niso prizadete regionarne bezgavke in ni 12 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo zasevkov v oddaljenih organih (N0, M0). V stadi- ju regionarne razširitve je bolezen, kjer je tumor opredeljen kot T3 in T4 (razen v omenjenih izje- mah) in/ali so prizadete tudi regionarne bez- gavke (N 1), zasevkov v oddaljenih bezgavkah in organih pa ni (M0). V stadiju oddaljene razši- ritve pa je tista bolezen, pri kateri so zasevki že v oddaljenih bezgavkah ali organih (M 1). Maligni limfomi so opredeljeni po klasifikaciji Ann-Arbor. V tabeli 11 so uradni podatki o umrljivosti za rakom. Tabelo so pripravili na Inštitutu za varo- vanje zdravja RS. Tabela 12 prikazuje prevalenco vseh in pogo- stejših rakov na dan 31. 12. 2003. included), where neither regional node involve- ment nor distant metastases are found (N0, MO). The regional stage includes tumours classified as T3 and T4 (exceptions already mentioned) and/or regional node metastases (N 1), if no metastases in distant lymph nodes or organs (MO) are found. The disease with metastases in distant nodes or organs is classified as the remote stage (M 1). Malignant lymphomas are classified according to AnnArbor System. Official data on cancer mortality are given in Table 11. The table has been prepared at the Institute of Public Health of the Republic of Slovenia. Data on prevalence of all and most frequent cancers on December 31, 2003 are presented in Table 12. Cancer Incidence in Slovenia 2003 13 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Onkološki inštitut Ljubljana, Register raka za Slovenijo 14 Incidenca raka v Sloveniji 2003 ZAHVALA Zdravniki, medicinske sestre in administrativno osebje iz slovenskih bolnišnic in drugih zdrav- stvenih ustanov so Registru pošiljali Prijavnice s podatki o novih bolnikih z rakom in njihovi nadaljnji usodi in nam pomagali dopolnjevati prijave z manjkajočimi informacijami. Vsaj polovico podatkov, obdelanih v tem poro- čilu, sta prispevali sodelavki Bolnišničnega regi- stra Onkološkega inštituta v Ljubljani Ana Dotzauer in Maruška Ferjančič. Naše delo bi bilo bistveno težje brez dolgolet- nega sodelovanja s Centralnim Registrom pre- bivalstva RS, z Inštitutom za varovanje zdravja RS in Statističnim uradom RS. Vsem imenovanim in tudi drugim, ki so kakor- koli prispevali, da smo lahko prikazali rezultate našega dela v tem poročilu, se najlepše zahvaljujemo. Uredniški odbor ACKNOWLEDGEMENT Physicians, nurses, and administrative staff from Slovenian hospitals and other health institutions have provided the data on new cancer patients and their medical history as well as helped us in obtaining additional information when needed. Our co-workers at the Hospital Registry of the Institute of Oncology, Mrs. Ana Dotzauer and Maruška Ferjančič have contributed at least a half of the information presented in this report. The long-term collaboration with the Population Registry of the Republic of Slovenia, the Institute of Public Health of the Republic of Slovenia and the Statistical Office of the Republic of Slovenia is indispensable for our work. We thank all of them as well as to all others who have helped to present the results of our work in this report. Editors Cancer Incidence in Slovenia 2003 15 Institute of Oncology Ljubljana, Cancer Registry of Slovenia REFERENCE / References – Ravnihar B, Gruden I. Statističen pregled in kratka analiza prijavljenih rakovnih obolenj iz področja LRS za leto 1950. Zdrav Vestn 1951; 20: 264-77. – Epidemiological and Vital Statistics Report. Geneva: World Health Organization, 1961-1966. – World Health Statistics Report. Geneva: World Health Organization, 1970-1974. – Rak v Sloveniji (1965-77). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 1967-1980. – Incidenca raka v Sloveniji (1978-2000). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 1981-2003. – Doll R, Payne P, Waterhouse J, eds. Cancer inci- dence in five continents. Vol 1. Berlin: Springer, 1966. – Doll R, Muir C, Waterhouse J, eds. Cancer inci- dence in five continents. Vol 2. Lyon: International Agency for Research on Cancer, 1970. – Waterhouse J, Muir C, Correa C, Powell J, eds. Cancer incidence in five continents. Vol 3. Lyon: International Agency for Research on Cancer, 1976 (IARC Sci Publ 15). – Waterhouse J, Muir C, Shanmugaratnam K, Powell J, eds. Cancer incidence in five continents. Vol 4. Lyon: International Agency for Research on Cancer, 1982 (IARC Sci Publ 42). – Muir C, Waterhouse J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. Vol 5. Lyon: International Agency for Research on Cancer, 1987 (IARC Sci Publ 88). – Parkin DM, Muir C, Whelan S, Gao Y, Ferlay J, Powell J, eds. Cancer incidence in five continents Lyon. Vol 6. International Agency for Research on Cancer, 1992 (IARC Sci Publ 120). – Parkin DM, Whelan S, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents. Vol 7. Lyon: International Agency for Research on Cancer, 1997 (IARC Sci Publ 143). – Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer incidence in five continents. Vol 8. Lyon: International Agency for Research on Cancer, 2002 (IARC Sci Publ 155). – European Network of Cancer Registries. EUROCIM version 4.0. European incidence database V2.4, ICD-10 dictionary (2003), Lyon 2001. – Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. Version 1.0. IARC CancerBase No. 5. Lyon: IARC Press, 2001. – Šteliarova-Foucher E, Berrino F, Coebergh JW et al. ACCISpass 1.01 software for analysis and presen- tation of data on incidence and survival of chil- dren and adolescents in Europe. Lyon: ENCR, 2002. – Berrino F, Capocaccia R, Esteve J et al, eds. Survival of cancer patients in Europe: the EUROCARE-2 study. Lyon: International Agency for Research on Cancer, 1999. – Berrino F, Capocaccia R, Gatta G et al, eds. Survival of cancer patients in Europe: the EURO- CARE-3 study. Ann Oncol 2003: 14 (Suppl 5). – Pompe-Kirn V, Primic-Žakelj M, Ferligoj A, Škrk J. Zemljevidi incidence raka v Sloveniji 1978-1987 (Atlas of Cancer Incidence in Slovenia 1978-1987). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 1992. – Pompe-Kirn V, Zakotnik B, Benulič T, Volk N, Škrk J. Preživetje bolnikov z rakom v Sloveniji 1963-1990 (Cancer Patients’ Survival in Slovenia 1963-1990). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 1995. – Pompe-Kirn V, Zakotnik B, Zadnik V. Preživetje bol- nikov z rakom v Sloveniji 1983-1997 (Cancer Patients’ Survival in Slovenia 1983-1997). Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2003. – Savezni zavod za zdravstvenu zaštitu. Međunarodna klasifikacija bolesti, povreda i uzroka smrti. 8. revizija. Novi sad: Savezni zavod za zdravstvenu zaštitu, 1970. – Inštitut za varovanje zdravja RS. Mednarodna klasi- fikacija bolezni in sorodnih zdravstvenih problemov za statistične namene. 10. revizija (International Statistical Classification of Diseaseses and Related health Problems). Ljubljana: Inštitut za varovanje zdravja, 1995. – World Health Organisation. International Calssifi- cation of Diseases for Oncology. Geneva: World Health Organisation, 2000. – Uredba o standardni klasifikaciji teritorialnih enot – SKTE. Ur. l. RS št. 28/2000. – Moller B, Fekjaer H, Hakulinen T et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med 2003; 15: 2751-66. – Jensen OM, Parkin M et al, eds. Cancer registra- tion principles and methods. Lyon: International Agency for Research on Cancer, 1991. (IARC Sci Publ 95). – Statistični letopis republike Slovenije 2004. Ljubljana: Statistični urad Republike Slovenije, 2005. Onkološki inštitut Ljubljana, Register raka za Slovenijo 16 Incidenca raka v Sloveniji 2003 Tabela A. Breme raka - Slovenija 2003 Table A. Cancer burden - Slovenia 2003 Tabela B. Prevalenca glede na obdobje opazovanja - Slovenija, 31. 12. 2003 Table B. Prevalence by period of observation - Slovenia, December 31, 2003 Skupaj Moški Ženske Total Males Females Incidenca 9997 5026 4971Incidence Umrljivost 5058 2817 2241Mortality Prevalenca 57108 22382 34726Prevalence Od tega izgubljenih Lost to follow-up Obdobje Število bolnikov Število Odstotek Period Number of patients Number Percentage 1950-2003 57105 2430 4,3 1964-2003 55526 1354 2,4 1974-2003 53577 928 1,7 1984-2003 48780 371 0,8 1994-2003 37508 86 0,2 Tabela C. Stabilnost podatkov - število in odstotek novih primerov raka, prijavljenih po izdaji letnega poročila, po obdobju - Slovenija, 1965-2002 Table C. Data stability - number and percentage of new cases reported after the publication of annual reports, by time period - Slovenia, 1965-2002 Naknadno prijavljeni Subsequently registered Obdobje Letno poročilo 12. 4. 2006 Število Odstotek Period Annual report April 12, 2006 Number Percentage 1965-68 14696 14844 148 1,0 1969-72 15719 16170 451 2,9 1973-76 17711 18275 564 3,2 1977-80 19176 19895 719 3,7 1981-84 20701 21417 716 3,5 1985-88 22715 23374 659 2,9 1989-92 25973 26697 724 2,8 1993-96 29141 30411 1270 4,4 1997-00 33859 35219 1360 4,0 2001-02 18414 19192 778 4,2 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 17 Tabela D: Opazovana in napovedana incidenca raka v Sloveniji v obdobju 1994-2006 Table D. Observed and predicted cancer incidence in Slovenia in the period1994-2006 Šifra Primarna Opazovane Opazovane Napovedane vrednosti MKB lokacija vrednosti 1994-1998 vrednosti 1999-2003 za 2006 Spol Število Incidenčna Število Incidenčna Število Incidenčna stopnja stopnja stopnja na 100.000 na 100.000 na 100.000 ICD Primary Sex Observed Observed Predicted values code site values 1994-1998 values 1999-2003 for 2006 Number Incidence rate Number Incidence rate Number Incidence rate per 100,000 per 100,000 per 100,000 Skupaj 8046 406,4 9421 473,7 10223 511,4 C00 Vse lokacije Total – Moški 4083 424,9 4808 495,4 5280 538,7 C96 All sites MaleŽenske 3963 387,8 4612 452,1 4943 484,1Female C00 Usta in žrelo M 265 27,6 256 26,4 261 26,6 -C14 Mouth and pharynx Ž 42 4,1 56 5,5 58 5,7 C15 Požiralnik M 76 7,9 78 8,0 83 8,5Oesophagus Ž 14 1,4 19 1,9 22 2,2 C16 Želodec M 294 30,6 291 30,0 313 31,9Stomach Ž 204 20,0 183 17,9 199 19,5 C18 Debelo črevo M 253 26,4 340 35,0 378 38,6Colon Ž 243 23,7 281 27,5 306 30,0 Rektum in rektosigmoidna C19 zveza M 251 26,1 291 30,0 320 32,7 -C20 Rectum and Ž 196 19,2 213 20,9 229 22,4 rectosigmoid junction C22 Jetra in intrahepatični vodi M 65 6,7 82 8,5 90 9,2Liver and intrahepatic bile ducts Ž 36 3,5 39 3,9 42 4,1 C23 Žolčnik in žolčevodi M 40 4,2 52 5,4 56 5,7 -C24 Gallbladder and billiary tract Ž 72 7,1 77 7,6 80 7,8 C25 Trebušna slinavka M 93 9,6 120 12,4 131 13,4Pancreas Ž 105 10,3 118 11,5 130 12,7 C32 Grlo M 97 10,1 102 10,5 112 11,4Larynx Ž 9 0,9 10 1,0 11 1,1 C33 Sapnik, sapnici in pljuča M 812 84,5 822 84,7 891 90,9 -C34 Trachea, bronchus and lung Ž 184 18,0 254 24,9 272 26,6 C43 Maligni melanom kože M 93 9,7 129 13,3 142 14,5Malignant melanoma of skin Ž 109 10,7 143 14,0 150 14,7 C44 Druge maligne neoplazme kože M 413 43,0 609 62,8 689 70,3Skin, other malignomas Ž 476 46,6 676 66,3 742 72,7 C48 Vezivno in mehko tkivo M 23 2,4 25 2,6 29 3,0 -C49 Connective and soft tissue Ž 25 2,5 27 2,6 28 2,7 C50 Dojka M 8 0,8 10 1,0 11 1,1Breast Ž 848 82,9 1013 99,3 1058 103,6 C53 Maternični vrat M – – – – – –Cervix uteri Ž 211 20,6 202 19,8 206 20,2 C54 Maternično telo M – – – – – –Corpus uteri Ž 256 25,0 281 27,5 300 29,4 C56 Jajčnik M – – – – – –Ovary Ž 179 17,5 179 17,5 186 18,2 C61 Prostata M 400 41,7 587 60,5 697 71,1Prostate Ž – – – – – – C62 Modo M 67 7,0 91 9,4 89 9,1Testis Ž – – – – – – C64 Ledvica z ledvičnim mehom M 122 12,7 133 13,7 147 15,0 -C65 Kidney with renal pelvis Ž 76 7,4 78 7,7 79 7,7 C67 Sečni mehur M 147 15,3 162 16,6 178 18,2Bladder Ž 51 5,0 59 5,8 64 6,3 C70 Centralni in avtonomni živčni sistem M 54 5,6 71 7,3 72 7,3 -C72 Central and autonomic Ž 49 4,8 58 5,7 64 6,3 nervous system C73 Ščitnica M 16 1,6 25 2,6 25 2,6Thyroid gland Ž 54 5,3 73 7,2 76 7,4 C81 Hodgkinova bolezen M 21 2,2 22 2,2 24 2,4Hodgkin's disease Ž 19 1,9 22 2,2 23 2,3 C82 ne-Hodgkinovi limfomi M 95 9,9 104 10,7 117 11,9 -C85 non-Hodgkin's lymphoma Ž 99 9,7 117 11,5 126 12,3 Difuzni plazmocitom in maligne neoplazme plazmocitov M 31 3,2 39 4,0 41 4,2C90 Multiple myeloma and Ž 40 3,9 45 4,4 48 4,7 malignant plasma cell neoplasms C91 Levkemije M 100 10,4 105 10,9 111 11,3 -C95 Leukaemias Ž 45 4,4 47 4,6 44 4,3 Onkološki inštitut Ljubljana, Register raka za Slovenijo 18 Incidenca raka v Sloveniji 2003 Slika 1. Najpogostejše rakave bolezni po spolu - Slovenija 2003 Figure 1. The leading cancer sites by sex - Slovenia 2003 * Pojasnilo – Explantion Debelo črevo in danka – Colorectum: C18-C20 Glava in vrat – Head and neck: C00-C14, C30-C32 NHL: ne-Hodgkinovi limfomi – NHL: non-Hodkgin's lymphoma: C82-C85 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 19 Slika 3. Najpogostejše rakave bolezni po starostnih skupinah in spolu - Slovenija 2000-2003 Figure 3. The leading cancer sites by age groups and sex - Slovenia 2000-2003 Slika 2. Odstotni delež vseh rakov po starostnih skupinah in spolu - Slovenija 2003 Figure 2. Percentage distribution of all cancer sites by age groups and sex - Slovenia 2003 nadaljevanje / cont’d ➝ 20 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Slika 3. – Figure 3. Nadaljevanje – Continued nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2003 21 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Slika 3. – Figure 3. Nadaljevanje – Continued * Pojasnilo – Explanation Glava in vrat - Head and neck : C00-C14, C30-C32 Debelo črevo in danka - Colorectum: C18-C20 Sapnik, sapnici in pljuča - Trachea, bronchus and lung: C33-C34 Kosti in sklepni hrustanec - Bone and articular cartilage: C40-C41 Vezivno in mehko tkivo - Connective and soft tissue: C48-C49 Ledvica z ledvičnim mehom - Kidney with renal pelvis: C64-C65 Centralni in avtonomni živčni sistem - Central and autonomic nervous system: C70-C72 ne-Hodgkinovi limfomi - non-Hodgkin's lymphoma: C82-C85 Levkemije - Leukaemias: C91-C95 Onkološki inštitut Ljubljana, Register raka za Slovenijo 22 Incidenca raka v Sloveniji 2003 Slika 4. Groba in kumulativna letna incidenca vseh rakov po spolu - Slovenija 1950-2003 Figure 4. Crude and cumulative annual cancer incidence; all sites by sex - Slovenia 1950-2003 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 23 Slika 5. Groba letna incidenca izbranih rakov po spolu - Slovenija 1950-2003 Figure 5. Crude annual cancer incidence by selected primary sites and sex - Slovenia 1950-2003 MOŠKI – MALES ŽENSKE – FEMALES Onkološki inštitut Ljubljana, Register raka za Slovenijo 24 Incidenca raka v Sloveniji 2003 Povprečne letne kumulativne incidenčne stopnje 1999–2003 Glava in vrat - moški Head and neck - males MKB-10/ICD-10 : C00-C14, C30-C32 Povprečne letne grobe incidenčne stopnje 1999–2003 Povprečne letne starostno specifične incidenčne stopnje 1999-2003 Slike 6 - Figures 6 Slovenija 3,0 /100 2,60 – 3,04 3,05 – 3,48 3,49 – 3,92 3,93 – 4,36 4,37 – 4,80 Delež bolnikov odkritih po posameznih stadijih, 1973-2003 Slovenija 38,10 / 100.000 31,10 – 36,72 36,73 – 42,34 42,35 – 47,96 47,97 – 53,58 53,59 – 59,20 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 25 Average annual cumulative incidence rates 1999–2003 Glava in vrat - ženske Head and neck - females MKB-10/ICD-10 : C00-C14, C30-C32 Average annual crude incidence rates 1999–2003 Average annual age specific incidence rates 1999-2003 Slike 7 - Figures 7 Slovenia 0.2 /100 0.00 – 0.14 0.15 – 0.28 0.29 – 0.42 0.43 – 0.56 0.57 – 0.70 Slovenia 7.10 /100,000 3.10 – 4.32 4.33 – 5.54 5.55 – 6.76 6.77 – 7.98 7.99 – 9.20 Percentage of patients by stage at diagnosis, 1973-2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Povprečne letne kumulativne incidenčne stopnje 1999–2003 26 Incidenca raka v Sloveniji 2003 Želodec - moški Stomach - males MKB-10/ICD-10 : C16 Povprečne letne grobe incidenčne stopnje 1999–2003 Povprečne letne starostno specifične incidenčne stopnje 1999-2003 Slike 8 - Figures 8 Slovenija 2,4 /100 1,60 – 1,94 1,95 – 2,28 2,29 – 2,62 2,63 – 2,96 2,97 – 3,30 Delež bolnikov odkritih po posameznih stadijih, 1973-2003 Slovenija 30,00 /100.000 21,70 – 25,36 25,37 – 29,02 29,03 – 32,68 32,69 – 36,34 36,35 – 40,00 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 27 Average annual cumulative incidence rates 1999–2003 Želodec - ženske Stomach - females MKB-10/ICD-10 : C16 Average annual crude incidence rates 1999–2003 Average annual age specific incidence rates 1999-2003 Slike 9 - Figures 9 Slovenia 1.0 /100 0.60 – 0.74 0.75 – 0.88 0.89 – 1.02 1.03 – 1.16 1.17 – 1.30 Slovenia 17.90 /100,000 12.50 – 14.58 14.59 – 16.66 16.67 – 18.74 18.75 – 20.82 20.83 – 22.90 Percentage of patients by stage at diagnosis, 1973-2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo 28 Incidenca raka v Sloveniji 2003 Povprečne letne kumulativne incidenčne stopnje 1999–2003 Maligni melanom - moški Malignant melanoma - males MKB-10/ICD-10 : C43 Povprečne letne grobe incidenčne stopnje 1999–2003 Povprečne letne starostno specifične incidenčne stopnje 1999-2003 Slike 10 - Figures 10 Slovenija 1,0 /100 0,70 – 0,86 0,87 – 1,02 1,03 – 1,18 1,19 – 1,34 1,35 – 1,50 Delež bolnikov odkritih po posameznih stadijih, 1973-2003 Slovenija 13,30 /100.000 9,20 – 11,06 11,07 – 12,92 12,93 – 14,78 14,79 – 16,64 16,65 – 18,50 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 29 Average annual cumulative incidence rates 1999–2003 Maligni melanom - ženske Malignant melanoma - females MKB-10/ICD-10 : C43 Average annual crude incidence rates 1999–2003 Average annual age specific incidence rates 1999-2003 Slike 11 - Figures 11 Slovenia 0.9 /100 0.40 – 0.60 0.61 – 0.80 0.81 – 1.00 1.01 – 1.20 1.21 – 1.41 Slovenia 14.00 /100,000 6.70 – 9.74 9.75 – 12.78 12.79 – 15.82 15.83 – 18.86 18.87 – 21.90 Percentage of patients by stage at diagnosis, 1973-2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo 30 Incidenca raka v Sloveniji 2003 MOŠKI – MALES Slika 12. Relativno 5-letno preživetje bolnikov z izbranimi raki po spolu, zbolelih v letih 1998-2002 in 1993-1997 Figure 12. Five year relative survival for selected cancer sites by sex in periods 1998-2002 and 1993-1997 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 31 Slika 12. – Figure 12. Nadaljevanje – Continued ŽENSKE – FEMALES Tabela 1. Prebivalstvo Slovenije po starosti in spolu na dan 30. junija 2003* Table 1. Population of Slovenia by age and sex on June 30, 2003* Starost Skupaj Moški Ženske Age Total Males Females 0 - 4 89184 46068 43116 5 - 9 95502 49033 46469 10 - 14 110162 56630 53532 15 - 19 129624 66337 63287 20 - 24 148275 76499 71776 25 - 29 150526 77941 72585 30 - 34 143089 73240 69849 35 - 39 154881 78062 76819 40 - 44 154936 78944 75992 45 - 49 159366 81961 77405 50 - 54 148629 76489 72140 55 - 59 109152 54179 54973 60 - 64 106304 50669 55635 65 - 69 94886 42504 52382 70 - 74 85194 34140 51054 75 - 79 62022 20207 41815 80+ 55041 14533 40508 Vse starosti Total 1996773 977436 1019337 *Vir: Statistični urad Republike Slovenije Source: Statistical Office of the Republic of Slovenia 32 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 2. Prebivalstvo Slovenije po statističnih regijah po spolu na dan 30. junija 2003* Table 2. Population of Slovenia by statistical regions by sex on June 30, 2003* Statistična regija Skupaj Moški Ženske Health region Total Males Females Gorenjska 197904 96686 101218 Goriška 119754 58992 60762 JV Slovenija 138274 68516 69758 Koroška 73855 36815 37040 Notranjsko-kraška 50855 25214 25641 Obalno-kraška 105058 51954 53104 Osrednjeslovenska 494117 239405 254712 Podravska 319474 155883 163591 Pomurska 123335 59755 63580 Savinjska 257402 126673 130729 Spodnjesavska 70860 35176 35684 Zasavska 45885 22367 23518 Slovenija Skupaj 1996773 977436 1019337 Total *Vir: Statistični urad Republike Slovenije Source: Statistical Office of the Republic of Slovenia Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 33 34 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 3. Število novih primerov raka, število in odstotek mikroskopsko potrjenih primerov, število in odstotek primerov, ugotovljenih z drugimi preiskavami in število in odstotek registriranih samo iz zdravniških poročil o vzroku smrti, po lokaciji in spolu - Slovenija 2003 Table 3. Total number of new cancer cases, number and percentage of microscopically confirmed cases, number and percentage of cases confirmed by other investigations, and number and percentage of cases registered from death certificates only, by site and sex - Slovenia 2003 Šifra Spol Število Mikroskopsko Ugotovljeni Registrirani MKB* Primarna lokacija novih potrjeni z drugimi samo iz zdrav- primerov primeri preiskavami niških poročil o vzroku smrti Število (%**) Število (%**) Število (%**) Number Microscopically Confirmed Registered from of new confirmed by other death certifi- ICD Sex cases cases investigations cates only code* Primary site Number (%**) Number (%**) Number (%**) C00 Vse lokacije M+Ž 9997 9294 (93) 566 (6) 137 (1) – M 5026 4626 (92) 339 (7) 61 (1) C96 All sites Ž 4971 4668 (94) 227 (5) 76 (2) C00 Ustnica M 17 16 (94) 0 (0) 1 (6) Lip Ž 6 6 0 0 C01 Baza jezika M 13 13 0 0 Base of tongue Ž 4 4 0 0 C02 Jezik, drugi deli M 20 20 (100) 0 (0) 0 (0) Tongue, other & unspecified parts Ž 4 4 0 0 C03 Dlesen M 3 3 0 0 Gum Ž 5 5 0 0 C04 Ustno dno M 31 31 (100) 0 (0) 0 (0) Floor of mouth Ž 8 8 0 0 C05 Nebo M 12 12 0 0 Palate Ž 0 0 0 0 C06 Usta, drugi deli M 21 21 (100) 0 (0) 0 (0) Mouth, other & unspecified parts Ž 2 2 0 0 C07 Parotidna žleza M 4 4 0 0 Parotid gland Ž 6 6 0 0 C08 Druge in neopredeljene velike M 2 2 0 0 žleze slinavke Other & unspecified major salivary glands Ž 0 0 0 0 C09 Tonzila M 20 20 (100) 0 (0) 0 (0) Tonsil Ž 6 6 0 0 C10 Orofarinks M 47 47 (100) 0 (0) 0 (0) Oropharynx Ž 6 6 0 0 C11 Nazofarinks M 3 3 0 0 Nasopharynx Ž 2 2 0 0 C12 Piriformni sinus M 16 16 (100) 0 (0) 0 (0) Pyriform sinus Ž 1 1 0 0 C13 Hipofarinks M 19 18 (95) 1 (5) 0 (0) Hypopharynx Ž 3 3 0 0 C14 Druga in slabo opredeljena mesta na ustnici, v ustni votlini in farinksu M 1 1 0 0 Other and ill-defined sites in the lip, Ž 1 0 0 1 oral cavity and pharynx Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Spol Število Mikroskopsko Ugotovljeni Registrirani MKB* Primarna lokacija novih potrjeni z drugimi samo iz zdrav- primerov primeri preiskavami niških poročil o vzroku smrti Število (%**) Število (%**) Število (%**) Number Microscopically Confirmed Registered from of new confirmed by other death certifi- ICD Sex cases cases investigations cates only code* Primary site Number (%**) Number (%**) Number (%**) C15 Požiralnik M 79 72 (91) 5 (6) 2 (3) Oesophagus Ž 20 17 (85) 0 (0) 3 (15) C16 Želodec M 284 268 (94) 11 (4) 5 (2) Stomach Ž 191 179 (94) 7 (4) 5 (3) C17 Tanko črevo M 11 11 0 0 Small intestine Ž 5 5 0 0 C18 Debelo črevo M 361 349 (97) 10 (3) 2 (1) Colon Ž 295 274 (93) 15 (5) 6 (2) C19 Rektosigmoidna zveza M 53 49 (92) 4 (8) 0 (0) Rectosigmoid junction Ž 45 41 (91) 3 (7) 1 (2) C20 Rektum M 259 250 (97) 8 (3) 1 (0) Rectum Ž 185 174 (94) 6 (3) 5 (3) C21 Anus in analni kanal M 11 11 0 0 Anus and anal canal Ž 6 6 0 0 C22 Jetra in intrahepatični vodi M 79 49 (62) 28 (35) 2 (3) Liver and intrahepatic bile ducts Ž 55 31 (56) 17 (31) 7 (13) C23 Žolčnik M 15 9 (60) 6 (40) 0 (0) Gallbladder Ž 27 18 (67) 5 (19) 4 (15) C24 Drugi in neopredeljeni deli M 37 23 (62) 14 (38) 0 (0) biliarnega trakta Billiary tract, other and unspecified parts Ž 22 14 (64) 8 (36) 0 (0) C25 Trebušna slinavka M 126 67 (53) 49 (39) 10 (8) Pancreas Ž 109 58 (53) 47 (43) 4 (4) C26 Druga in slabo opredeljena mesta M 0 0 0 0 v prebavnih organih Other and ill-defined digestive organs Ž 4 2 1 1 C30 Nosna votlina in srednje uho M 1 1 0 0 Nasal cavity and middle ear Ž 1 1 0 0 C31 Obnosni sinusi M 7 7 0 0 Accessory sinuses Ž 4 4 0 0 C32 Grlo M 94 92 (98) 0 (0) 2 (2) Larynx Ž 5 5 0 0 C33 Sapnik M 7 7 0 0 Trachea Ž 0 0 0 0 C34 Sapnica in pljuča M 871 802 (92) 58 (7) 11 (1) Bronchus and lung Ž 280 250 (89) 21 (8) 9 (3) C37 Timus M 1 1 0 0 Thymus Ž 2 2 0 0 Cancer Incidence in Slovenia 2003 35 36 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Spol Število Mikroskopsko Ugotovljeni Registrirani MKB* Primarna lokacija novih potrjeni z drugimi samo iz zdrav- primerov primeri preiskavami niških poročil o vzroku smrti Število (%**) Število (%**) Število (%**) Number Microscopically Confirmed Registered from of new confirmed by other death certifi- ICD Sex cases cases investigations cates only code* Primary site Number (%**) Number (%**) Number (%**) C38 Srce, mediastinum, plevra M 2 2 0 0 Heart, mediastinum, pleura Ž 3 2 1 0 C39 Druga in slabo opredeljena mesta v dihalih in prsnih organih M 0 0 0 0 Other and ill-defined sites in the respiratory Ž 0 0 0 0 system and intrathoracic organs C40 Kosti, sklepni hrustanec udov M 12 12 0 0 Bone and articular cartilage of limbs Ž 8 8 0 0 C41 Kosti, sklepni hrustanec, drugje M 8 8 0 0 Bone and articular cartilage of other and unspecified parts Ž 2 2 0 0 C43 Maligni melanom kože M 167 167 (100) 0 (0) 0 (0) Malignant melanoma of skin Ž 164 164 (100) 0 (0) 0 (0) C44 Druge maligne neoplazme kože M 729 723 (99) 6 (1) 0 (0) Skin, other malignomas Ž 834 830 (100) 4 (0) 0 (0) C45 Mezoteliom M 20 20 (100) 0 (0) 0 (0) Mesothelioma Ž 12 12 0 0 C46 Kaposijev sarkom M 1 1 0 0 Kaposi's sarcoma Ž 0 0 0 0 C47 Periferni živci in avtonomno živčevje M 3 3 0 0 Peripheral nerves and autonomic nervous system Ž 1 1 0 0 C48 Retroperitonej in peritonej M 6 6 0 0 Retroperitoneum and peritoneum Ž 12 12 0 0 C49 Drugo vezivno in mehko tkivo M 18 18 (100) 0 (0) 0 (0) Other connective and soft tissue Ž 21 21 (100) 0 (0) 0 (0) C50 Dojka M 13 13 0 0 Breast Ž 1083 1050 (97) 23 (2) 10 (1) C51 Žensko zunanje spolovilo M – – – – Vulva Ž 56 56 (100) 0 (0) 0 (0) C52 Nožnica M – – – – Vagina Ž 15 15 (100) 0 (0) 0 (0) C53 Maternični vrat M – – – – Cervix uteri Ž 208 207 (100) 1 (0) 0 (0) C54 Maternično telo M – – – – Corpus uteri Ž 285 284 (100) 1 (0) 0 (0) C55 Maternica, neopredeljeno M – – – – Uterus, unspecified part Ž 16 11 (69) 2 (13) 3 (19) C56 Jajčnik M – – – – Ovary Ž 182 177 (97) 4 (2) 1 (1) Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Spol Število Mikroskopsko Ugotovljeni Registrirani MKB* Primarna lokacija novih potrjeni z drugimi samo iz zdrav- primerov primeri preiskavami niških poročil o vzroku smrti Število (%**) Število (%**) Število (%**) Number Microscopically Confirmed Registered from of new confirmed by other death certifi- ICD Sex cases cases investigations cates only code* Primary site Number (%**) Number (%**) Number (%**) C57 Drugi in neopredeljeni ženski spolni organi M – – – – Other & unspecified parts of female genital organs Ž 9 8 0 1 C58 Posteljica M – – – – Placenta Ž 0 0 0 0 C60 Penis M 10 9 1 0 Penis Ž – – – – C61 Prostata M 558 483 (87) 61 (11) 14 (3) Prostate Ž – – – – C62 Modo M 109 109 (100) 0 (0) 0 (0) Testis Ž – – – – C63 Drugi in neopredeljeni moški spolni organi M 2 2 0 0 Other and unspecified male Ž – – – – genital organs C64 Ledvica razen meha M 121 102 (84) 19 (16) 0 (0) Kidney, except renal pelvis Ž 72 60 (83) 12 (17) 0 (0) C65 Ledvični meh M 9 9 0 0 Renal pelvis Ž 7 7 0 0 C66 Sečevod M 4 4 0 0 Ureter Ž 0 0 0 0 C67 Sečni mehur M 164 158 (96) 4 (2) 2 (1) Bladder Ž 63 58 (92) 5 (8) 0 (0) C68 Drugi in neopredeljeni sečni organi M 1 1 0 0 Other and unspecified urinary organs Ž 0 0 0 0 C69 Oko in očesni adneksi M 10 6 3 1 Eye and adnexa Ž 9 4 5 0 C70 Meninge M 3 3 0 0 Meninges Ž 1 1 0 0 C71 Možgani M 56 48 (86) 7 (13) 1 (2) Brain Ž 66 52 (79) 10 (15) 4 (6) C72 Hrbtni mozeg, možganski živci in drugi deli CŽS M 4 2 1 1 Spinal cord, cranial nerves and other parts of CNS Ž 2 1 1 0 C73 Ščitnica M 23 23 (100) 0 (0) 0 (0) Thyroid gland Ž 92 92 (100) 0 (0) 0 (0) C74 Nadledvična žleza M 0 0 0 0 Adrenal gland Ž 1 1 0 0 C75 Druge endokrine žleze in sorodne strukture M 1 1 0 0 Other endocrine glands and related structures Ž 1 1 0 0 Cancer Incidence in Slovenia 2003 37 38 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Spol Število Mikroskopsko Ugotovljeni Registrirani MKB* Primarna lokacija novih potrjeni z drugimi samo iz zdrav- primerov primeri preiskavami niških poročil o vzroku smrti Število (%**) Število (%**) Število (%**) Number Microscopically Confirmed Registered from of new confirmed by other death certifi- ICD Sex cases cases investigations cates only code* Primary site Number (%**) Number (%**) Number (%**) C76 Druga in slabo opredeljena mesta M 3 0 1 2 Other and ill-defined sites Ž 13 7 4 2 C77 Metastaza in neopredeljena maligna neoplazma bezgavk M 17 17 (100) 0 (0) 0 (0) Metastasis and unspecified Ž 10 9 1 0 malignant neoplasm of lymph nodes C78 Metastaze dihal in prebavil M 43 19 (45) 23 (53) 1 (2) Metastases of respiratory and digestive organs Ž 36 27 (75) 9 (25) 0 (0) C79 Metastaze, drugje M 21 12 (57) 9 (43) 0 (0) Metastases of other sites Ž 17 13 (76) 3 (18) 1 (6) Maligna neoplazma brez opredeljenega mesta M 40 29 (73) 9 (23) 2 (5) C80 Malignant neoplasm without Ž 44 28 (64) 10 (23) 6 (14) specification of site C81 Hodgkinova bolezen M 32 32 (100) 0 (0) 0 (0) Hodgkin's disease Ž 22 22 (100) 0 (0) 0 (0) C82 Folikularni ne-Hodgkinov limfom M 16 16 (100) 0 (0) 0 (0) Follicular non-Hodgkin's lymphoma Ž 41 41 (100) 0 (0) 0 (0) C83 Difuzni ne-Hodgkinov limfom M 59 59 (100) 0 (0) 0 (0) Diffuse non-Hodgkin's lymphoma Ž 76 76 (100) 0 (0) 0 (0) C84 Limfomi celic T in kožni limfom celic T M 8 8 0 0 Peripheral and cutaneous T-cell lymphomas Ž 7 7 0 0 C85 Druge in neopredeljene vrste ne-Hodgkinovega limfoma M 12 12 0 0 Other and unspecified types Ž 16 16 (100) 0 (0) 0 (0) of non-Hodgkin's lymphoma C88 Maligne imunoproliferativne bolezni M 2 2 0 0 Malignant immunoproliferative diseases Ž 2 2 0 0 C90 Difuzni plazmocitom in maligne neoplazme plazmocitov M 50 48 (96) 1 (2) 1 (2) Multiple myeloma and malignant plasma Ž 42 41 (98) 1 (2) 0 (0) cell neoplasms C91.0– Limfatična levkemija, akutna M 18 18 (100) 0 (0) 0 (0) Lymphoblastic leukaemia, acute Ž 7 7 0 0 C91.1– Limfatična levkemija, druga M 30 30 (100) 0 (0) 0 (0) C91.9 Lymphoid leukaemia, other Ž 28 26 (93) 0 (0) 2 (7) C92 Mieloična levkemija M 48 48 (100) 0 (0) 0 (0) Myeloid leukaemia Ž 33 33 (100) 0 (0) 0 (0) C93 Monocitna levkemija M 3 3 0 0 Monocytic leukaemia Ž 2 2 0 0 Tabela 3. – Table 3. Nadaljevanje – Continued Šifra Spol Število Mikroskopsko Ugotovljeni Registrirani MKB* Primarna lokacija novih potrjeni z drugimi samo iz zdrav- primerov primeri preiskavami niških poročil o vzroku smrti Število (%**) Število (%**) Število (%**) Number Microscopically Confirmed Registered from of new confirmed by other death certifi- ICD Sex cases cases investigations cates only code* Primary site Number (%**) Number (%**) Number (%**) C94 Druge opredeljene levkemije M 1 1 0 0 Other leukaemias of specified cells Ž 0 0 0 0 C95 Levkemija z neopredeljenim celičnim tipom M 1 1 0 0 Leukaemia, unspecified cell type Ž 3 3 0 0 Druge in neopredeljene maligne neoplazme limfatičnega, C96 krvotvornega in sorodnega tkiva M 43 43 (100) 0 (0) 0 (0) Other and unspecified malignant Ž 37 37 (100) 0 (0) 0 (0) neoplasms of lymphoid, haematopoietic and related tissue Zgoraj neupoštevani Not included above D03 Melanom, in situ M 12 12 0 0 Melanoma, in situ Ž 12 12 0 0 D05 Dojka, in situ M 0 0 0 0 Breast, in situ Ž 84 83 (99) 1 (1) 0 (0) D06 Maternični vrat, in situ (CIN III) M – – – – Cervix uteri, in situ (CIN III) Ž 868 868 (100) 0 (0) 0 (0) D09.0 Karcinom in situ mehurja M 82 82 (100) 0 (0) 0 (0) Bladder, in situ Ž 26 26 (100) 0 (0) 0 (0) D32.0 Meninge, benigna neoplazma M 13 13 0 0 Benign neoplasm of meninges Ž 47 46 (98) 1 (2) 0 (0) D33.0 Možgani, benigna neoplazma M 0 0 0 0 - D33.2 Benign neopasm of brain Ž 1 1 0 0 D39.1 Jajčnik, neopl. negotovega značaja M 0 0 0 0 Ovary, neopl. of uncertain behavior Ž 33 33 (100) 0 (0) 0 (0) D43.0 Možgani, neopredeljeno M 8 3 5 0 - D43.2 Brain, uncertain or unknown Ž 4 1 3 0 * MKB - Mednarodna klasifikacija bolezni, deseta revizija, 1995 ICD - International Classification of Diseases, Tenth Revision, 1995 ** Odstotki niso računani, če je število novih primerov manjše od 15 Percentages are not calculated when number of new cases is less than 15 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Cancer Incidence in Slovenia 2003 39 40 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 4a. Število novih primerov raka po lokaciji (MKB-10), spolu in starosti - Slovenija 2003 Table 4a. Number of new cancer cases by primary site (ICD-10), sex, and age - Slovenia 2003 Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Skupaj 9997 15 12 7 24 42 97 129 215 358 593 847 896 1152 1460 1599 1346 1205 C00 Vse lokacije Total – Moški 5026 9 9 4 15 26 51 55 82 143 249 402 449 663 844 892 633 500 C96 All sites Male Ženske 4971 6 3 3 9 16 46 74 133 215 344 445 447 489 616 707 713 705 Female C00 Ustnica M 17 – – – – – – – – 1 2 – – 1 5 2 3 3Lip Ž 6 – – – – – – 1 – – – – – – – 1 1 3 C01 Baza jezika M 13 – – – – – – – 1 1 2 2 2 2 – 2 1 –Base of tongue Ž 4 – – – – – – – – – – 2 1 – – – – 1 C02 Jezik, drugi deli M 20 – – – – – – – – 1 1 4 4 3 2 1 1 3Tongue, other & Ž 4 – – – – – – – – – – 2 – – 1 – 1 –unspecified parts C03 Dlesen M 3 – – – – – – – – – – – – – 2 1 – –Gum Ž 5 – – – – – – – – – – 1 – – – 1 1 2 C04 Ustno dno M 31 – – – – – – – – 2 5 3 4 7 4 3 3 –Floor of mouth Ž 8 – – – – – – – – 1 2 3 1 – – 1 – – C05 Nebo M 12 – – – 1 – – – – – 1 2 2 2 – 1 1 2Palate Ž – – – – – – – – – – – – – – – – – – C06 Usta, drugi deli M 21 – – – – – – – – 1 2 1 6 6 2 1 1 1Mouth, other & Ž 2 – – – – – – – – – – – – – 1 – – 1unspecified parts C07 Parotidna žleza M 4 – – – – – – – – – – – 2 1 1 – – –Parotid gland Ž 6 – – – – – 1 – – – – – – 1 1 – 2 1 C08 Druge in neopredeljene M 2 – – – – – – – – – – 1 – – 1 – – –velike žleze slinavke Other & unspecified Ž – – – – – – – – – – – – – – – – – – major salivary glands C09 Tonzila M 20 – – – – – – – – 1 1 6 1 4 3 1 3 –Tonsil Ž 6 – – – – – – – – – – 1 – 2 – 2 1 – C10 Orofarinks M 47 – – – – – – – – 4 9 11 2 8 9 2 2 –Oropharynx Ž 6 – – – – – – – – – 2 1 2 – – – – 1 C11 Nazofarinks M 3 – – – – – – – – – 1 – 1 1 – – – –Nasopharynx Ž 2 – – – – – – – – – – – – – 1 – 1 – C12 Piriformni sinus M 16 – – – – – – – – 2 3 5 2 3 – 1 – –Pyriform sinus Ž 1 – – – – – – – – – – 1 – – – – – – C13 Hipofarinks M 19 – – – – – – – – – 1 6 1 1 5 3 2 –Hypopharynx Ž 3 – – – – – – – – – – 1 – 1 – 1 – – C14 Druga in slabo oprede- ljena mesta na ustnici, v ustni votlini in farinksu M 1 – – – – – – – – 1 – – – – – – – – Other and ill-defined sites Ž 1 – – – – – – – – – – – – – – – – 1 in the lip, oral cavity and pharynx C15 Požiralnik M 79 – – – – – – – 1 5 7 9 7 11 17 8 8 6Oesophagus Ž 20 – – – – – – – – 1 1 2 1 – 4 2 5 4 C16 Želodec M 284 – – – 1 – 2 4 2 9 17 17 21 33 53 48 40 37Stomach Ž 191 – – – – – – 1 3 6 9 4 11 9 21 37 50 40 C17 Tanko črevo M 11 – – – – – – – – – 3 1 1 1 – 5 – –Small intestine Ž 5 – – – – – – – – 1 – 1 – – 1 – 1 1 C18 Debelo črevo M 361 – – – 1 – – – 4 4 13 15 29 46 64 75 69 41Colon Ž 295 – – – – – 2 – 2 1 12 25 32 30 39 49 45 58 C19 Rektosigmoidna zveza M 53 – – – – – – – 1 – – 5 3 8 10 13 8 5Rectosigmoid junction Ž 45 – – – – – – – – – 2 1 3 3 11 9 6 10 C20 Rektum M 259 – – – – – – 1 1 6 12 9 25 38 56 50 31 30Rectum Ž 185 – – – – – – – 1 5 5 3 14 26 28 34 33 36 C21 Anus in analni kanal M 11 – – – – – – – – 1 2 – 1 – 1 4 2 –Anus and anal canal Ž 6 – – – – – – – – – 1 – 1 – – 1 1 2 C22 Jetra in intrahepatični vodi M 79 – – – – – – – – 2 5 7 7 14 23 13 6 2Liver and intrahepatic Ž 55 – – – – – – – – 2 2 2 5 5 4 8 14 13bile ducts C23 Žolčnik M 15 – – – – – – – – – – – 1 1 3 2 5 3Gallbladder Ž 27 – – – – – – – – – – – – 4 4 3 6 10 C24 Drugi in neopredeljeni deli biliarnega trakta M 37 – – – – – – – 1 – – 2 4 1 11 8 2 8 Billiary tract, other and Ž 22 – – – – – – – – – – 2 1 1 1 5 8 4 unspecified parts C25 Trebušna slinavka M 126 – – – – – – – 1 3 9 14 13 19 23 17 14 13Pancreas Ž 109 – – – – – – 1 2 1 4 6 3 9 13 20 21 29 Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Tabela 4a. – Table 4a. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Druga in slabo opredeljena mesta v prebavnih organih M – – – – – – – – – – – – – – – – – –C26 Other and ill-defined Ž 4 – – – – – – – – – 1 – – – – – 2 1 digestive organs C30 Nosna votlina in srednje uho M 1 – – – – – – – – – – – – – – – – 1 Nasal cavity and Ž 1 – – – – – – – – – – – – – – – 1 – middle ear C31 Obnosni sinusi M 7 – – – – – – – – 1 – 1 1 1 2 – 1 –Accessory sinuses Ž 4 – – – – – – – 1 – – – – – 2 – – 1 C32 Grlo M 94 – – – – – – – 2 2 9 13 11 14 19 12 5 7Larynx Ž 5 – – – – – – – – 1 – – 2 2 – – – – C33 Sapnik M 7 – – – – – – – – – – 1 2 – 1 2 1 –Trachea Ž – – – – – – – – – – – – – – – – – – C34 Sapnica in pljuča M 871 – – – – – 1 3 2 18 42 90 95 130 155 178 96 61Bronchus and lung Ž 280 – – – 1 – – – 3 8 25 21 29 35 39 52 41 26 C37 Timus M 1 – – – – – – – – – – – – – – – 1 –Thymus Ž 2 – – – – – – – – – – 1 – – 1 – – – C38 Srce, mediastinum, plevra M 2 – – – – – 1 – – – – 1 – – – – – –Heart, mediastinum, pleura Ž 3 2 – – – – – – – – – – – – – – 1 – Druga in slabo oprede- ljena mesta v dihalih C39 in prsnih organih M – – – – – – – – – – – – – – – – – –Other and ill-defined sites Ž – – – – – – – – – – – – – – – – – – in the respiratory system and intrathoracic organs C40 Kosti, sklepni hrustanec udov M 12 – – – 1 2 1 – 1 1 – 2 1 2 1 – – –Bone and articular Ž 8 – – 1 – – – 1 – 1 – 2 1 – – 2 – –cartilage of limbs Kosti, sklepni hrustanec, drugje C41 Bone and articular M 8 – – – 1 – – 1 1 – – 3 1 – – – – 1 cartilage of other and Ž 2 – – – – – – – – – – 1 – – – 1 – – unspecified parts C43 Maligni melanom kože M 167 – – – – 1 2 9 8 12 20 17 12 24 19 19 16 8Malignant melanoma Ž 164 – 1 – 2 3 7 11 8 6 17 19 18 11 11 15 18 17of skin Druge maligne C44 neoplazme kože M 729 – 1 – – – 1 3 10 20 29 63 52 88 106 136 128 92 Skin, other malignomas Ž 834 – – – – 1 1 11 21 19 28 48 66 58 110 138 158 175 C45 Mezoteliom M 20 – – – – – – – – – 4 4 3 2 3 1 1 2Mesothelioma Ž 12 – – – – – – 1 – – – – 1 – 2 2 5 1 C46 Kaposijev sarkom M 1 – – – – – – – – – – – 1 – – – – –Kaposi's sarcoma Ž – – – – – – – – – – – – – – – – – – C47 Periferni živci in avtonomno živčevje M 3 – – – – 1 – 1 – – – – – 1 – – – – Peripheral nerves and Ž 1 – – – – – – – 1 – – – – – – – – – autonomic nervous system C48 Retro- in peritonej M 6 – – – – 1 – – 2 – 2 1 – – – – – –Retro- and peritoneum Ž 12 – – – – – – – – – 1 1 1 3 4 2 – – Drugo vezivno in C49 mehko tkivo M 18 – – 1 1 1 – – 1 – – 3 1 1 1 1 3 4Other connective Ž 21 – – – – 1 1 1 3 1 5 1 – – 2 2 2 2 and soft tissue C50 Dojka M 13 – – – – – – – – 1 – 1 4 2 2 2 1 –Breast Ž 1083 – – – – – 4 19 30 74 120 146 126 128 124 110 107 95 C51 Žensko zunanje spolovilo M – – – – – – – – – – – – – – – – – –Vulva Ž 56 – – – – – – – 3 – 3 3 6 5 10 9 10 7 C52 Nožnica M – – – – – – – – – – – – – – – – – –Vagina Ž 15 – – – – – – – – – 2 – 1 1 3 3 2 3 C53 Maternični vrat M – – – – – – – – – – – – – – – – – –Cervix uteri Ž 208 – – – – 1 12 13 25 39 28 21 19 15 11 9 7 8 C54 Maternično telo M – – – – – – – – – – – – – – – – – –Corpus uteri Ž 285 – – – – 1 – 1 2 10 11 39 38 47 45 38 28 25 C55 Maternica, neopredeljeno M – – – – – – – – – – – – – – – – – –Uterus, unspecified Ž 16 – – – – – – – 1 2 1 1 1 2 2 2 2 2 C56 Jajčnik M – – – – – – – – – – – – – – – – – –Ovary Ž 182 – – – 4 1 1 – 2 4 24 21 21 24 27 25 16 12 Cancer Incidence in Slovenia 2003 41 42 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 4a. – Table 4a. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Drugi in neopredeljeni ženski spolni organi M – – – – – – – – – – – – – – – – – – C57 Other and unspecified parts Ž 9 – – – – – – – – – – – 4 2 – – 1 2 of female genital organs C58 Posteljica M – – – – – – – – – – – – – – – – – –Placenta Ž – – – – – – – – – – – – – – – – – – C60 Penis M 10 – – – – – – – – 1 1 – 2 1 2 1 2 –Penis Ž – – – – – – – – – – – – – – – – – – C61 Prostata M 558 1 – – – – – – – 1 2 17 39 86 112 139 85 76Prostate Ž – – – – – – – – – – – – – – – – – – C62 Modo M 109 – – – 2 12 27 18 27 12 7 1 1 – 1 1 – –Testis Ž – – – – – – – – – – – – – – – – – – C63 Drugi in neopredeljeni moški spolni organi M 2 – – – – – – 1 – – – – – – 1 – – – Other and unspecified Ž – – – – – – – – – – – – – – – – – – male genital organs C64 Ledvica razen meha M 121 1 – – – – 1 1 5 3 6 12 9 18 19 25 13 8Kidney, except renal pelvis Ž 72 1 – – – – 1 – – 1 3 12 3 10 13 11 8 9 C65 Ledvični meh M 9 – – – – – – – – – 1 – – 3 – 1 1 3Renal pelvis Ž 7 – – – – – – – – 1 – – – – 1 1 4 – C66 Sečevod M 4 – – – – – – – – – 2 – 1 – – 1 – –Ureter Ž – – – – – – – – – – – – – – – – – – C67 Sečni mehur M 164 – – – – – – – – – 7 7 14 14 28 35 33 26Bladder Ž 63 – – – – – – – 1 – 1 4 1 6 14 17 6 13 Drugi in neopredeljeni sečni organi M 1 – – – – – – – – – – – – – 1 – – – C68 Other and unspecified Ž – – – – – – – – – – – – – – – – – – urinary organs C69 Oko in očesni adneksi M 10 1 – – – – – – – – – 2 1 1 1 2 2 –Eye and adnexa Ž 9 – – – – – – – 1 1 1 – – 1 3 1 1 – C70 Meninge M 3 – – – – – – – 1 1 – 1 – – – – – –Meninges Ž 1 – – – – – – – – – – 1 – – – – – – C71 Možgani M 56 1 – 1 1 3 1 1 – 1 4 9 13 8 3 6 2 2Brain Ž 66 1 – – – – 3 1 5 4 4 8 4 9 7 10 7 3 Hrbtni mozeg, možganski živci in drugi deli CŽS M 4 – – – 1 – – – – – 1 – – 2 – – – – C72 Spinal cord, cranial nerves Ž 2 – – – – – – – – – – – – – – 2 – – and other parts of CNS C73 Ščitnica M 23 – – – – – 1 – 2 6 2 1 4 2 1 2 1 1Thyroid gland Ž 92 – – – 1 3 4 4 9 9 13 13 7 8 6 7 5 3 C74 Nadledvična žleza M – – – – – – – – – – – – – – – – – –Adrenal gland Ž 1 – – – – – – – – – – – – – – – 1 – C75 Druge endokrine žleze in sorodne strukture M 1 – 1 – – – – – – – – – – – – – – – Other endocrine glands Ž 1 – 1 – – – – – – – – – – – – – – – and related structures Druga in slabo opredeljena mesta M 3 – – – – – – – – – – – – – – 1 – 2C76 Other and ill-defined sites Ž 13 – – – – – – – – 1 1 – 1 – 1 3 3 3 C77 Metastaza in neoprede- ljena maligna neoplazma bezgavk M 17 – – – – – – – 1 – 1 3 3 – 2 3 3 1 Metastasis and unspecified Ž 10 – – – – – – – – – – – – 2 2 3 1 2 malignant neoplasm of lymph nodes Metastaze dihal in prebavil M 43 – – – – – – 1 – 1 – 3 6 4 8 6 7 7 C78 Metastases of respiratory Ž 36 – – – – – 1 – – 1 1 1 2 – 5 5 9 11 and digestive organs C79 Metastaze, drugje M 21 – – – – – – – – 2 – 2 1 1 1 9 2 3Metastases of other sites Ž 17 – – – – – – – – – – – 3 – 2 6 3 3 Maligna neoplazma brez opredeljenega mesta M 40 – – – – – – – – 1 3 3 4 9 8 7 1 4C80 Malignant neoplasm Ž 44 – – – – – – – – 2 2 1 2 5 4 11 8 9 without specification of site C81 Hodgkinova bolezen M 32 1 2 – 1 3 6 3 1 4 1 3 3 1 1 1 1 –Hodgkin's disease Ž 22 – – – – 4 4 1 6 2 – – – 1 3 1 – – Folikularni ne-Hodgkinov limfom M 16 – – – – – – – – 2 3 2 1 4 – 2 1 1C82 Follicular non-Hodgkin's Ž 41 – – 1 – – – 3 – 1 5 7 3 4 3 5 8 1 lymphoma Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 4a. – Table 4a. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Difuzni ne-Hodgkinov limfom M 59 – 3 1 – – 2 2 1 3 – 2 6 9 9 6 7 8C83 Diffuse non-Hodgkin's Ž 76 – – – – – – 3 – 4 1 4 1 2 8 21 15 17 lymphoma C84 Limfomi celic T in kožni limfom celic T M 8 – – – – – 1 1 1 – – – – – 3 1 – 1 Peripheral and cutaneous Ž 7 – – 1 – – – – 1 – – 1 – – 3 – 1 – T-cell lymphomas Druge in neopredeljene vrste ne-Hodgkinovega limfoma M 12 – – 1 – – – – – 1 – – – 1 2 2 3 2C85 Other and unspecified types Ž 16 1 – – – 1 – – – – 2 1 – 2 1 – 3 5 of non-Hodgkin's lymphoma C88 Maligne imunoprolife- rativne bolezni M 2 – – – – – – – – – – – 1 1 – – – – Malignant immunopro- Ž 2 – – – – – – – – – – – – – 2 – – – liferative diseases Difuzni plazmocitom in maligne neoplazme plazmocitov M 50 – – – – – – – – 2 2 8 7 5 12 7 3 4C90 Multiple myeloma and Ž 42 – – – – – – – – – – 2 4 4 6 10 9 7 malignant plasma cell neoplasms C91.0 Limfatična levkemija, akutna M 18 2 1 – 3 1 2 2 – – – – 2 2 3 – – – Lymphoblastic Ž 7 1 1 – – – – – 1 – – 1 – 2 – 1 – – leukaemia, acute C91.1 - Limfatična levkemija, druga M 30 – – – – – – – – – 3 4 2 5 4 4 4 4 C91.9 Lymphoid leukaemia, other Ž 28 – – – – – – – – – – – 3 7 1 – 7 10 C92 Mieloična levkemija M 48 – 1 – 1 1 2 3 2 1 1 1 3 6 11 4 3 8Myeloid leukaemia Ž 33 – – – 1 – 3 1 – 3 2 1 1 2 2 2 9 6 C93 Monocitna levkemija M 3 – – – – – – – – 1 – – – 1 – 1 – –Monocytic leukaemia Ž 2 – – – – – – – – – – – – – – – 2 – C94 Druge opredeljene levkemije M 1 1 – – – – – – – – – – – – – – – – Other leukaemias Ž – – – – – – – – – – – – – – – – – – of specified cells Levkemija z neoprede- ljenim celičnim tipom M 1 1 – – – – – – – – – – – – – – – –C95 Leukaemia, unspecified Ž 3 – – – – – – – – – – – – – 1 1 – 1 cell type Druge in neopredeljene maligne neoplazme limfatičnega, krvotvornega C96 in sorodnega tkiva M 43 – – – – – – – 2 1 – 1 3 3 7 13 4 9Other and unspecified Ž 37 – – – – – 1 – 1 2 2 5 3 – 5 5 5 8 malignant neoplasms of lymphoid, haematopoietic and related tissue Zgoraj neupoštevani Not included above D03 Melanom, in situ M 12 – – – – – – 1 1 1 2 1 2 1 1 1 1 –Melanoma, in situ Ž 12 – – – – – – 2 – – 3 1 – 1 3 2 – – D05 Dojka, in situ M – – – – – – – – – – – – – – – – – –Breast, in situ Ž 84 – – – – – – – 3 4 11 19 9 15 10 8 3 2 D06 Maternični vrat, in situ (CIN III) M – – – – – – – – – – – – – – – – – –Cervix uteri, in situ (CIN III) Ž 868 – – – 5 54 147 183 155 126 96 45 26 9 13 3 2 4 D09.0 Karcinom in situ mehurja M 82 – – – – – – – 2 – 2 3 8 12 16 18 12 9Bladder, in situ Ž 26 – – – – – – – 2 – 1 1 1 4 4 5 4 4 Meninge, benigna neoplazma M 13 – – – 1 – – – – 1 1 2 1 1 2 2 2 –D32.0 Benign neoplasm of Ž 47 – – – – – – – 2 3 7 5 3 6 1 13 4 3 meninges D33.0 Možgani, benigna neoplazma M – – – – – – – – – – – – – – – – – –- D33.2 Benign neopasm of brain Ž 1 – – – – – – – – – – – 1 – – – – – Jajčnik, neopl. negotovega značaja M – – – – – – – – – – – – – – – – – –D39.1 Ovary, neopl. of Ž 33 – – – – 1 – 3 3 4 – 6 2 2 4 2 5 1 uncertain behavior D43.0 Možgani, neopredeljeno M 8 – – 1 – – – 2 – – – – 1 – 1 2 – 1 - D43.2 Brain, uncertain or unknown Ž 4 – – – – – – – – – – – 1 – 2 1 – – Cancer Incidence in Slovenia 2003 43 44 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 4b. Število novih primerov raka po lokaciji (MKB-8), spolu in starosti - Slovenija 2003 Table 4b. Number of new cancer cases by primary site (ICD-8), sex, and age - Slovenia 2003 Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Skupaj 9926 15 12 7 24 42 96 129 213 355 591 842 889 1148 1449 1586 1339 1189 140 Vse lokacije Total – Moški 4989 9 9 4 15 26 51 55 81 142 249 401 445 659 840 883 629 491 209 All sites Male Ženske 4937 6 3 3 9 16 45 74 132 213 342 441 444 489 609 703 710 698 Female 140 Ustnica M 17 – – – – – – – – 1 2 – – 1 5 2 3 3Lip Ž 6 – – – – – – 1 – – – – – – – 1 1 3 141 Jezik M 33 – – – – – – – 1 2 3 7 6 4 2 3 2 3Tongue Ž 9 – – – – – – – – – 1 4 1 – 1 – 1 1 142 Slinavke M 7 – – – – – – – – – – 1 2 2 2 – – –Salivary glands Ž 8 – – – – – 1 – – – – – – 1 1 1 2 2 143 Dlesni M 3 – – – – – – – – – – – – – 2 1 – –Gum Ž 6 – – – – – – – – – – 1 – – – 2 1 2 144 Ustno dno M 31 – – – – – – – – 2 5 3 4 7 4 3 3 –Floor of mouth Ž 8 – – – – – – – – 1 2 3 1 – – 1 – – 145 Usta, drugo M 33 – – – 1 – – – – 1 3 3 8 8 2 2 2 3Mouth, other parts Ž 4 – – – – – – – – – – – – – 1 – 1 2 146 Orofarinks M 70 – – – – – – – – 6 10 16 4 13 12 3 6 –Oropharynx Ž 16 – – – – – – – – – 2 2 2 2 – 3 1 4 147 Epifarinks M 4 – – – – – – – – – 1 – 1 1 1 – – –Epipharynx Ž 3 – – – – – – – – – – – – – 1 1 1 – 148 Hipofarinks M 36 – – – – – – – – 3 4 11 3 4 5 4 2 –Hypopharynx Ž 4 – – – – – – – – – – 2 – 1 – 1 – – 149 Žrelo, neoznačeno M – – – – – – – – – – – – – – – – – –Pharynx, not specified Ž 1 – – – – – – – – – – – – – – – – 1 150 Požiralnik M 79 – – – – – – – 1 5 7 9 7 11 17 8 8 6Oesophagus Ž 20 – – – – – – – – 1 1 2 1 – 4 2 5 4 151 Želodec M 298 – – – 1 – 2 4 2 10 18 18 23 33 55 51 43 38Stomach Ž 219 – – – – – – 3 3 8 10 5 13 10 24 42 58 43 152 Tanko črevo M 12 – – – – – – – – – 3 1 1 1 1 5 – –Small intestine Ž 8 – – – – – – – – 1 – 2 – 1 2 – 1 1 153 Debelo črevo M 363 – – – 1 – 1 – 4 4 13 15 29 46 64 75 69 42Colon Ž 295 – – – – – 2 – 2 1 12 25 32 30 39 49 46 57 154 Rektum M 322 – – – – – – 1 2 7 14 14 29 46 67 67 41 34Rectum Ž 237 – – – – – – – 1 5 8 4 18 29 39 44 40 49 155 Jetra M 63 – – – – – – – – 2 5 6 3 12 19 10 5 1Liver Ž 38 – – – – – – 1 – 2 2 2 5 4 1 5 11 5 156 Žolčnik, žolčni vodi M 52 – – – – – – – 1 – – 2 5 2 14 10 7 11Gallbladder, bile ducts Ž 49 – – – – – – – – – – 2 1 5 5 8 14 14 157 Trebušna slinavka M 126 – – – – – – – 1 3 9 14 13 19 23 17 14 13Pancreas Ž 109 – – – – – – 1 2 1 4 6 3 9 13 20 21 29 158 Retro- in peritonej M 7 – – – – 1 – – 2 – 2 1 – – – – – 1Retro- and peritoneum Ž 15 – – – – – – – – – 1 1 1 3 5 3 – 1 159 Prebavila, drugo M – – – – – – – – – – – – – – – – – –Digestive organs, other Ž 3 – – – – – – – – – 1 – – – – – 1 1 160 Nos, obnosne votline,drugo M 9 – – – – – – – – 1 – 1 1 1 2 – 1 2Nose, sinuses, etc. Ž 6 1 – – – – – – 1 – – – – – 2 – 1 1 161 Grlo M 95 – – – – – – – 2 2 9 13 11 14 20 12 5 7Larynx Ž 5 – – – – – – – – 1 – – 2 2 – – – – 162 Sapnik, sapnica, pljuča M 879 – – – – – 1 3 2 18 42 92 97 130 156 180 97 61Trachea, bronchus, lung Ž 281 – – – 1 – – – 3 8 25 21 30 35 39 52 41 26 163 Plevra, mediastinum, drugo M 21 – – – – – 1 – – – 4 5 3 2 3 1 1 1Pleura, mediastinum, etc. Ž 11 1 – – – – – 1 – – – – 1 – 1 2 5 – 170 Kosti M 21 – – – 2 2 1 1 2 1 – 5 2 2 1 – 1 1Bone Ž 13 – – 1 – – – 2 – 1 – 3 1 – – 5 – – 171 Mehka tkiva M 19 – – 1 1 1 – – 1 – – 3 2 1 1 1 3 4Soft tissues Ž 23 – – – – 1 1 1 3 1 5 1 – – 2 2 4 2 172 Koža, maligni melanom M 167 – – – – 1 2 9 8 12 20 17 12 24 19 19 16 8Skin, malignant melanoma Ž 164 – 1 – 2 3 7 11 8 6 17 19 18 11 11 15 18 17 173 Koža, drugi malignomi M 731 – 1 – – – 1 3 10 20 29 63 53 88 106 137 128 92Skin, other malignancies Ž 839 – – – – 1 1 11 21 19 28 48 67 60 110 139 158 176 174 Dojka M 13 – – – – – – – – 1 – 1 4 2 2 2 1 –Breast Ž 1084 – – – – – 4 19 30 74 120 146 126 128 124 110 107 96 Institute of Oncology Ljubljana, Cancer Registry of Slovenia nadaljevanje / cont’d ➝ Tabela 4b. – Table 4b. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ 180 Maternica, vrat M – – – – – – – – – – – – – – – – – –Uterus, cervix Ž 208 – – – – 1 12 13 25 39 28 21 19 15 11 9 7 8 181 Horioepiteliom M – – – – – – – – – – – – – – – – – –Chorioepithelioma Ž – – – – – – – – – – – – – – – – – – 182 Maternica, telo, drugo M – – – – – – – – – – – – – – – – – –Uterus, corpus, etc. Ž 301 – – – – 1 – 1 3 12 12 40 39 49 47 40 30 27 183 Jajčnik, jajcevod, drugo M – – – – – – – – – – – – – – – – – –Ovary, Fallopian tube, other Ž 188 – – – 4 1 1 – 2 4 24 21 25 25 27 25 17 12 184 Nožnica, vulva, drugo M – – – – – – – – – – – – – – – – – –Vagina, vulva, etc. Ž 74 – – – – – – – 3 – 5 3 7 7 13 12 12 12 185 Prostata M 558 1 – – – – – – – 1 2 17 39 86 112 139 85 76Prostate Ž – – – – – – – – – – – – – – – – – – 186 Modo M 109 – – – 2 12 27 18 27 12 7 1 1 – 1 1 – –Testis Ž – – – – – – – – – – – – – – – – – – 187 Penis, obmodek, drugo M 12 – – – – – – 1 – 1 1 – 2 1 3 1 2 –Penis, epididymis, etc. Ž – – – – – – – – – – – – – – – – – – 188 Sečni mehur M 164 – – – – – – – – – 7 7 14 14 28 35 33 26Bladder Ž 63 – – – – – – – 1 – 1 4 1 6 14 17 6 13 189 Ledvica, sečevod, drugo M 136 1 – – – – 1 1 5 3 9 13 10 21 20 27 14 11Kidney, ureter, etc. Ž 80 1 – – – – 1 – – 2 3 12 3 10 14 12 13 9 190 Oko M 10 1 – – – – – – – – – 2 1 1 1 2 2 –Eye Ž 12 – – – – – – – 1 1 2 – – 1 3 1 3 – 191 Možgani M 58 1 – 1 1 3 1 1 – 1 4 9 14 9 3 6 2 2Brain Ž 68 1 – 1 – – 3 1 5 4 4 8 4 9 7 11 7 3 192 Živčevje, drugo M 10 – – – 1 1 – 1 1 1 1 1 – 3 – – – –Nervous system, other Ž 5 1 – – – – – – 1 – – 1 – – – 2 – – 193 Ščitnica M 23 – – – – – 1 – 2 6 2 1 4 2 1 2 1 1Thyroid Ž 93 – – – 1 3 4 4 9 9 14 13 7 8 6 7 5 3 194 Endokrine žleze, druge M 2 – 1 – – – – – – – – – – – – – 1 –Endocrine glands, other Ž 4 – 1 – – – – – – – – 1 – – 1 – 1 – 195 Slabo opredeljene lokacije M 3 – – – – – – – – – – – – – – 1 – 2Ill-defined site Ž 13 – – – – – – – – 1 1 – 1 – 1 3 3 3 196 Metastaze v bezgavkah M 17 – – – – – – – 1 – 1 3 3 – 2 3 3 1Lymph node metastases Ž 10 – – – – – – – – – – – – 2 2 3 1 2 197 Metastaze v dihalih, prebavilih M 59 – – – – – – 1 – 1 – 4 10 6 12 9 8 8 Respirative, digestive Ž 55 – – – – – 1 – – 1 1 1 2 1 8 8 12 20 tract metastases 198 Metastaze, drugje M 21 – – – – – – – – 2 – 2 1 1 1 9 2 3Metastases, other Ž 17 – – – – – – – – – – – 3 – 2 6 3 3 199 Malignomi, neopredeljeni M 40 – – – – – – – – 1 3 3 4 9 8 7 1 4Malignancies, unspecified Ž 43 – – – – – – – – 2 2 1 2 5 4 11 8 8 200 + Ne-Hodgkinovi limfomi M 65 – 3 2 – – 2 3 2 4 2 1 2 12 9 7 6 10 202 Non-Hodgkin's lymphoma Ž 78 – – 1 – 1 – 2 1 3 4 11 – 4 11 13 14 13 201 Hodgkinov limfom M 32 1 2 – 1 3 6 3 1 4 1 3 3 1 1 1 1 –Hodgkin's disease Ž 22 – – – – 4 4 1 6 2 – – – 1 3 1 – – 203 Plazmocitom M 50 – – – – – – – – 2 2 8 7 5 12 7 3 4Plasmocytoma Ž 40 – – – – – – – – – – 2 4 3 6 9 9 7 204.0 Levkemija, limfatična, akutna M 18 2 1 – 3 1 2 2 – – – – 2 2 3 – – – Leukaemia, lymphatic, Ž 7 1 1 – – – – – 1 – – 1 – 2 – 1 – – acute Levkemija, limfatična, 204.1 drugo M 28 – – – – – – – – – 3 3 2 5 4 4 4 3 - 204.9 Leukaemia, lymphatic, Ž 27 – – – – – – – – – – – 3 7 1 – 6 10 other 205 Levkemija, mieloična M 41 – 1 – 1 1 2 3 2 1 1 – 3 4 8 4 2 8Leukaemia, myeloic Ž 28 – – – 1 – 3 1 – 2 2 1 – 2 1 1 9 5 206 Levkemija, monocitna M 9 – – – – – – – – 1 – – – 3 3 1 1 –Leukaemia, monocytic Ž 6 – – – – – – – – 1 – – – – 1 1 2 1 207 Levkemije, druge M 5 2 – – – – – – – – – 2 – – – – – 1Leukaemias, other Ž 6 – – – – – – – – – – – 1 1 1 1 1 1 208 Policitemija, prava M 6 – – – – – – – 1 – – – – – 2 3 – –Polycithemia vera Ž 3 – – – – – – – – – – – – – – 1 1 1 209 Mielofibroza M 2 – – – – – – – – – – – – – 1 1 – –Myelofibrosis Ž 2 – – – – – – – – – – 1 – – – – 1 – Cancer Incidence in Slovenia 2003 45 46 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 4b. – Table 4b. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Zgoraj neupoštevani Not included above 219 Maternični vrat, in situ (CIN III) M – – – – – – – – – – – – – – – – – – + 234 Cervix uteri, in situ (CIN III) Ž 869 – – – 5 54 147 183 156 126 96 45 26 9 13 3 2 4 225.0 Možgani, benigni tumor M 14 – – – 1 – – – – 1 1 3 1 1 2 2 2 – + 225.2 Brain, benign tumor Ž 50 – – – – – – – 2 3 7 6 4 6 1 14 4 3 232.2 Maligni melanom, in situ M 12 – – – – – – 1 1 1 2 1 2 1 1 1 1 –Malignant melanoma, in situ Ž 12 – – – – – – 2 – – 3 1 – 1 3 2 – – 233 Dojka, in situ M – – – – – – – – – – – – – – – – – –Breast, in situ Ž 84 – – – – – – – 3 4 11 19 9 15 10 8 3 2 Jajčnik, neopl. negotovega značaja M – – – – – – – – – – – – – – – – – –235 Ovary, neopl. Ž 33 – – – – 1 – 3 3 4 – 6 2 2 4 2 5 1 of uncertain behavior 237.6 Sečni mehur, in situ M 82 – – – – – – – 2 – 2 3 8 12 16 18 12 9Urinary bladder, in situ Ž 25 – – – – – – – 1 – 1 1 1 4 4 5 4 4 238.1 Možgani, neopredeljeno M 8 – – 1 – – – 2 – – – – 1 – 1 2 – 1Brain, unspecified Ž 6 – – – – – – – – – – 2 1 – 2 1 – – na d a lje va nj e / co nt ’d ➝ na d a lje va nj e / co nt ’d ➝ Ta b el a 5 . In ci d en ca ra ka n a 1 00 .0 00 p re b iv a lc ev p o sp ol u in s ta ro st i t er k um ul a tiv na s to p nj a (K S) p o lo ka ci ji - S lo ve ni ja 2 00 3 Ta b le 5 . C a nc er in ci d en ce p er 1 00 .0 00 p op ul a tio n b y se x a nd a g e, a nd c um ul a tiv e ra te ( C R) b y sit e - S lo ve ni a 2 00 3 Ši fra Pr im a rn a V se S t a r o s t i KS M KB lo ka ci ja Sp ol st a ro st i A g e C R IC D Pr im a ry Se x A ll co d e sit e a g es 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 7 4 Sk up a j 50 0, 7 16 ,8 12 ,6 6, 4 18 ,5 28 ,3 64 ,4 90 ,2 13 8, 8 23 1, 1 37 2, 1 56 9, 9 82 0, 9 10 83 ,7 15 38 ,7 18 76 ,9 21 70 ,2 21 89 ,3 34 ,3 C 00 V se lo ka ci je To ta l – M oš ki 51 4, 2 19 ,5 18 ,4 7, 1 22 ,6 34 ,0 65 ,4 75 ,1 10 5, 0 18 1, 1 30 3, 8 52 5, 6 82 8, 7 13 08 ,5 19 85 ,7 26 12 ,8 31 32 ,6 34 40 ,4 40 ,5 C 96 A ll sit es M a le Že ns ke 48 7, 7 13 ,9 6, 5 5, 6 14 ,2 22 ,3 63 ,4 10 5, 9 17 3, 1 28 2, 9 44 4, 4 61 6, 9 81 3, 1 87 8, 9 11 76 ,0 13 84 ,8 17 05 ,1 17 40 ,4 30 ,0 Fe m a le C 00 Us tn ic a M 1, 7 – – – – – – – – 1, 3 2, 4 – – 2, 0 11 ,8 5, 9 14 ,8 20 ,6 0, 1 Li p Ž 0, 6 – – – – – – 1, 4 – – – – – – – 2, 0 2, 4 7, 4 0, 0 C 01 Ba za je zi ka M 1, 3 – – – – – – – 1, 3 1, 3 2, 4 2, 6 3, 7 3, 9 – 5, 9 4, 9 – 0, 1 Ba se o f t on g ue Ž 0, 4 – – – – – – – – – – 2, 8 1, 8 – – – – 2, 5 0, 0 C 02 Je zi k, d ru g i d el i M 2, 0 – – – – – – – – 1, 3 1, 2 5, 2 7, 4 5, 9 4, 7 2, 9 4, 9 20 ,6 0, 1 To ng ue , o th er & Ž 0, 4 – – – – – – – – – – 2, 8 – – 1, 9 – 2, 4 – 0, 0 un sp ec ifi ed p a rts C 03 D le se n M 0, 3 – – – – – – – – – – – – – 4, 7 2, 9 – – 0, 0 G um Ž 0, 5 – – – – – – – – – – 1, 4 – – – 2, 0 2, 4 4, 9 0, 0 C 04 Us tn o d no M 3, 2 – – – – – – – – 2, 5 6, 1 3, 9 7, 4 13 ,8 9, 4 8, 8 14 ,8 – 0, 3 Fl oo r o f m ou th Ž 0, 8 – – – – – – – – 1, 3 2, 6 4, 2 1, 8 – – 2, 0 – – 0, 1 C 05 N eb o M 1, 2 – – – 1, 5 – – – – – 1, 2 2, 6 3, 7 3, 9 – 2, 9 4, 9 13 ,8 0, 1 Pa la te Ž – – – – – – – – – – – – – – – – – – – C 06 Us ta , d ru g i d el i M 2, 1 – – – – – – – – 1, 3 2, 4 1, 3 11 ,1 11 ,8 4, 7 2, 9 4, 9 6, 9 0, 2 M ou th , o th er & Ž 0, 2 – – – – – – – – – – – – – 1, 9 – – 2, 5 0, 0 un sp ec ifi ed p a rts C 07 Pa ro tid na ž le za M 0, 4 – – – – – – – – – – – 3, 7 2, 0 2, 4 – – – 0, 0 Pa ro tid g la nd Ž 0, 6 – – – – – 1, 4 – – – – – – 1, 8 1, 9 – 4, 8 2, 5 0, 0 C 08 D ru g e in n eo p re d el je ne ve lik e žl ez e sl in a vk e M 0, 2 – – – – – – – – – – 1, 3 – – 2, 4 – – – 0, 0 O th er & u ns p ec ifi ed Ž – – – – – – – – – – – – – – – – – – – m a jo r s a liv a ry g la nd s C 09 To nz ila M 2, 0 – – – – – – – – 1, 3 1, 2 7, 8 1, 8 7, 9 7, 1 2, 9 14 ,8 – 0, 2 To ns il Ž 0, 6 – – – – – – – – – – 1, 4 – 3, 6 – 3, 9 2, 4 – 0, 0 C 10 O ro fa rin ks M 4, 8 – – – – – – – – 5, 1 11 ,6 14 ,4 3, 7 15 ,8 21 ,2 5, 9 9, 9 – 0, 4 O ro p ha ry nx Ž 0, 6 – – – – – – – – – 2, 6 1, 4 3, 6 – – – – 2, 5 0, 0 C 11 N a zo fa rin ks M 0, 3 – – – – – – – – – 1, 2 – 1, 8 2, 0 – – – – 0, 0 N a so p ha ry nx Ž 0, 2 – – – – – – – – – – – – – 1, 9 – 2, 4 – 0, 0 Cancer Incidence in Slovenia 2003 47 Institute of Oncology Ljubljana, Cancer Registry of Slovenia na d a lje va nj e / co nt ’d ➝ Ta b el a 5 . – Ta b le 5 . N a d a lje va nj e – C on tin ue d Ši fra Pr im a rn a V se S t a r o s t i KS M KB lo ka ci ja Sp ol st a ro st i A g e C R IC D Pr im a ry Se x A ll co d e sit e a g es 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 7 4 C 12 Pi rif or m ni s in us M 1, 6 – – – – – – – – 2, 5 3, 7 6, 5 3, 7 5, 9 – 2, 9 – – 0, 1 Py rif or m s in us Ž 0, 1 – – – – – – – – – – 1, 4 – – – – – – 0, 0 C 13 H ip of a rin ks M 1, 9 – – – – – – – – – 1, 2 7, 8 1, 8 2, 0 11 ,8 8, 8 9, 9 – 0, 2 H yp op ha ry nx Ž 0, 3 – – – – – – – – – – 1, 4 – 1, 8 – 2, 0 – – 0, 0 D ru g a in s la b o op re d el je na m es ta n a u st ni ci , C 14 v us tn i v ot lin i i n fa rin ks u M 0, 1 – – – – – – – – 1, 3 – – – – – – – – 0, 0 O th er a nd il l-d ef in ed s ite s in Ž 0, 1 – – – – – – – – – – – – – – – – 2, 5 0, 0 th e lip , o ra l c a vi ty a nd p ha ry nx C 15 Po ži ra ln ik M 8, 1 – – – – – – – 1, 3 6, 3 8, 5 11 ,8 12 ,9 21 ,7 40 ,0 23 ,4 39 ,6 41 ,3 0, 6 O es op ha g us Ž 2, 0 – – – – – – – – 1, 3 1, 3 2, 8 1, 8 – 7, 6 3, 9 12 ,0 9, 9 0, 1 C 16 Že lo d ec M 29 ,1 – – – 1, 5 – 2, 6 5, 5 2, 6 11 ,4 20 ,7 22 ,2 38 ,8 65 ,1 12 4, 7 14 0, 6 19 8, 0 25 4, 6 2, 2 St om a ch Ž 18 ,7 – – – – – – 1, 4 3, 9 7, 9 11 ,6 5, 5 20 ,0 16 ,2 40 ,1 72 ,5 11 9, 6 98 ,7 0, 9 C 17 Ta nk o čr ev o M 1, 1 – – – – – – – – – 3, 7 1, 3 1, 8 2, 0 – 14 ,6 – – 0, 1 Sm a ll in te st in e Ž 0, 5 – – – – – – – – 1, 3 – 1, 4 – – 1, 9 – 2, 4 2, 5 0, 0 C 18 D eb el o čr ev o M 36 ,9 – – – 1, 5 – – – 5, 1 5, 1 15 ,9 19 ,6 53 ,5 90 ,8 15 0, 6 21 9, 7 34 1, 5 28 2, 1 2, 8 C ol on Ž 28 ,9 – – – – – 2, 8 – 2, 6 1, 3 15 ,5 34 ,7 58 ,2 53 ,9 74 ,5 96 ,0 10 7, 6 14 3, 2 1, 7 C 19 Re kt os ig m oi d na z ve za M 5, 4 – – – – – – – 1, 3 – – 6, 5 5, 5 15 ,8 23 ,5 38 ,1 39 ,6 34 ,4 0, 5 Re ct os ig m oi d ju nc tio n Ž 4, 4 – – – – – – – – – 2, 6 1, 4 5, 5 5, 4 21 ,0 17 ,6 14 ,3 24 ,7 0, 3 C 20 Re kt um M 26 ,5 – – – – – – 1, 4 1, 3 7, 6 14 ,6 11 ,8 46 ,1 75 ,0 13 1, 8 14 6, 5 15 3, 4 20 6, 4 2, 2 Re ct um Ž 18 ,1 – – – – – – – 1, 3 6, 6 6, 5 4, 2 25 ,5 46 ,7 53 ,5 66 ,6 78 ,9 88 ,9 1, 1 C 21 A nu s in a na ln i k a na l M 1, 1 – – – – – – – – 1, 3 2, 4 – 1, 8 – 2, 4 11 ,7 9, 9 – 0, 1 A nu s a nd a na l c a na l Ž 0, 6 – – – – – – – – – 1, 3 – 1, 8 – – 2, 0 2, 4 4, 9 0, 0 C 22 Je tra in in tra he p a tič ni v od i M 8, 1 – – – – – – – – 2, 5 6, 1 9, 2 12 ,9 27 ,6 54 ,1 38 ,1 29 ,7 13 ,8 0, 8 Liv er a nd in tra he p a tic b ile d uc ts Ž 5, 4 – – – – – – – – 2, 6 2, 6 2, 8 9, 1 9, 0 7, 6 15 ,7 33 ,5 32 ,1 0, 2 C 23 Žo lč ni k M 1, 5 – – – – – – – – – – – 1, 8 2, 0 7, 1 5, 9 24 ,7 20 ,6 0, 1 G a llb la d d er Ž 2, 6 – – – – – – – – – – – – 7, 2 7, 6 5, 9 14 ,3 24 ,7 0, 1 D ru g i i n ne op re d el je ni d el i b ili a rn eg a tr a kt a M 3, 8 – – – – – – – 1, 3 – – 2, 6 7, 4 2, 0 25 ,9 23 ,4 9, 9 55 ,0 0, 3 C 24 Bi llia ry tr a ct , o th er a nd Ž 2, 2 – – – – – – – – – – 2, 8 1, 8 1, 8 1, 9 9, 8 19 ,1 9, 9 0, 1 un sp ec ifi ed p a rts C 25 Tr eb uš na s lin a vk a M 12 ,9 – – – – – – – 1, 3 3, 8 11 ,0 18 ,3 24 ,0 37 ,5 54 ,1 49 ,8 69 ,3 89 ,5 1, 0 Pa nc re a s Ž 10 ,7 – – – – – – 1, 4 2, 6 1, 3 5, 2 8, 3 5, 5 16 ,2 24 ,8 39 ,2 50 ,2 71 ,6 0, 5 D ru g a in s la b o op re d el je na m es ta C 26 v p re b a vn ih o rg a ni h M – – – – – – – – – – – – – – – – – – – O th er a nd il l-d ef in ed Ž 0, 4 – – – – – – – – – 1, 3 – – – – – 4, 8 2, 5 0, 0 d ig es tiv e or g a ns 48 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo na d a lje va nj e / co nt ’d ➝ Ta b el a 5 . – Ta b le 5 . N a d a lje va nj e – C on tin ue d Ši fra Pr im a rn a V se S t a r o s t i KS M KB lo ka ci ja Sp ol st a ro st i A g e C R IC D Pr im a ry Se x A ll co d e sit e a g es 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 7 4 N os na v ot lin a in sr ed nj e uh o M 0, 1 – – – – – – – – – – – – – – – – 6, 9 0, 0 C 30 N a sa l c a vi ty a nd m id d le e a r Ž 0, 1 – – – – – – – – – – – – – – – 2, 4 – 0, 0 C 31 O b no sn i s in us i M 0, 7 – – – – – – – – 1, 3 – 1, 3 1, 8 2, 0 4, 7 – 4, 9 – 0, 1 A cc es so ry s in us es Ž 0, 4 – – – – – – – 1, 3 – – – – – 3, 8 – – 2, 5 0, 0 C 32 G rlo M 9, 6 – – – – – – – 2, 6 2, 5 11 ,0 17 ,0 20 ,3 27 ,6 44 ,7 35 ,1 24 ,7 48 ,2 0, 8 La ry nx Ž 0, 5 – – – – – – – – 1, 3 – – 3, 6 3, 6 – – – – 0, 0 C 33 Sa p ni k M 0, 7 – – – – – – – – – – 1, 3 3, 7 – 2, 4 5, 9 4, 9 – 0, 1 Tr a ch ea Ž – – – – – – – – – – – – – – – – – – – C 34 Sa p ni ca in p lju ča M 89 ,1 – – – – – 1, 3 4, 1 2, 6 22 ,8 51 ,2 11 7, 7 17 5, 3 25 6, 6 36 4, 7 52 1, 4 47 5, 1 41 9, 7 7, 6 Br on ch us a nd lu ng Ž 27 ,5 – – – 1, 6 – – – 3, 9 10 ,5 32 ,3 29 ,1 52 ,8 62 ,9 74 ,5 10 1, 9 98 ,1 64 ,2 1, 8 C 37 Ti m us M 0, 1 – – – – – – – – – – – – – – – 4, 9 – 0, 0 Th ym us Ž 0, 2 – – – – – – – – – – 1, 4 – – 1, 9 – – – 0, 0 C 38 Sr ce , m ed ia st in um , p le vr a M 0, 2 – – – – – 1, 3 – – – – 1, 3 – – – – – – 0, 0 H ea rt, m ed ia st in um , p le ur a Ž 0, 3 4, 6 – – – – – – – – – – – – – – 2, 4 – 0, 0 C 39 D ru g a in s la b o op re d el je na m es ta v d ih a lih in p rs ni h or g a ni h M – – – – – – – – – – – – – – – – – – – O th er a nd il l-d ef in ed s ite s Ž – – – – – – – – – – – – – – – – – – – in th e re sp ira to ry s ys te m a nd in tra th or a ci c or g a ns Ko st i, sk le p ni h ru st a ne c ud ov M 1, 2 – – – 1, 5 2, 6 1, 3 – 1, 3 1, 3 – 2, 6 1, 8 3, 9 2, 4 – – – 0, 1 C 40 Bo ne a nd a rti cu la r Ž 0, 8 – – 1, 9 – – – 1, 4 – 1, 3 – 2, 8 1, 8 – – 3, 9 – – 0, 1 ca rti la g e of li m b s C 41 Ko st i, sk le p ni h ru st a ne c, d ru g je M 0, 8 – – – 1, 5 – – 1, 4 1, 3 – – 3, 9 1, 8 – – – – 6, 9 0, 0 Bo ne a nd a rti cu la r c a rti la g e Ž 0, 2 – – – – – – – – – – 1, 4 – – – 2, 0 – – 0, 0 of o th er a nd u ns p ec ifi ed p a rts C 43 M a lig ni m el a no m k ož e M 17 ,1 – – – – 1, 3 2, 6 12 ,3 10 ,2 15 ,2 24 ,4 22 ,2 22 ,1 47 ,4 44 ,7 55 ,7 79 ,2 55 ,0 1, 3 M a lig na nt m el a no m a o f s ki n Ž 16 ,1 – 2, 2 – 3, 2 4, 2 9, 6 15 ,7 10 ,4 7, 9 22 ,0 26 ,3 32 ,7 19 ,8 21 ,0 29 ,4 43 ,0 42 ,0 1, 0 C 44 D ru g e m a lig ne ne op la zm e ko že M 74 ,6 – 2, 0 – – – 1, 3 4, 1 12 ,8 25 ,3 35 ,4 82 ,4 96 ,0 17 3, 7 24 9, 4 39 8, 4 63 3, 4 63 3, 0 5, 4 Sk in , o th er m a lig no m a s Ž 81 ,8 – – – – 1, 4 1, 4 15 ,7 27 ,3 25 ,0 36 ,2 66 ,5 12 0, 1 10 4, 3 21 0, 0 27 0, 3 37 7, 9 43 2, 0 4, 4 C 45 M ez ot el io m M 2, 0 – – – – – – – – – 4, 9 5, 2 5, 5 3, 9 7, 1 2, 9 4, 9 13 ,8 0, 1 M es ot he lio m a Ž 1, 2 – – – – – – 1, 4 – – – – 1, 8 – 3, 8 3, 9 12 ,0 2, 5 0, 1 C 46 Ka p os ije v sa rk om M 0, 1 – – – – – – – – – – – 1, 8 – – – – – 0, 0 Ka p os i's s a rc om a Ž – – – – – – – – – – – – – – – – – – – Cancer Incidence in Slovenia 2003 49 Institute of Oncology Ljubljana, Cancer Registry of Slovenia na d a lje va nj e / co nt ’d ➝ Ta b el a 5 . – Ta b le 5 . N a d a lje va nj e – C on tin ue d Ši fra Pr im a rn a V se S t a r o s t i KS M KB lo ka ci ja Sp ol st a ro st i A g e C R IC D Pr im a ry Se x A ll co d e sit e a g es 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 7 4 Pe rif er ni ž iv ci in a vt on om no ž iv če vj e M 0, 3 – – – – 1, 3 – 1, 4 – – – – – 2, 0 – – – – 0, 0 C 47 Pe rip he ra l n er ve s a nd Ž 0, 1 – – – – – – – 1, 3 – – – – – – – – – 0, 0 a ut on om ic n er vo us s ys te m C 48 Re tro - i n p er ito ne j M 0, 6 – – – – 1, 3 – – 2, 6 – 2, 4 1, 3 – – – – – – 0, 0 Re tro - a nd p er ito ne um Ž 1, 2 – – – – – – – – – 1, 3 1, 4 1, 8 5, 4 7, 6 3, 9 – – 0, 1 D ru g o ve zi vn o in m eh ko tk iv o M 1, 8 – – 1, 8 1, 5 1, 3 – – 1, 3 – – 3, 9 1, 8 2, 0 2, 4 2, 9 14 ,8 27 ,5 0, 1 C 49 O th er c on ne ct iv e a nd Ž 2, 1 – – – – 1, 4 1, 4 1, 4 3, 9 1, 3 6, 5 1, 4 – – 3, 8 3, 9 4, 8 4, 9 0, 1 so ft tis su e C 50 D oj ka M 1, 3 – – – – – – – – 1, 3 – 1, 3 7, 4 3, 9 4, 7 5, 9 4, 9 – 0, 1 Br ea st Ž 10 6, 2 – – – – – 5, 5 27 ,2 39 ,1 97 ,4 15 5, 0 20 2, 4 22 9, 2 23 0, 1 23 6, 7 21 5, 5 25 5, 9 23 4, 5 7, 2 C 51 Že ns ko z un a nj e sp ol ov ilo M – – – – – – – – – – – – – – – – – – – Vu lv a Ž 5, 5 – – – – – – – 3, 9 – 3, 9 4, 2 10 ,9 9, 0 19 ,1 17 ,6 23 ,9 17 ,3 0, 3 C 52 N ož ni ca M – – – – – – – – – – – – – – – – – – – Va g in a Ž 1, 5 – – – – – – – – – 2, 6 – 1, 8 1, 8 5, 7 5, 9 4, 8 7, 4 0, 1 C 53 M a te rn ič ni v ra t M – – – – – – – – – – – – – – – – – – – C er vi x ut er i Ž 20 ,4 – – – – 1, 4 16 ,5 18 ,6 32 ,5 51 ,3 36 ,2 29 ,1 34 ,6 27 ,0 21 ,0 17 ,6 16 ,7 19 ,7 1, 4 C 54 M a te rn ič no te lo M – – – – – – – – – – – – – – – – – – – C or p us u te ri Ž 28 ,0 – – – – 1, 4 – 1, 4 2, 6 13 ,2 14 ,2 54 ,1 69 ,1 84 ,5 85 ,9 74 ,4 67 ,0 61 ,7 2, 0 C 55 M a te rn ic a , n eo p re d el je no M – – – – – – – – – – – – – – – – – – – Ut er us , u ns p ec ifi ed Ž 1, 6 – – – – – – – 1, 3 2, 6 1, 3 1, 4 1, 8 3, 6 3, 8 3, 9 4, 8 4, 9 0, 1 C 56 Ja jč ni k M – – – – – – – – – – – – – – – – – – – O va ry Ž 17 ,9 – – – 6, 3 1, 4 1, 4 – 2, 6 5, 3 31 ,0 29 ,1 38 ,2 43 ,1 51 ,5 49 ,0 38 ,3 29 ,6 1, 3 D ru g i i n ne op re d el je ni že ns ki s p ol ni o rg a ni M – – – – – – – – – – – – – – – – – – – C 57 O th er a nd u ns p ec ifi ed p a rts Ž 0, 9 – – – – – – – – – – – 7, 3 3, 6 – – 2, 4 4, 9 0, 1 of fe m a le g en ita l o rg a ns C 58 Po st el jic a M – – – – – – – – – – – – – – – – – – – Pl a ce nt a Ž – – – – – – – – – – – – – – – – – – – C 60 Pe ni s M 1, 0 – – – – – – – – 1, 3 1, 2 – 3, 7 2, 0 4, 7 2, 9 9, 9 – 0, 1 Pe ni s Ž – – – – – – – – – – – – – – – – – – – C 61 Pr os ta ta M 57 ,1 2, 2 – – – – – – – 1, 3 2, 4 22 ,2 72 ,0 16 9, 7 26 3, 5 40 7, 1 42 0, 6 52 2, 9 4, 7 Pr os ta te Ž – – – – – – – – – – – – – – – – – – – C 62 M od o M 11 ,2 – – – 3, 0 15 ,7 34 ,6 24 ,6 34 ,6 15 ,2 8, 5 1, 3 1, 8 – 2, 4 2, 9 – – 0, 7 Te st is Ž – – – – – – – – – – – – – – – – – – – C 63 D ru g i i n ne op re d el je ni m oš ki s p ol ni o rg a ni M 0, 2 – – – – – – 1, 4 – – – – – – 2, 4 – – – 0, 0 O th er a nd u ns p ec ifi ed Ž – – – – – – – – – – – – – – – – – – – m a le g en ita l o rg a ns 50 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo na d a lje va nj e / co nt ’d ➝ Ta b el a 5 . – Ta b le 5 . N a d a lje va nj e – C on tin ue d Ši fra Pr im a rn a V se S t a r o s t i KS M KB lo ka ci ja Sp ol st a ro st i A g e C R IC D Pr im a ry Se x A ll co d e sit e a g es 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 7 4 C 64 Le d vi ca ra ze n m eh a M 12 ,4 2, 2 – – – – 1, 3 1, 4 6, 4 3, 8 7, 3 15 ,7 16 ,6 35 ,5 44 ,7 73 ,2 64 ,3 55 ,0 1, 0 Ki d ne y, e xc ep t r en a l p el vi s Ž 7, 1 2, 3 – – – – 1, 4 – – 1, 3 3, 9 16 ,6 5, 5 18 ,0 24 ,8 21 ,5 19 ,1 22 ,2 0, 5 C 65 Le d vi čn i m eh M 0, 9 – – – – – – – – – 1, 2 – – 5, 9 – 2, 9 4, 9 20 ,6 0, 1 Re na l p el vi s Ž 0, 7 – – – – – – – – 1, 3 – – – – 1, 9 2, 0 9, 6 – 0, 0 C 66 Se če vo d M 0, 4 – – – – – – – – – 2, 4 – 1, 8 – – 2, 9 – – 0, 0 U re te r Ž – – – – – – – – – – – – – – – – – – – C 67 Se čn i m eh ur M 16 ,8 – – – – – – – – – 8, 5 9, 2 25 ,8 27 ,6 65 ,9 10 2, 5 16 3, 3 17 8, 9 1, 2 Bl a d d er Ž 6, 2 – – – – – – – 1, 3 – 1, 3 5, 5 1, 8 10 ,8 26 ,7 33 ,3 14 ,3 32 ,1 0, 4 D ru g i i n ne op re d el je ni se čn i o rg a ni M 0, 1 – – – – – – – – – – – – – 2, 4 – – – 0, 0 C 68 O th er a nd u ns p ec ifi ed Ž – – – – – – – – – – – – – – – – – – – ur in a ry o rg a ns C 69 O ko in o če sn i a d ne ks i M 1, 0 2, 2 – – – – – – – – – 2, 6 1, 8 2, 0 2, 4 5, 9 9, 9 – 0, 1 Ey e a nd a d ne xa Ž 0, 9 – – – – – – – 1, 3 1, 3 1, 3 – – 1, 8 5, 7 2, 0 2, 4 – 0, 1 C 70 M en in g e M 0, 3 – – – – – – – 1, 3 1, 3 – 1, 3 – – – – – – 0, 0 M en in g es Ž 0, 1 – – – – – – – – – – 1, 4 – – – – – – 0, 0 C 71 M ož g a ni M 5, 7 2, 2 – 1, 8 1, 5 3, 9 1, 3 1, 4 – 1, 3 4, 9 11 ,8 24 ,0 15 ,8 7, 1 17 ,6 9, 9 13 ,8 0, 5 Br a in Ž 6, 5 2, 3 – – – – 4, 1 1, 4 6, 5 5, 3 5, 2 11 ,1 7, 3 16 ,2 13 ,4 19 ,6 16 ,7 7, 4 0, 5 H rb tn i m oz eg , m ož g a ns ki ži vc i i n d ru g i d el i C ŽS M 0, 4 – – – 1, 5 – – – – – 1, 2 – – 3, 9 – – – – 0, 0 C 72 Sp in a l c or d , c ra ni a l n er ve s Ž 0, 2 – – – – – – – – – – – – – – 3, 9 – – 0, 0 a nd o th er p a rts o f C N S C 73 Šč itn ic a M 2, 4 – – – – – 1, 3 – 2, 6 7, 6 2, 4 1, 3 7, 4 3, 9 2, 4 5, 9 4, 9 6, 9 0, 2 Th yr oi d g la nd Ž 9, 0 – – – 1, 6 4, 2 5, 5 5, 7 11 ,7 11 ,8 16 ,8 18 ,0 12 ,7 14 ,4 11 ,5 13 ,7 12 ,0 7, 4 0, 6 C 74 N a d le d vi čn a ž le za M – – – – – – – – – – – – – – – – – – – A d re na l g la nd Ž 0, 1 – – – – – – – – – – – – – – – 2, 4 – 0, 0 C 75 D ru g e en d ok rin e žl ez e in s or od ne s tru kt ur e M 0, 1 – 2, 0 – – – – – – – – – – – – – – – 0, 0 O th er e nd oc rin e g la nd s Ž 0, 1 – 2, 2 – – – – – – – – – – – – – – – 0, 0 a nd re la te d s tru ct ur es D ru g a in s la b o op re d el je na m es ta M 0, 3 – – – – – – – – – – – – – – 2, 9 – 13 ,8 0, 0 C 76 O th er a nd il l-d ef in ed s ite s Ž 1, 3 – – – – – – – – 1, 3 1, 3 – 1, 8 – 1, 9 5, 9 7, 2 7, 4 0, 1 C 77 M et a st a za in n eo p re d el je na m a lig na n eo p la zm a b ez g a vk M 1, 7 – – – – – – – 1, 3 – 1, 2 3, 9 5, 5 – 4, 7 8, 8 14 ,8 6, 9 0, 1 M et a st a sis a nd u ns p ec ifi ed Ž 1, 0 – – – – – – – – – – – – 3, 6 3, 8 5, 9 2, 4 4, 9 0, 1 m a lig na nt n eo p la sm of ly m p h no d es Cancer Incidence in Slovenia 2003 51 Institute of Oncology Ljubljana, Cancer Registry of Slovenia na d a lje va nj e / co nt ’d ➝ Ta b el a 5 . – Ta b le 5 . N a d a lje va nj e – C on tin ue d Ši fra Pr im a rn a V se S t a r o s t i KS M KB lo ka ci ja Sp ol st a ro st i A g e C R IC D Pr im a ry Se x A ll co d e sit e a g es 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 7 4 M et a st a ze d ih a l i n p re b a vi l M 4, 4 – – – – – – 1, 4 – 1, 3 – 3, 9 11 ,1 7, 9 18 ,8 17 ,6 34 ,6 48 ,2 0, 3 M et a st a se s of re sp ira to ry C 78 a nd d ig es tiv e or g a ns Ž 3, 5 – – – – – 1, 4 – – 1, 3 1, 3 1, 4 3, 6 – 9, 5 9, 8 21 ,5 27 ,2 0, 1 C 79 M et a st a ze , d ru g je M 2, 1 – – – – – – – – 2, 5 – 2, 6 1, 8 2, 0 2, 4 26 ,4 9, 9 20 ,6 0, 2 M et a st a se s of o th er s ite s Ž 1, 7 – – – – – – – – – – – 5, 5 – 3, 8 11 ,8 7, 2 7, 4 0, 1 M a lig na n eo p la zm a b re z op re d el je ne g a m es ta M 4, 1 – – – – – – – – 1, 3 3, 7 3, 9 7, 4 17 ,8 18 ,8 20 ,5 4, 9 27 ,5 0, 4 C 80 M a lig na nt n eo p la sm Ž 4, 3 – – – – – – – – 2, 6 2, 6 1, 4 3, 6 9, 0 7, 6 21 ,5 19 ,1 22 ,2 0, 2 w ith ou t s p ec ifi ca tio n of s ite C 81 H od g ki no va b ol ez en M 3, 3 2, 2 4, 1 – 1, 5 3, 9 7, 7 4, 1 1, 3 5, 1 1, 2 3, 9 5, 5 2, 0 2, 4 2, 9 4, 9 – 0, 2 H od g ki n' s d ise a se Ž 2, 2 – – – – 5, 6 5, 5 1, 4 7, 8 2, 6 – – – 1, 8 5, 7 2, 0 – – 0, 2 Fo lik ul a rn i n e- H od g ki no v lim fo m M 1, 6 – – – – – – – – 2, 5 3, 7 2, 6 1, 8 7, 9 – 5, 9 4, 9 6, 9 0, 1 C 82 Fo llic ul a r n on -H od g ki n' s Ž 4, 0 – – 1, 9 – – – 4, 3 – 1, 3 6, 5 9, 7 5, 5 7, 2 5, 7 9, 8 19 ,1 2, 5 0, 3 ly m p ho m a C 83 D ifu zn i n e- H od g ki no v lim fo m M 6, 0 – 6, 1 1, 8 – – 2, 6 2, 7 1, 3 3, 8 – 2, 6 11 ,1 17 ,8 21 ,2 17 ,6 34 ,6 55 ,0 0, 4 D iff us e no n- H od g ki n' s ly m p ho m a Ž 7, 5 – – – – – – 4, 3 – 5, 3 1, 3 5, 5 1, 8 3, 6 15 ,3 41 ,1 35 ,9 42 ,0 0, 4 Li m fo m i c el ic T in k ož ni lim fo m c el ic T M 0, 8 – – – – – 1, 3 1, 4 1, 3 – – – – – 7, 1 2, 9 – 6, 9 0, 1 C 84 Pe rip he ra l a nd c ut a ne ou s Ž 0, 7 – – 1, 9 – – – – 1, 3 – – 1, 4 – – 5, 7 – 2, 4 – 0, 1 T- ce ll ly m p ho m a s C 85 D ru g e in n eo pr ed el je ne v rs te ne -H od g ki no ve g a li m fo m a M 1, 2 – – 1, 8 – – – – – 1, 3 – – – 2, 0 4, 7 5, 9 14 ,8 13 ,8 0, 1 O th er a nd u ns p ec ifi ed ty p es Ž 1, 6 2, 3 – – – 1, 4 – – – – 2, 6 1, 4 – 3, 6 1, 9 – 7, 2 12 ,3 0, 1 of n on -H od g ki n' s ly m p ho m a M a lig ne im un op ro lif er a tiv ne b ol ez ni M 0, 2 – – – – – – – – – – – 1, 8 2, 0 – – – – 0, 0 C 88 M a lig na nt im m un op ro lif er a tiv e Ž 0, 2 – – – – – – – – – – – – – 3, 8 – – – 0, 0 d ise a se s C 90 D ifu zn i p la zm oc ito m in m a lig ne ne op la zm e p la zm oc ito v M 5, 1 – – – – – – – – 2, 5 2, 4 10 ,5 12 ,9 9, 9 28 ,2 20 ,5 14 ,8 27 ,5 0, 4 M ul tip le m ye lo m a a nd Ž 4, 1 – – – – – – – – – – 2, 8 7, 3 7, 2 11 ,5 19 ,6 21 ,5 17 ,3 0, 2 m a lig na nt p la sm a c el l ne op la sm s C 91 .0 Lim fa tič na le vk em ija , a ku tn a M 1, 8 4, 3 2, 0 – 4, 5 1, 3 2, 6 2, 7 – – – – 3, 7 3, 9 7, 1 – – – 0, 2 Ly m ph ob la sti c le uk ae m ia , a cu te Ž 0, 7 2, 3 2, 2 – – – – – 1, 3 – – 1, 4 – 3, 6 – 2, 0 – – 0, 1 C 91 .1 - Lim fa tič na le vk em ija , d ru ga M 3, 1 – – – – – – – – – 3, 7 5, 2 3, 7 9, 9 9, 4 11 ,7 19 ,8 27 ,5 0, 2 C 91 .9 Ly m p ho id le uk a em ia , o th er Ž 2, 7 – – – – – – – – – – – 5, 5 12 ,6 1, 9 – 16 ,7 24 ,7 0, 1 52 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Ta b el a 5 . – Ta b le 5 . N a d a lje va nj e – C on tin ue d Ši fra Pr im a rn a V se S t a r o s t i KS M KB lo ka ci ja Sp ol st a ro st i A g e C R IC D Pr im a ry Se x A ll co d e sit e a g es 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 7 4 C 92 M ie lo ič na le vk em ija M 4, 9 – 2, 0 – 1, 5 1, 3 2, 6 4, 1 2, 6 1, 3 1, 2 1, 3 5, 5 11 ,8 25 ,9 11 ,7 14 ,8 55 ,0 0, 4 M ye lo id le uk a em ia Ž 3, 2 – – – 1, 6 – 4, 1 1, 4 – 3, 9 2, 6 1, 4 1, 8 3, 6 3, 8 3, 9 21 ,5 14 ,8 0, 1 C 93 M on oc itn a le vk em ija M 0, 3 – – – – – – – – 1, 3 – – – 2, 0 – 2, 9 – – 0, 0 M on oc yt ic le uk a em ia Ž 0, 2 – – – – – – – – – – – – – – – 4, 8 – 0, 0 C 94 D ru ge o pr ed el je ne le vk em ije M 0, 1 2, 2 – – – – – – – – – – – – – – – – 0, 0 O th er le uk a em ia s Ž – – – – – – – – – – – – – – – – – – – of s p ec ifi ed c el ls C 95 Le vk em ija z n eo p re d el je ni m ce lič ni m ti p om M 0, 1 2, 2 – – – – – – – – – – – – – – – – 0, 0 Le uk a em ia , u ns p ec ifi ed c el l t yp e Ž 0, 3 – – – – – – – – – – – – – 1, 9 2, 0 – 2, 5 0, 0 D ru g e in n eo p re d el je ne m a lig ne n eo p la zm e lim fa tič ne g a , k rv ot vo rn eg a a li so ro d ne g a tk iv a M 4, 4 – – – – – – – 2, 6 1, 3 – 1, 3 5, 5 5, 9 16 ,5 38 ,1 19 ,8 61 ,9 0, 4 C 96 O th er a nd u ns pe ci fie d m al ig na nt Ž 3, 6 – – – – – 1, 4 – 1, 3 2, 6 2, 6 6, 9 5, 5 – 9, 5 9, 8 12 ,0 19 ,7 0, 2 ne op la sm s of ly m p ho id , ha em a to p oi et ic a nd re la te d ti ss ue Zg or a j n eu p oš te va ni N ot in cl ud ed a b ov e D 03 M el a no m , i n si tu M 1, 2 – – – – – – 1, 4 1, 3 1, 3 2, 4 1, 3 3, 7 2, 0 2, 4 2, 9 4, 9 – 0, 1 M el a no m a , i n sit u Ž 1, 2 – – – – – – 2, 9 – – 3, 9 1, 4 – 1, 8 5, 7 3, 9 – – 0, 1 D 05 D oj ka , i n si tu M – – – – – – – – – – – – – – – – – – – Br ea st , i n sit u Ž 8, 2 – – – – – – – 3, 9 5, 3 14 ,2 26 ,3 16 ,4 27 ,0 19 ,1 15 ,7 7, 2 4, 9 0, 6 D 06 M at er ni čn i v ra t, in s itu (C IN II I) M – – – – – – – – – – – – – – – – – – – C er vi x ut er i, in s itu ( C IN II I) Ž 85 ,2 – – – 7, 9 75 ,2 20 2, 5 26 2, 0 20 1, 8 16 5, 8 12 4, 0 62 ,4 47 ,3 16 ,2 24 ,8 5, 9 4, 8 9, 9 6, 0 D 09 .0 Ka rc in om in s itu m eh ur ja M 8, 4 – – – – – – – 2, 6 – 2, 4 3, 9 14 ,8 23 ,7 37 ,6 52 ,7 59 ,4 61 ,9 0, 7 Bl a d d er , i n sit u Ž 2, 6 – – – – – – – 2, 6 – 1, 3 1, 4 1, 8 7, 2 7, 6 9, 8 9, 6 9, 9 0, 2 D 32 .0 M en in ge , b en ig na n eo pl az m a M 1, 3 – – – 1, 5 – – – – 1, 3 1, 2 2, 6 1, 8 2, 0 4, 7 5, 9 9, 9 – 0, 1 Be ni g n ne op la sm o f m en in g es Ž 4, 6 – – – – – – – 2, 6 3, 9 9, 0 6, 9 5, 5 10 ,8 1, 9 25 ,5 9, 6 7, 4 0, 3 D 33 .0 -M ož ga ni , b en ig na n eo pl az m a M – – – – – – – – – – – – – – – – – – – D 33 .2 Be ni g n ne op la sm o f b ra in Ž 0, 1 – – – – – – – – – – – 1, 8 – – – – – 0, 0 D 39 .1 Ja jč ni k, n eo p l. ne g ot ov eg a z na ča ja M – – – – – – – – – – – – – – – – – – – O va ry , n eo p l. Ž 3, 2 – – – – 1, 4 – 4, 3 3, 9 5, 3 – 8, 3 3, 6 3, 6 7, 6 3, 9 12 ,0 2, 5 0, 2 of u nc er ta in b eh a vi or D 43 .0 -M ož g a ni , n eo p re d el je no M 0, 8 – – 1, 8 – – – 2, 7 – – – – 1, 8 – 2, 4 5, 9 – 6, 9 0, 1 D 43 .2 Br a in , u nc er ta in o r u nk no w n Ž 0, 4 – – – – – – – – – – – 1, 8 – 3, 8 2, 0 – – 0, 0 Cancer Incidence in Slovenia 2003 53 Institute of Oncology Ljubljana, Cancer Registry of Slovenia 54 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 6a. Število novih primerov raka po statističnih regijah, po najpogostejših lokacijah in spolu - Slovenija 2003 Table 6a. Number of new cancer cases by statistical regions, by most frequent sites and sex - Slovenia 2003 Statistična Spol Skupaj Lokacija (šifre MKB-10) Druga regija C00-C96 C16 C18 C19 C20 C34 C44 C50 C53 C54 C61 Other D06* Statistical region Sex All sites Site (ICD-10 codes) Slovenija, skupaj M 5026 284 361 53 259 871 729 13 – – 558 1898 – Slovenia, total Ž 4971 191 295 45 185 280 834 1083 208 285 – 1565 868 Pomurska M 312 14 22 1 26 56 40 0 – – 50 103 – Ž 297 6 24 1 14 14 82 50 4 17 – 85 41 Podravska M 712 61 66 7 40 142 75 2 – – 71 248 – Ž 692 48 51 8 36 43 78 154 35 37 – 202 89 Koroška M 178 8 11 1 6 35 30 1 – – 17 69 – Ž 165 8 10 5 5 10 37 29 6 7 – 48 19 Savinjska M 490 30 36 10 19 101 48 3 – – 36 207 – Ž 596 23 46 6 24 40 65 129 36 29 – 198 161 Zasavska M 115 7 8 0 6 15 15 0 – – 8 56 – Ž 101 5 9 3 3 7 11 20 2 5 – 36 14 Spodnjeposavska M 163 13 8 5 15 26 11 1 – – 12 72 – Ž 166 7 7 3 6 3 19 36 12 12 – 61 37 Jugovzhodna Slovenija M 357 32 22 4 24 53 45 1 – – 29 147 – Ž 320 11 15 0 9 21 45 77 10 20 – 112 29 Osrednjeslovenska M 1385 59 95 14 59 217 259 3 – – 173 506 – Ž 1436 48 71 13 42 84 283 300 57 83 – 455 242 Gorenjska M 576 24 42 5 25 106 92 1 – – 74 207 – Ž 511 17 31 3 16 18 96 116 27 34 – 153 109 Notranjsko-kraška M 152 10 11 1 8 20 24 0 – – 19 59 – Ž 113 1 2 1 4 7 17 28 3 8 – 42 21 Goriška M 279 11 19 4 13 58 35 0 – – 24 115 – Ž 278 9 15 1 14 17 36 81 7 13 – 85 36 Obalno-kraška M 307 15 21 1 18 42 55 1 – – 45 109 – Ž 296 8 14 1 12 16 65 63 9 20 – 88 70 Opis šifer MKB Description of the ICD code * Neupoštevano v skupnem številu: D06 - Maternični vrat, in situ (CIN III) Not included in All sites: D06 - Cervix uteri, in situ (CIN III) C16 Želodec Stomach C18 Debelo črevo Colon C19 Rektosigmoidna zveza Rectosigmoid junction C20 Rektum Rectum C34 Sapnica in pljuča Bronchus and lung C44 Druge maligne neoplazme kože Skin, other malignomas C50 Dojka Breast C53 Maternični vrat Cervix uteri C54 Maternično telo Corpus uteri C61 Prostata Prostate D06 Maternični vrat, CIN III Cervix uteri, in situ Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 6b. Starostno standardizirana* incidenca raka po statističnih regijah, po najpogostejših lokacijah in spolu - Slovenija 2003 Table 6b. Age standardised* cancer incidence rate by statistical regions, by most frequent sites and sex - Slovenia 2003 Statistična Spol Skupaj Lokacija (šifre MKB-10) Druga regija C00-C96 C16 C18 C19 C20 C34 C44 C50 C53 C54 C61 Other D06** Statistical region Sex All sites Site (ICD-10 codes) Slovenija, skupaj M 503,8 28,4 36,1 5,3 26,1 87,3 72,6 1,3 – – 55,6 191,0 – Slovenia, total Ž 479,5 18,4 28,3 4,3 17,6 26,9 80,3 104,9 20,3 27,6 – 150,9 85,2 Pomurska M 516,3 22,2 36,5 1,5 43,4 93,4 64,9 0,0 – – 84,5 169,8 – Ž 445,2 8,4 35,6 1,5 20,6 21,2 120,1 77,1 6,5 25,9 – 128,3 65,1 Podravska M 439,9 37,7 40,8 4,4 24,9 87,0 46,3 1,2 – – 43,9 153,7 – Ž 406,6 28,3 29,9 4,7 21,0 25,3 45,9 90,6 20,8 21,6 – 118,5 54,2 Koroška M 493,0 22,4 30,5 2,6 16,5 97,1 84,8 2,7 – – 45,5 191,0 – Ž 472,0 23,6 28,3 14,0 14,3 28,0 107,6 81,9 16,6 19,6 – 138,1 50,4 Savinjska M 401,2 24,2 29,4 8,2 16,6 82,9 39,0 2,4 – – 29,6 168,9 – Ž 464,4 18,3 36,3 4,7 18,2 30,7 51,6 100,3 27,6 22,6 – 154,0 122,3 Zasavska M 487,7 28,7 32,6 0,0 26,5 63,5 63,7 0,0 – – 33,5 239,2 – Ž 403,4 18,2 36,2 12,0 11,5 28,8 42,6 81,0 8,3 20,5 – 144,2 60,7 Spodnjeposavska M 452,7 34,9 21,8 13,7 41,5 72,9 29,2 2,7 – – 33,9 202,0 – Ž 447,1 18,2 18,7 7,6 15,3 8,1 50,4 99,1 33,4 32,7 – 163,6 107,0 Jugovzhodna Slovenija M 547,5 49,1 34,3 5,6 36,3 82,5 68,8 1,7 – – 46,2 223,1 – Ž 477,0 16,4 22,3 0,0 13,4 31,5 66,4 115,8 15,0 29,5 – 166,5 42,3 Osrednjeslovenska M 564,8 23,9 38,8 5,7 24,4 88,8 104,8 1,2 – – 70,0 207,2 – Ž 559,3 19,0 27,7 5,1 16,2 32,6 110,4 116,4 22,1 32,4 – 177,5 94,0 Gorenjska M 593,0 24,5 43,6 5,1 25,3 108,7 94,5 1,0 – – 74,9 215,4 – Ž 508,6 16,9 30,2 3,1 16,1 18,2 95,7 116,1 27,0 34,0 – 151,5 109,0 Notranjsko-kraška M 556,4 37,0 40,7 3,4 29,0 71,8 87,1 0,0 – – 67,3 220,2 – Ž 422,3 2,9 5,7 4,0 15,5 27,1 59,0 108,4 11,9 31,5 – 156,4 84,0 Goriška M 428,6 16,1 27,5 6,0 20,6 90,1 52,0 0,0 – – 36,3 180,1 – Ž 420,8 12,3 22,0 1,4 20,9 26,2 53,4 124,6 11,1 19,6 – 129,2 61,4 Obalno-kraška M 521,9 24,4 33,8 1,5 30,6 72,4 92,2 1,5 – – 77,4 188,1 – Ž 523,0 14,3 24,7 1,8 21,0 28,2 114,8 111,6 16,0 34,8 – 156,0 130,8 * Standard - prebivalstvo Slovenije po popisu 2002 Standard - population of Slovenia according to census 2002 Opis šifer MKB Description of the ICD code C16 Želodec Stomach C18 Debelo črevo Colon C19 Rektosigmoidna zveza Rectosigmoid junction C20 Rektum Rectum C34 Sapnica in pljuča Bronchus and lung C44 Druge maligne neoplazme kože Skin, other malignomas C50 Dojka Breast C53 Maternični vrat Cervix uteri C54 Maternično telo Corpus uteri C61 Prostata Prostate D06 Maternični vrat, CIN III Cervix uteri, in situ Cancer Incidence in Slovenia 2003 55 ** Neupoštevano v skupnem številu: D06 - Maternični vrat, in situ (CIN III) Not included in All sites: D06 - Cervix uteri, in situ (CIN III) 56 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 7. Število histološko (in citološko) potrjenih novih primerov raka - po histološki vrsti in lokaciji - Slovenija 2003 Table 7. Number of histologically (and cytologically) confirmed new cancer cases by histologic type and site - Slovenia 2003 Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C00 C01 C02 C03 C04 C05 C06 C07 C08 C09 Vse vrste/ All Types 8393 901 22 – 15 2 24 – 7 1 39 – 12 – 23 – 10 – 2 – 26 – Small cell carcinoma 160 68 – – – – – – – – – – – – – – – – – – – – Non-small cell carcinoma 44 36 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 20 – 15 – 24 – 6 – 39 – 11 – 21 – – – – – 25 – Basal cell carcinoma 1230 19 – – – – – – – – – – – – – – – – – – – – Transitional cell carcinoma 214 4 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 4047 245 – – – – – – – – – – – – 2 – 4 – 2 – – – Other specified carcinomas 136 26 – – – – – – – – – – 1 – – – 5 – – – 1 – Carcinoma, unspecified 167 171 2 – – 2 – – 1 1 – – – – – – – – – – – – Malignant thymoma 3 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – – – – – – – – – – – – – – – – – Fibrosarcoma 4 – – – – – – – – – – – – – – – 1 – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – – – – – – – – – – – – – – – Liposarcoma 18 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 30 – – – – – – – – – – – – – – – – – – – – – Rhabdomyosarcoma 4 1 – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 6 4 – – – – – – – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 43 – – – – – – – – – – – – – – – – – – – – – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors 3 – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 42 – – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 13 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 101 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 – – – – – – – – – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 50 4 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 68 21 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 9 31 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 1 – – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 9 15 – – – – – – – – – – – – – – – – – – – – nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2003 57 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 7. – Table 7. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C10 C11 C12 C13 C14 C15 C16 C17 C18 C19 Vse vrste/ All Types 8393 901 53 – 5 – 17 – 21 – 1 – 86 3 437 10 16 – 618 5 90 – Small cell carcinoma 160 68 – – – – – – – – – – – – – – – – 1 – – – Non-small cell carcinoma 44 36 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 53 – 5 – 17 – 21 – 1 – 59 1 – – – – – – – – Basal cell carcinoma 1230 19 – – – – – – – – – – – – – – – – – – – – Transitional cell carcinoma 214 4 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 4047 245 – – – – – – – – – – 16 1 412 3 11 – 601 2 90 – Other specified carcinomas 136 26 – – – – – – – – – – 3 – 2 – – – 2 – – – Carcinoma, unspecified 167 171 – – – – – – – – – – 7 1 14 7 – – 14 3 – – Malignant thymoma 3 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – – – – – – – – – – – – – – – – – Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – – – – – – – – – – – – – – – Liposarcoma 18 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 30 – – – – – – – – – – – – – 1 – – – – – – – Rhabdomyosarcoma 4 1 – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 6 4 – – – – – – – – – – 1 – – – – – – – – – Malignant complex mixed and stromal tumors 43 – – – – – – – – – – – – – 8 – 5 – – – – – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors 3 – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 42 – – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 13 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 101 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 – – – – – – – – – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 50 4 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 68 21 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 9 31 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 1 – – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 9 15 – – – – – – – – – – – – – – – – – – – – 58 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Tabela 7. – Table 7. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C20 C21 C22 C23 C24 C25 C26 C30 C31 C32 Vse vrste/ All Types 8393 901 422 2 17 – 61 19 26 1 34 3 102 23 – 2 2 – 10 1 97 – Small cell carcinoma 160 68 1 – – – – – – – – – 1 – – – – – – – – – Non-small cell carcinoma 44 36 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 – – 10 – – – 1 – – – – – – – – – 2 – 93 – Basal cell carcinoma 1230 19 – – – – – – – – – – – – – – – – – – – – Transitional cell carcinoma 214 4 – – 2 – – – – – – – – – – – – – – – – – Adenocarcinoma 4047 245 412 2 5 – 58 16 22 – 31 1 86 16 – – – – 5 – – – Other specified carcinomas 136 26 – – – – 1 – 2 – 1 – 3 – – – – – 1 – – – Carcinoma, unspecified 167 171 9 – – – 1 2 1 1 2 2 12 6 – 2 – – – – 4 – Malignant thymoma 3 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – – – – – – – – – – – 2 – 1 – – – Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – – – – – – – – – – – – – – – Liposarcoma 18 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 30 – – – – – – – – – – – – – – – – – 1 – – – Rhabdomyosarcoma 4 1 – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – 1 – – – – – – – – – – – – – – – Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 6 4 – – – – – – – – – – – – – – – – – 1 – – Malignant complex mixed and stromal tumors 43 – – – – – – – – – – – – – – – – – – – – – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors 3 – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 42 – – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 13 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 101 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 – – – – – – – – – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 50 4 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 68 21 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 9 31 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 1 – – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 9 15 – – – – – 1 – – – – – 1 – – – – – – – – nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2003 59 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 7. – Table 7. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C33 C34 C37 C38 C39 C40 C41 C43 C44 C45 Vse vrste/ All Types 8393 901 6 1 696 356 3 – 4 – – – 18 2 10 – 327 4 1521 32 31 1 Small cell carcinoma 160 68 1 – 148 65 – – – – – – – – – – – – – – – – Non-small cell carcinoma 44 36 1 – 43 36 – – – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 3 – 221 101 – – – – – – – – – – – – 276 10 – – Basal cell carcinoma 1230 19 – – – – – – – – – – – – – – – – 1223 19 – – Transitional cell carcinoma 214 4 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 4047 245 – 1 216 115 – – – – – – – – – – – – 12 2 – – Other specified carcinomas 136 26 – – 53 18 – – – – – – – – – – – – 1 – – – Carcinoma, unspecified 167 171 1 – 10 16 – – – – – – – – – – – – – 1 – – Malignant thymoma 3 – – – – – 3 – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – – – – – – – – – – – 327 4 – – – – Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – – – – – – – – – – – 6 – – – Liposarcoma 18 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 30 – – – 1 – – – – – – – – – – – – – 2 – – – Rhabdomyosarcoma 4 1 – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – – – – – 4 2 2 – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – 10 – 6 – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – 1 – – – 2 – 1 – – – – – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – – – 1 – – – Sarcoma, unspecified 6 4 – – – – – – 1 – – – 2 – – – – – – – – – Malignant complex mixed and stromal tumors 43 – – – 1 – – – – – – – – – – – – – – – – – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – – – – – 31 1 Malignant gonadal stromal tumors 3 – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 42 – – – – – – – 1 – – – – – – – – – – – – – Malignant trophoblastic tumors 13 – – – 1 – – – – – – – – – – – – – – – – – Malignant gliomas 101 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 – – – – – – – 1 – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 50 4 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 68 21 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 9 31 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 1 – – – – – – – – – – – – – 1 – – – – – – – Malignant tumor, unspecified 9 15 – – 2 5 – – – – – – – – – – – – – – – – 60 Incidenca raka v Sloveniji 2003 nadaljevanje / cont’d ➝ Tabela 7. – Table 7. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C46 C47 C48 C49 C50 C51 C52 C53 C54 C55 Vse vrste/ All Types 8393 901 1 – 4 – 18 – 36 3 937 126 56 – 15 – 207 – 283 1 11 – Small cell carcinoma 160 68 – – – – – – – – – – – – 1 – 2 – – – – – Non-small cell carcinoma 44 36 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 – – – – – – – – – – 43 – 7 – 170 – – – – – Basal cell carcinoma 1230 19 – – – – – – – – – – 6 – – – 1 – – – – – Transitional cell carcinoma 214 4 – – – – – – – – – – – – – – – – – – – – Adenocarcinoma 4047 245 – – – – 1 – – – 922 24 3 – – – 19 – 238 1 1 – Other specified carcinomas 136 26 – – – – – – – – 2 – – – 3 – 12 – 29 – – – Carcinoma, unspecified 167 171 – – – – – – – – 11 101 1 – 2 – 2 – – – – – Malignant thymoma 3 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – – – – – – – 2 – 1 – – – – – – – Fibrosarcoma 4 – – – – – – – 3 – – – – – – – – – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – 3 – 1 – – – – – – – – – – – Liposarcoma 18 – – – – – 6 – 11 – – – – – – – – – – – – – Leiomyosarcoma 30 – – – – – 5 – 9 – – – 1 – 1 – – – 4 – 4 – Rhabdomyosarcoma 4 1 – – – – – – 3 1 – – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – 3 – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – 1 – – – – – – – – – – – Kaposi sarcoma 1 – 1 – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – 1 – – – – – – – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – 1 – – – – – – – – – 1 – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 6 4 – – – – 1 – 1 2 – 1 – – – – – – – – – – Malignant complex mixed and stromal tumors 43 – – – – – 2 – 1 – – – – – – – 1 – 11 – 6 – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors 3 – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – – – – – 2 – – – – – – – – – – – – – – – Other malignant germ cell tumors 42 – – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 13 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 101 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 – – – 1 – – – – – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – 3 – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 50 4 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 68 21 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 9 31 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 1 – – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 9 15 – – – – 1 – – – – – – – – – – – – – – – Onkološki inštitut Ljubljana, Register raka za Slovenijo nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2003 61 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 7. – Table 7. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C56 C57 C58 C60 C61 C62 C63 C64 C65 C66 Vse vrste/ All Types 8393 901 163 14 8 – – – 9 – 477 6 109 – 2 – 159 3 16 – 4 – Small cell carcinoma 160 68 – – – – – – – – – – – – – – – – – – – – Non-small cell carcinoma 44 36 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 – – – – – – 8 – – – – – – – – – – – – – Basal cell carcinoma 1230 19 – – – – – – – – – – – – – – – – – – – – Transitional cell carcinoma 214 4 – – – – – – – – 2 – – – – – – – 16 – 4 – Adenocarcinoma 4047 245 149 8 6 – – – – – 421 4 – – – – 156 3 – – – – Other specified carcinomas 136 26 2 – – – – – – – 1 – – – – – – – – – – – Carcinoma, unspecified 167 171 3 6 – – – – – – 52 2 – – – – 1 – – – – – Malignant thymoma 3 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – – – – – – – – – – – – – – – – – Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – – – – – – – – – – – – – – – Liposarcoma 18 – – – – – – – – – – – – – 1 – – – – – – – Leiomyosarcoma 30 – – – – – – – 1 – – – – – – – – – – – – – Rhabdomyosarcoma 4 1 – – – – – – – – 1 – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – – – – – 1 – – – – – – – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 6 4 – – – – – – – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 43 – 2 – 2 – – – – – – – – – 1 – 2 – – – – – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors 3 – 3 – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – 2 – – – – – – – – – 57 – – – – – – – – – Other malignant germ cell tumors 42 – 2 – – – – – – – – – 39 – – – – – – – – – Malignant trophoblastic tumors 13 – – – – – – – – – – – 12 – – – – – – – – – Malignant gliomas 101 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 – – – – – – – – – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 50 4 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 68 21 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 9 31 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 1 – – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 9 15 – – – – – – – – – – – – – – – – – – – – 62 Incidenca raka v Sloveniji 2003 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 7. – Table 7. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C67 C68 C69 C70 C71 C72 C73 C74 C75 C76 Vse vrste/ All Types 8393 901 211 5 1 – 9 1 4 – 100 – 3 – 107 8 – 1 2 – 4 3 Small cell carcinoma 160 68 3 – – – – – – – – – – – – – – – – – – – Non-small cell carcinoma 44 36 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 6 – – – 1 – – – – – – – – – – – – – – 2 Basal cell carcinoma 1230 19 – – – – – – – – – – – – – – – – – – – – Transitional cell carcinoma 214 4 189 3 1 – – – – – – – – – – – – – – – – – Adenocarcinoma 4047 245 3 – – – – – – – – – – – 104 3 – 1 – – 1 1 Other specified carcinomas 136 26 6 – – – – – – – – – – – 3 5 – – – – – – Carcinoma, unspecified 167 171 3 1 – – – – – – – – – – – – – – – – 2 – Malignant thymoma 3 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – 7 1 – – – – – – – – – – – – – – Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – – – – – – – – – – – – – – – Liposarcoma 18 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 30 – – – – – – – – – – – – – – – – – – – – – Rhabdomyosarcoma 4 1 – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 6 4 – – – – – – – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 43 – – – – – – – – – – – – – – – – – – – 1 – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors 3 – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – – – – – – – – – – – – – – – – – 2 – – – Other malignant germ cell tumors 42 – – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 13 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 101 – – – – – – – – – 98 – 3 – – – – – – – – – Malignant neuroepithelial tumors 3 – – – – – 1 – – – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – 4 – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – – – – – – – – – – – Hodgkin lymphoma 50 4 – – – – – – – – – – – – – – – – – – – – Plasma cell tumors 68 21 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 9 31 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 1 – – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 9 15 1 1 – – – – – – 2 – – – – – – – – – – – nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2003 63 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 7. – Table 7. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C77 C78 C79 C80 C81 C82 C83 C84 C85 C88 Vse vrste/ All Types 8393 901 14 12 23 23 18 7 20 37 50 4 53 4 107 28 15 – 14 14 4 – Small cell carcinoma 160 68 – – – 1 1 1 1 1 – – – – – – – – – – – – Non-small cell carcinoma 44 36 – – – – – – – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 9 3 1 – 4 2 – 1 – – – – – – – – – – – – Basal cell carcinoma 1230 19 – – – – – – – – – – – – – – – – – – – – Transitional cell carcinoma 214 4 – 1 – – – – – – – – – – – – – – – – – – Adenocarcinoma 4047 245 2 3 16 12 6 2 14 24 – – – – – – – – – – – – Other specified carcinomas 136 26 1 1 – 1 1 – – 1 – – – – – – – – – – – – Carcinoma, unspecified 167 171 2 3 5 8 3 1 2 5 – – – – – – – – – – – – Malignant thymoma 3 – – – – – – – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – 2 – 2 1 – – – – – – – – – – – – Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – – – – – – – – – – – – – – – Liposarcoma 18 – – – – – – – – – – – – – – – – – – – – – Leiomyosarcoma 30 – – – – – – – – – – – – – – – – – – – – – Rhabdomyosarcoma 4 1 – – – – – – – – – – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – – – – – – – Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – – – – – – – – – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – – – – – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – – – – – – – – – – – – – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – – Sarcoma, unspecified 6 4 – – – – – – – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 43 – – – – – – – – – – – – – – – – – – – – – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – – – – – – – Malignant gonadal stromal tumors 3 – – – – – – – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – – – – – – – – – – – – – – – – – – – – – Other malignant germ cell tumors 42 – – – – – – – – – – – – – – – – – – – – – Malignant trophoblastic tumors 13 – – – – – – – – – – – – – – – – – – – – – Malignant gliomas 101 – – – – – – – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 – – – – – – – – – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – 53 4 107 28 15 – 14 14 4 – Hodgkin lymphoma 50 4 – – – – – – – – 50 4 – – – – – – – – – – Plasma cell tumors 68 21 – – – – – – – – – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – – – – – – – – – – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – – – – – – – – – – – – – – – – – – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – – – – – – – – – Myelodysplastic syndromes 9 31 – – – – – – – – – – – – – – – – – – – – Other specified malignant tumors 1 – – – – – – – – – – – – – – – – – – – – – Malignant tumor, unspecified 9 15 – 1 1 1 1 1 1 4 – – – – – – – – – – – – 64 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 7. – Table 7. Nadaljevanje – Continued Histološka vrsta Skupaj L o k a c i j a ( š i f r e M K B - 1 0 ) Histologic type All sites S i t e ( I C D - 1 0 c o d e s ) C90 C91 C92 C93 C94 C95 C96 Vse vrste/ All Types 8393 901 68 21 49 32 68 13 5 – – 1 3 1 15 65 Small cell carcinoma 160 68 – – – – – – – – – – – – – – Non-small cell carcinoma 44 36 – – – – – – – – – – – – – – Squamous cell carcinoma 1172 120 – – – – – – – – – – – – – – Basal cell carcinoma 1230 19 – – – – – – – – – – – – – – Transitional cell carcinoma 214 4 – – – – – – – – – – – – – – Adenocarcinoma 4047 245 – – – – – – – – – – – – – – Other specified carcinomas 136 26 – – – – – – – – – – – – – – Carcinoma, unspecified 167 171 – – – – – – – – – – – – – – Malignant thymoma 3 – – – – – – – – – – – – – – – Malignant paraganglioma/ pheochromocytoma – – – – – – – – – – – – – – – – Malignant melanoma 344 6 – – – – – – – – – – – – – – Fibrosarcoma 4 – – – – – – – – – – – – – – – Fibrohistiocytic sarcoma 10 – – – – – – – – – – – – – – – Liposarcoma 18 – – – – – – – – – – – – – – – Leiomyosarcoma 30 – – – – – – – – – – – – – – – Rhabdomyosarcoma 4 1 – – – – – – – – – – – – – – Synovial sarcoma 3 – – – – – – – – – – – – – – – Angiosarcoma 2 – – – – – – – – – – – – – – – Kaposi sarcoma 1 – – – – – – – – – – – – – – – Osteosarcoma 7 2 – – – – – – – – – – – – – – Chondrosarcoma 16 – – – – – – – – – – – – – – – Ewing sarcoma/PNET 7 – – – – – – – – – – – – – – – Other specified sarcomas 1 – – – – – – – – – – – – – – – Sarcoma, unspecified 6 4 – – – – – – – – – – – – – – Malignant complex mixed and stromal tumors 43 – – – – – – – – – – – – – – – Malignat fibroepithelial tumors – – – – – – – – – – – – – – – – Malignant mesothelioma 31 1 – – – – – – – – – – – – – – Malignant gonadal stromal tumors 3 – – – – – – – – – – – – – – – Dysgerminoma and seminoma 63 – – – – – – – – – – – – – – – Other malignant germ cell tumors 42 – – – – – – – – – – – – – – – Malignant trophoblastic tumors 13 – – – – – – – – – – – – – – – Malignant gliomas 101 – – – – – – – – – – – – – – – Malignant neuroepithelial tumors 3 – – – – – – – – – – – – – – – Malignant meningioma 4 – – – – – – – – – – – – – – – Malignant nerve sheath tumors 3 – – – – – – – – – – – – – – – Non Hodgkin lymphoma 193 46 – – – – – – – – – – – – – – Hodgkin lymphoma 50 4 – – – – – – – – – – – – – – Plasma cell tumors 68 21 68 21 – – – – – – – – – – – – Chronic lymphoid leukemia 23 28 – – 23 28 – – – – – – – – – – Leukemia except chronic lymphoid 102 19 – – 26 4 68 13 5 – – 1 3 1 – – Other lymphoreticular neoplasms – – – – – – – – – – – – – – – – Chronic myeloproliferative diseases 6 34 – – – – – – – – – – – – 6 34 Myelodysplastic syndromes 9 31 – – – – – – – – – – – – 9 31 Other specified malignant tumors 1 – – – – – – – – – – – – – – – Malignant tumor, unspecified 9 15 – – – – – – – – – – – – – – Cancer Incidence in Slovenia 2003 65 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 8. Število primerov ne-Hodgkinovih limfomov* po lokaciji, spolu in starosti Slovenija 2003 Table 8. Total number of non-Hodgkin's malignant lymphomas* by site, sex, and age - Slovenia 2003 Šifra Vse S t a r o s t i MKB-8 Lokacija Spol starosti A g e ICD-8 Site Sex All code ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Skupaj 235 1 3 4 – 1 3 9 3 11 11 17 11 22 29 37 38 35 Vse lokacije Total Moški 95 – 3 2 – – 3 3 2 6 3 4 7 14 14 11 11 12 All sites Male Ženske 140 1 – 2 – 1 – 6 1 5 8 13 4 8 15 26 27 23 Female 141 Jezik M – – – – – – – – – – – – – – – – – –Tongue Ž 1 – – – – – – – – – 1 – – – – – – – 142 Slinavke M 1 – – – – – – – – – – – – 1 – – – –Salivary glands Ž 2 – – – – – – – – – – – – – – 1 – 1 143 Dlesni M – – – – – – – – – – – – – – – – – –Gum Ž 1 – – – – – – – – – – – – – – 1 – – 145 Usta, drugo M – – – – – – – – – – – – – – – – – –Mouh, other parts Ž 2 – – – – – – – – – – – – – – – 1 1 146 Orofarinks M 3 – – – – – – – – 1 – – 1 – – – 1 –Oropharynx Ž 3 – – – – – – – – – – – – – – – – 3 147 Epifarinks M 1 – – – – – – – – – – – – – 1 – – –Epipharynx Ž 1 – – – – – – – – – – – – – – 1 – – 151 Želodec M 13 – – – – – – – – 1 1 1 2 – 2 2 3 1Stomach Ž 27 – – – – – – 2 – 2 1 1 2 1 3 5 8 2 152 Tanko črevo M 1 – – – – – – – – – – – – – 1 – – –Small intestine Ž 3 – – – – – – – – – – 1 – 1 1 – – – 153 Debelo črevo M 2 – – – – – 1 – – – – – – – – 1 – –Colon Ž – – – – – – – – – – – – – – – – – – 154 Rektum M – – – – – – – – – – – – – – – – – –Rectum Ž 1 – – – – – – – – – – – – – – – – 1 155 Jetra M – – – – – – – – – – – – – – – – – –Liver Ž 1 – – – – – – 1 – – – – – – – – – – 158 Retro- in peritonej M – – – – – – – – – – – – – – – – – –Retro- and peritoneum Ž 1 – – – – – – – – – – – – – – 1 – – 160 Nos, obnosne votline, drugo M 1 – – – – – – – – – – – – – – – – 1Nose, sinuses, etc. Ž 1 1 – – – – – – – – – – – – – – – – 161 Grlo M 1 – – – – – – – – – – – – – 1 – – –Larynx Ž – – – – – – – – – – – – – – – – – – 162 Sapnik, sapnica, pljuča M 1 – – – – – – – – – – 1 – – – – – –Trachea, bronchus, lung Ž 1 – – – – – – – – – – – 1 – – – – – 170 Kosti M 1 – – – – – – – – – – – – – – – 1 –Bone Ž 3 – – – – – – 1 – – – – – – – 2 – – 171 Mehka tkiva M 1 – – – – – – – – – – – 1 – – – – –Soft tissues Ž 1 – – – – – – – – – – – – – – – 1 – 173 Koža, drugi malignomi M 1 – – – – – – – – – – – – – – 1 – –Skin, other malignancies Ž 5 – – – – – – – – – – – 1 2 – 1 – 1 174 Dojka M – – – – – – – – – – – – – – – – – –Breast Ž 1 – – – – – – – – – – – – – – – – 1 189 Ledvica, sečevod, drugo M 1 – – – – – – – – – – 1 – – – – – –Kidney, ureter, etc. Ž 1 – – – – – – – – – – – – – – – 1 – 190 Oko M – – – – – – – – – – – – – – – – – –Eye Ž 3 – – – – – – – – – 1 – – – – – 2 – 191 Možgani M 2 – – – – – – – – – – – 1 1 – – – –Brain Ž 2 – – 1 – – – – – – – – – – – 1 – – 193 Ščitnica M – – – – – – – – – – – – – – – – – –Thyroid Ž 1 – – – – – – – – – 1 – – – – – – – 202 Bezgavke M 65 – 3 2 – – 2 3 2 4 2 1 2 12 9 7 6 10Lymph nodes Ž 78 – – 1 – 1 – 2 1 3 4 11 – 4 11 13 14 13 * Vključeni so samo citološko in histološko potrjeni primeri All cases included have been verified citologically and histologically Tabela 9. Število novih primerov raka po bolnišnicah ugotovitve diagnoze ter število in odstotek* primerov, napotenih na Onkološki inštitut Ljubljana (OI) - Slovenija 2003 Table 9. Number of new cancer cases diagnosed by reporting hospitals, and number and percentage* of cases referred to the Institute of Oncology Ljubljana (IO) - Slovenia 2003 Bolnišnice Število novih Napoteni na OI primerov Število Odstotek* Hospitals Number of new Referred to the IO cases Number Percent* Skupaj 9860 4831 49Total Onkološki inštitut, Ljubljana 712 712 100 Institute of Oncology Ljubljana Klinični center Ljubljana 3045 1218 40 Medical center Ljubljana SPS Interna klinika 668 253 38 Klinični oddelek za gastroenterologijo 286 111 39 Drugi klinični oddelki 382 142 37 SPS Kirurška klinika 1748 558 32 Klinični oddelek za abdominalno kirurgijo 371 160 43 Klinični oddelek za nevrokirurgijo 108 76 70 Klinični oddelek za maksilofacialno in oralno kirurgijo 50 37 74 Klinični oddelek za plastično kirurgijo in opekline 676 66 10 Klinični oddelek za torakalno kirurgijo 85 44 52 Klinični oddelek za urologijo 448 172 38 Drugi klinični oddelki 10 3 SPS Ginekološka klinika 255 156 61 SPS Nevrološka klinika 25 13 52 SPS Pediatrična klinika 29 18 62 Dermatovenerološka klinika 32 17 53 Klinika za infekcijske bolezni in vročinska stanja 22 11 50 Klinika za otorinolaringologijo in cervikofacialno kirurgijo 209 163 78 Očesna klinika 34 8 24 Ortopedska klinika 23 21 91 66 Incidenca raka v Sloveniji 2003 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 9. – Table 9. Nadaljevanje – Continued Bolnišnice Število novih Napoteni na OI primerov Število Odstotek* Hospitals Number of new Referred to the IO cases Number Percent* Splošne in specialistične bolnišnice 5272 2521 48 General and special hospitals Splošna bolnišnica Brežice 112 56 50 Splošna bolnišnica Celje 677 358 53 Bolnišnica Golnik 466 336 72 Splošna bolnišnica Jesenice 240 107 45 Splošna bolnišnica Izola 287 126 44 Splošna bolnišnica Maribor 1415 588 42 Splošna bolnišnica Murska Sobota 455 171 38 Splošna bolnišnica dr. Franc Derganc Nova Gorica 355 184 52 Splošna bolnišnica Novo mesto 476 239 50 Splošna bolnišnica dr. Jožeta Potrča Ptuj 79 37 47 Splošna bolnišnica Slovenj Gradec 371 107 29 Splošna bolnišnica Trbovlje 74 40 54 Bolnišnica za ginekologijo in porodništvo Kranj 57 31 54 Bolnišnica Topolšica 149 101 68 Bolnišnica za ginekologijo in porodništvo Postojna 34 22 65 Bolnica Sežana 23 16 70 Ortopedska bolnica Valdoltra 2 2 Psihiatrična klinika Ljubljana – – Psihiatrična bolnišnica Begunje – – Psihiatrična bolnišnica Idrija – – Zasebne ordinacije 640 233 36 Private clinics Drugi zdravstveni zavodi 191 147 77 Other health institutions * Odstotki niso računani pri številih pod 15 Percentages are not calculated for less than 15 cases Cancer Incidence in Slovenia 2003 67 Institute of Oncology Ljubljana, Cancer Registry of Slovenia 68 Incidenca raka v Sloveniji 2003 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 10. Število in odstotek* novih primerov raka (brez registriranih samo iz zdravniških poročil o vzroku smrti) po stadiju, lokaciji in spolu - Slovenija 2003 Table 10. Number and percentage* of new cancer cases (without cases registered from death certificates only) by stage, site and sex - Slovenia 2003 S t a d i j Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number Localized Regional Remote Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C00 Vse lokacije M+Ž 9860 4450 45 2780 28 2267 23 362 4 – M 4965 2037 41 1469 30 1245 25 214 4 C96 All sites Ž 4895 2413 49 1311 27 1022 21 148 3 C00 Ustnica M 16 14 88 1 6 – – 1 6Lip Ž 6 6 – – – C01 Baza jezika M 13 1 10 2 –Base of tongue Ž 4 – 4 – – C02 Jezik, drugi deli M 20 7 35 13 65 – – – –Tongue, other & unspecified parts Ž 4 2 2 – – C03 Dlesen M 3 – 3 – –Gum Ž 5 1 3 1 – C04 Ustno dno M 31 10 32 21 68 – – – –Floor of mouth Ž 8 1 7 – – C05 Nebo M 12 3 9 – –Palate Ž – – – – – C06 Usta, drugi deli M 21 11 52 10 48 – – – –Mouth, other & unspecified parts Ž 2 1 1 – – C07 Parotidna žleza M 4 1 3 – –Parotid gland Ž 6 4 2 – – C08 Druge in neopredeljene velike žleze slinavke M 2 1 1 – – Other & unspecified major Ž – – – – – salivary glands C09 Tonzila M 20 6 30 14 70 – – – –Tonsil Ž 6 – 6 – – C10 Orofarinks M 47 3 6 42 89 2 4 – –Oropharynx Ž 6 2 4 – – C11 Nazofarinks M 3 1 2 – –Nasopharynx Ž 2 – 2 – – C12 Piriformni sinus M 16 2 13 14 88 – – – –Pyriform sinus Ž 1 – 1 – – C13 Hipofarinks M 19 3 16 15 79 1 5 – –Hypopharynx Ž 3 1 2 – – C14 Druga in slabo opredeljena mesta na ustnici, v ustni votlini in farinksu M 1 – 1 – – Other and ill-defined sites in the lip, Ž – – – – – oral cavity and pharynx C15 Požiralnik M 77 20 26 28 36 21 27 8 10Oesophagus Ž 17 2 12 12 71 1 6 2 12 C16 Želodec M 279 48 17 105 38 109 39 17 6Stomach Ž 186 39 21 67 36 59 32 21 11 C17 Tanko črevo M 11 5 3 3 –Small intestine Ž 5 3 1 1 – C18 Debelo črevo M 359 43 12 214 60 95 26 7 2Colon Ž 289 36 12 178 62 63 22 12 4 C19 Rektosigmoidna zveza M 53 14 26 22 42 14 26 3 6Rectosigmoid junction Ž 44 7 16 24 55 12 27 1 2 nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2003 69 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 10. – Table 10. Nadaljevanje – Continued S t a d i j Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number Localized Regional Remote Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C20 Rektum M 258 41 16 154 60 56 22 7 3Rectum Ž 180 26 14 108 60 32 18 14 8 C21 Anus in analni kanal M 11 3 5 1 2Anus and anal canal Ž 6 3 2 1 – C22 Jetra in intrahepatični vodi M 77 34 44 5 6 26 34 12 16Liver and intrahepatic bile ducts Ž 48 13 27 10 21 21 44 4 8 C23 Žolčnik M 15 1 7 4 27 9 60 1 7Gallbladder Ž 23 3 13 12 52 8 35 – – Drugi in neopredeljeni deli biliarnega trakta M 37 3 8 23 62 5 14 6 16C24 Billiary tract, other Ž 22 7 32 7 32 2 9 6 27 and unspecified parts C25 Trebušna slinavka M 116 2 2 36 31 68 59 10 9Pancreas Ž 105 6 6 23 22 65 62 11 10 Druga in slabo opredeljena mesta v prebavnih organih M – – – – –C26 Other and ill-defined Ž 3 – – 2 1 digestive organs C30 Nosna votlina in srednje uho M 1 – 1 – –Nasal cavity and middle ear Ž 1 – 1 – – C31 Obnosni sinusi M 7 1 5 – 1Accessory sinuses Ž 4 2 2 – – C32 Grlo M 92 52 57 39 42 1 1 – –Larynx Ž 5 2 3 – – C33 Sapnik M 7 – 3 4 –Trachea Ž – – – – – C34 Sapnica in pljuča M 860 141 16 349 41 346 40 24 3Bronchus and lung Ž 271 36 13 99 37 126 46 10 4 C37 Timus M 1 – – 1 –Thymus Ž 2 1 – 1 – C38 Srce, mediastinum, plevra M 2 – 1 1 –Heart, mediastinum, pleura Ž 3 1 2 – – Druga in slabo opredeljena mesta v dihalih in prsnih organih M – – – – –C39 Other and ill-defined sites in the respi- Ž – – – – – ratory system and intrathoracic organs C40 Kosti, sklepni hrustanec udov M 12 4 7 1 –Bone and articular cartilage of limbs Ž 8 3 4 1 – C41 Kosti, sklepni hrustanec, drugje M 8 1 5 – 2Bone and articular cartilage of other and unspecified parts Ž 2 1 1 – – C43 Maligni melanom kože M 167 131 78 28 17 4 2 4 2Malignant melanoma of skin Ž 164 136 83 20 12 3 2 5 3 C44 Druge maligne neoplazme kože M 729 711 98 16 2 1 – 1 –Skin, other malignomas Ž 834 820 98 13 2 – – 1 – C45 Mezoteliom M 20 9 45 6 30 2 10 3 15Mesothelioma Ž 12 5 6 1 – C46 Kaposijev sarkom M 1 1 – – –Kaposi's sarcoma Ž – – – – – 70 Incidenca raka v Sloveniji 2003 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 10. – Table 10. Nadaljevanje – Continued S t a d i j Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number Localized Regional Remote Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C47 Periferni živci in avtonomno živčevje M 3 2 – 1 –Peripheral nerves and autonomic nervous system Ž 1 1 – – – C48 Retro- in peritonej M 6 – 3 1 2Retro- and peritoneum Ž 12 3 8 1 – C49 Drugo vezivno in mehko tkivo M 18 8 44 7 39 3 17 – –Other connective and soft tissue Ž 21 12 57 7 33 2 10 – – C50 Dojka M 13 6 6 1 –Breast Ž 1073 536 50 435 41 94 9 8 1 C51 Žensko zunanje spolovilo M – – – – –Vulva Ž 56 42 75 13 23 1 2 – – C52 Nožnica M – – – – –Vagina Ž 15 6 40 5 33 4 27 – – C53 Maternični vrat M – – – – –Cervix uteri Ž 208 133 64 61 29 11 5 3 1 C54 Maternično telo M – – – – –Corpus uteri Ž 285 218 76 42 15 21 7 4 1 C55 Maternica, neopredeljeno M – – – – –Uterus, unspecified Ž 13 3 7 3 – C56 Jajčnik M – – – – –Ovary Ž 181 29 16 15 8 134 74 3 2 Drugi in neopredeljeni ženski spolni organi M – – – – –C57 Other and unspecified parts of Ž 8 – 3 5 – female genital organs C58 Posteljica M – – – – –Placenta Ž – – – – – C60 Penis M 10 7 2 1 –Penis Ž – – – – – C61 Prostata M 544 320 59 106 19 65 12 53 10Prostate Ž – – – – – C62 Modo M 109 66 61 28 26 13 12 2 2Testis Ž – – – – – Drugi in neopredeljeni moški spolni organi M 2 1 1 – – C63 Other and unspecified male Ž – – – – – genital organs C64 Ledvica razen meha M 121 70 58 20 17 25 21 6 5Kidney, except renal pelvis Ž 72 40 56 7 10 18 25 7 10 C65 Ledvični meh M 9 3 4 1 1Renal pelvis Ž 7 1 3 3 – C66 Sečevod M 4 1 3 – –Ureter Ž – – – – – C67 Sečni mehur M 162 115 71 29 18 10 6 8 5Bladder Ž 63 41 65 11 17 5 8 6 10 C68 Drugi in neopredeljeni sečni organi M 1 – – – 1Other and unspecified urinary organs Ž – – – – – C69 Oko in očesni adneksi M 9 6 3 – –Eye and adnexa Ž 9 8 1 – – C70 Meninge M 3 3 – – –Meninges Ž 1 1 – – – C71 Možgani M 55 54 98 – – 1 2 – –Brain Ž 62 61 98 1 2 – – – – Tabela 10. – Table 10. Nadaljevanje – Continued S t a d i j Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number Localized Regional Remote Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* Hrbtni mozeg, možganski živci in drugi deli CŽS M 3 3 – – –C72 Spinal cord, cranial nerves Ž 2 2 – – – and other parts of CNS C73 Ščitnica M 23 14 61 8 35 1 4 – –Thyroid gland Ž 92 69 75 13 14 7 8 3 3 C74 Nadledvična žleza M – – – – –Adrenal gland Ž 1 – 1 – – Druge endokrine žleze in sorodne strukture M 1 1 – – –C75 Other endocrine glands Ž 1 1 – – – and related structures C76 Druga in slabo opredeljena mesta M 1 – – – 1Other and ill-defined sites Ž 11 1 8 2 – Metastaza in neopredeljena maligna neoplazma bezgavk M 17 – – – – – – 17 100C77 Metastasis and unspecified Ž 10 – – – 10 malignant neoplasm of lymph nodes C78 Metastaze dihal in prebavil M 42 – – – – 42 100 – –Metastases of respiratory and digestive organs Ž 36 – – – – 36 100 – – C79 Metastaze, drugje M 21 – – – – 21 100 – –Metastases of other sites Ž 16 – – – – 16 100 – – Maligna neoplazma brez opredeljenega mesta M 38 – – – – 38 100 – –C80 Malignant neoplasm without Ž 38 – – – – 38 100 – – specification of site S t a d i j ( A n n – A r b o r ) Šifra Primarna Spol Število I II III + IV Neznan MKB lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek* S t a g e ICD Primary Sex Number I II III + IV Unknown code site of cases Number Percent* Number Percent* Number Percent* Number Percent* C81 Hodgkinova bolezen M 32 5 16 15 47 12 38 – –Hodgkin's disease Ž 22 1 5 12 55 9 41 – – C82- Ne-Hodgkinov limfom M 95 24 53 16 30 41 90 14 28 C85 Ne-Hodgkin's lymphoma Ž 140 33 78 29 52 62 119 16 52 * Odstotki niso računani pri številih pod 15 Percentages are not calculated for less than 15 cases Cancer Incidence in Slovenia 2003 71 Institute of Oncology Ljubljana, Cancer Registry of Slovenia 72 Incidenca raka v Sloveniji 2003 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 11. Število umrlih za rakom po lokaciji, spolu in starosti - Slovenija 2003* Table 11. Number of cancer deaths by site, sex and age - Slovenia 2003* Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Skupaj 5058 1 3 1 7 7 9 17 38 79 167 296 377 495 687 940 8691065 Vse lokacije Total Moški 2817 1 2 1 6 2 5 8 14 31 90 177 240 316 430 564 436 494 All sites Male Ženske 2241 – 1 – 1 5 4 9 24 48 77 119 137 179 257 376 433 571 Female C00 Ustnica M 1 – – – – – – – – – – – – – – – – 1Lip Ž 2 – – – – – – – – – – – – – – – – 2 C01 Baza jezika M 3 – – – – – – – – – 1 1 – – – – 1 –Base of tongue Ž – – – – – – – – – – – – – – – – – – C02 Jezik, drugi deli M 9 – – – – – – – – – 1 2 1 – 2 1 2 – Tongue, other & unspecified parts Ž 1 – – – – – – – 1 – – – – – – – – – C04 Ustno dno M 7 – – – – – – – – – 1 – – 2 1 1 2 –Floor of mouth Ž – – – – – – – – – – – – – – – – – – C05 Nebo M 1 – – – – – – – – – – – – – – 1 – –Palate Ž – – – – – – – – – – – – – – – – – – C06 Usta, drugi deli M 6 – – – – – – – – – – 1 1 2 1 – 1 –Mouth, other & unspecified parts Ž 4 – – – – – – – – – – 1 2 – – 1 – – C07 Parotidna žleza M 1 – – – – – – – – – – – – – – – 1 –Parotid gland Ž 2 – – – – – – – – 1 – – – – – – – 1 Druge in neopredeljene velike žleze slinavke M 1 – – – – – – – – – – – – 1 – – – – C08 Other & unspecified Ž – – – – – – – – – – – – – – – – – – major salivary glands C09 Tonzila M 2 – – – – – – – – – 1 – 1 – – – – –Tonsil Ž – – – – – – – – – – – – – – – – – – C10 Orofarinks M 46 – – – – – – – – 3 6 6 6 8 7 5 3 2Oropharynx Ž 5 – – – – – – – – – – 1 1 1 – 1 1 – C11 Nazofarinks M 3 – – – – – – – – – – – – 2 – – 1 –Nasopharynx Ž 3 – – – – – – – – – – – 1 – 1 – 1 – C13 Hipofarinks M 21 – – – – – – – – 1 2 2 2 7 4 1 1 1Hypopharynx Ž 3 – – – – – – – – – – 2 1 – – – – – Druga in slabo oprede– ljena mesta na ustnici, C14 v ustni votlini in farinksu M 9 – – – – – – – – – 1 – 1 2 1 1 1 2Other and ill–defined Ž 1 – – – – – – – – – – – – – – – – 1 sites in the lip, oral cavity and pharynx C15 Požiralnik M 58 – – – – – – – – 3 4 4 8 6 13 7 6 7Oesophagus Ž 16 – – – – – – – – – – – 1 – 4 2 2 7 C16 Želodec M 200 – – – – – – – 1 1 6 9 16 15 23 48 37 44Stomach Ž 145 – – – – – – – – 1 4 1 9 8 11 26 45 40 C17 Tanko črevo M 2 – – – – – – – – – – – – 1 – – 1 –Small intestine Ž 3 – – – – – – – – 1 – – – – – 1 – 1 C18 Debelo črevo M 194 – – – 1 – – – 1 2 5 8 11 23 35 33 34 41Colon Ž 167 – – – – – – 1 1 1 4 7 7 9 13 28 40 56 C19 Rektosigmoidna zveza M 32 – – – – – – – 1 – 2 2 1 2 5 7 8 4Rectosigmoid junction Ž 30 – – – – 1 – – – – – 1 2 1 3 7 5 10 C20 Rektum M 156 – – – – – – – 1 – 3 8 12 18 23 37 18 36Rectum Ž 132 – – – – – – – 1 – 1 5 5 8 15 23 26 48 C21 Anus in analni kanal M 3 – – – – – – – – – – – – 1 1 – – 1Anus and anal canal Ž 4 – – – – – – – – 1 – – – – – – 3 – C22 Jetra in intrahepatični vodi M 96 – – – – – – – 1 2 3 12 10 17 20 19 5 7 Liver and intrahepatic bile ducts Ž 66 – – – – – 1 – 1 1 1 2 3 6 6 11 15 19 C23 Žolčnik M 12 – – – – – – – – – – – – 2 1 – 6 3Gallbladder Ž 37 – – – – – – – – – 1 – – 4 2 8 10 12 nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2003 73 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 11. – Table 11. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Drugi in neopredeljeni deli biliarnega trakta M 15 – – – – – – – – – – 1 2 – 3 3 1 5C24 Billiary tract, other and Ž 16 – – – – – – – – – – – – 2 3 1 6 4 unspecified parts C25 Trebušna slinavka M 124 – – – – – – – 1 – 6 12 10 12 23 25 14 21Pancreas Ž 117 – – – – – – – 3 2 2 5 1 5 19 26 23 31 Druga in slabo opredeljena mesta v prebavnih organih M 6 – – – – – – – – – 1 1 – – 1 1 2 –C32 Other and ill–defined Ž 14 – – – – – – – – – – – – 1 – 1 4 8 digestive organs C31 Obnosni sinusi M 5 – – – – – – – – 1 – – 2 – – 1 1 –Accessory sinuses Ž 2 – – – – – – – – – – – – 1 – – – 1 C32 Grlo M 47 – – – – – – – – – 2 6 3 7 9 11 4 5Larynx Ž 5 – – – – – – – – – – – – 1 1 1 1 1 C33 Sapnik M 1 – – – – – – – – – – 1 – – – – – –Trachea Ž – – – – – – – – – – – – – – – – – – C34 Sapnica in pljuča M 753 – – – – – 1 1 2 7 20 49 80 102 140 163 109 79ronchus and lung Ž 259 – – – – – – – – 7 17 15 23 24 26 60 47 40 C37 Timus M 1 – – – – – – – – – – – – – – – 1 –Thymus Ž – – – – – – – – – – – – – – – – – – Srce, mediastinum, plevra M 8 – – – – – 1 – – – – – 2 1 – 1 2 1C38 Heart, mediastinum, Ž 7 – – – – – – – – – – – – – 1 2 1 3 pleura Druga in slabo opredeljena mesta v dihalih in prsnih organih M 3 – – – – – – – – – – – 1 1 – 1 – –C39 Other and ill–defined sites Ž – – – – – – – – – – – – – – – – – – in the respiratory system and intrathoracic organs Kosti, sklepni hrustanec udov M 1 – – – – – – – – – – – 1 – – – – –C40 Bone and articular Ž 5 – – – – – – – – 1 – – – – – 3 – 1 cartilage of limbs Kosti, sklepni hrustanec, drugje Bone and articular M 6 – – – – – – 1 – – – 1 1 – 1 1 – 1C41 cartilage of other and Ž 4 – – – – 2 – – – – – – – – – – 1 1 unspecified parts C43 Maligni melanom kože M 48 – – – – – – 3 2 1 1 4 6 5 8 8 5 5Malignant melanoma of skin Ž 38 – – – – 1 – – 1 5 4 3 3 2 5 3 3 8 C44 Druge maligne neoplazme kože M 7 – – – – – – – – – – 1 – – 3 1 1 1 Skin, other malignomas Ž 12 – – – – – – 1 – – – – 1 – – 1 – 9 C45 Mezoteliom M 19 – – – – – – – – – – 3 2 2 4 2 2 4Mesothelioma Ž 10 – – – – – – – – – – 2 – 1 3 – 2 2 Periferni živci in avtonomno živčevje M 1 – – – – – 1 – – – – – – – – – – –C47 Peripheral and autho– Ž 1 – – – – – – 1 – – – – – – – – – – nomic nervous system C48 Retro– in peritonej M 7 – – – 1 – – – – – 1 – – 1 – 3 1 –Retro– and peritoneum Ž 4 – – – – – – – – – – 1 – 1 – 1 1 – Drugo vezivno in mehko tkivo M 4 – 1 – – – – – – – – 1 – – 1 – 1 –C49 Other connective and Ž 5 – – – – – – – – – – 1 – – 1 – 1 2 soft tissue C50 Dojka M 1 – – – – – – – – – – 1 – – – – – –Breast Ž 372 – – – – – 1 3 8 11 17 36 35 35 43 53 54 76 C51 Žensko zunanje spolovilo M – – – – – – – – – – – – – – – – – –Vulva Ž 14 – – – – – 1 – – – – – – – 3 1 7 2 C52 Nožnica M – – – – – – – – – – – – – – – – – –Vagina Ž 3 – – – – – – – – – – – – – – 1 2 – C53 Maternični vrat M – – – – – – – – – – – – – – – – – –Cervix uteri Ž 55 – – – – – – 2 2 2 7 6 5 3 3 6 10 9 74 Incidenca raka v Sloveniji 2003 nadaljevanje / cont’d ➝ Onkološki inštitut Ljubljana, Register raka za Slovenijo Tabela 11. – Table 11. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ C54 Maternično telo M – – – – – – – – – – – – – – – – – –Corpus uteri Ž 40 – – – – – – – – 2 – – 1 3 6 9 10 9 C55 Maternica, neopredeljeno M – – – – – – – – – – – – – – – – – – Uterus, unspecified Ž 45 – – – – – – – 2 2 1 2 1 4 5 8 7 13 C56 Jajčnik M – – – – – – – – – – – – – – – – – –Ovary Ž 118 – – – – – – – – 4 5 9 15 15 19 18 15 18 Drugi in neopredeljeni ženski spolni organi M – – – – – – – – – – – – – – – – – –C57 Other and unspecified parts Ž 13 – – – – – – – – – – 1 2 1 2 2 2 3 of female genital organs C60 Penis M 4 – – – – – – – – – 1 1 – – – – 1 1Penis Ž – – – – – – – – – – – – – – – – – – C61 Prostata M 320 – – – – – – – – – 1 3 10 17 30 77 72 110Prostate Ž – – – – – – – – – – – – – – – – – – C62 Modo M 8 – – – – – 2 2 1 1 1 1 – – – – – –Testis Ž – – – – – – – – – – – – – – – – – – Drugi in neopredeljeni moški spolni organi M 2 – – – – – – – – 1 – – – – – 1 – –C63 Other and unspecified parts Ž – – – – – – – – – – – – – – – – – – male genital organs C64 Ledvica razen meha M 81 – – – – – – – – – 4 9 8 10 12 15 14 9Kidney, except renal pelvis Ž 36 – – – – – – – – 1 1 3 – 4 2 5 8 12 C65 Ledvični meh M 2 – – – – – – – – – – – – – 1 – 1 –Renal pelvis Ž 1 – – – – – – – – – – – – – – – – 1 C66 Sečevod M 1 – – – – – – – – – – – – – – – – 1Ureter Ž 1 – – – – – – – – – – – – – – – 1 – C67 Sečni mehur M 93 – – – – – – – – 2 2 4 6 9 9 15 24 22Bladder Ž 49 – – – – – – – – 2 – 1 1 – 8 5 10 22 Drugi in neopredeljeni sečni organi M 1 – – – – – – – – – – – – – – – – 1C68 Other and unspecified Ž 1 – – – – – – – – – – – 1 – – – – – urinary organs C69 Oko in očesni adneksi M 2 – – – – – – – – – – – – 1 – – 1 –Eye and adnexa Ž 2 – – – – – – – – – – – 1 – 1 – – – C70 Meninge M 1 – – – – – – – – – – – – – – – – 1Meninges Ž 4 – – – – – – – – – – – – 2 – – 1 1 C71 Možgani M 54 1 – – – – – – 1 2 4 6 12 9 4 8 3 4Brain Ž 60 – – – – – – – 4 1 1 7 3 12 10 11 7 4 Hrbtni mozeg, možganski živci in drugi deli CŽS M 3 – 1 – – – – – – 1 – – – 1 – – – –C72 Spinal cord, cranial nerves Ž 1 – – – – – – – – – – – – – – 1 – – and other parts of CNS C73 Ščitnica M 3 – – – – – – – – – – – – – – – 2 1Thyroid gland Ž 12 – – – – – – – – – – – – – 3 1 1 7 C74 Nadledvična žleza M 4 – – – – – – – – – 1 – – – – 3 – –Adrenal gland Ž – – – – – – – – – – – – – – – – – – Druge endokrine žleze in sorodne strukture M – – – – – – – – – – – – – – – – – –C75 Other endocrine glands Ž 1 – – – – – – – – – – – – – – – 1 – and related structures Druga in slabo opredeljena mesta M 10 – – – – – – – – – – – 1 1 1 1 – 6C76 Other and ill–defined sites Ž 18 – 1 – – – – – – 1 1 – 1 – 1 3 4 6 Metastaza in neopredeljena maligna C77 neoplazma bezgavk M 1 – – – – – – – – – – – – – – – 1 –Metastasis and Ž – – – – – – – – – – – – – – – – – – unspecified malignant neoplasm of lymph nodes C78 Metastaze dihal in prebavil M 25 – – – – – – – – – – 1 2 4 5 7 4 2Metastases of respiratory and digestive organs Ž 20 – – – – – 1 – – – – – – 2 2 4 6 5 nadaljevanje / cont’d ➝ Cancer Incidence in Slovenia 2003 75 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 11. – Table 11. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ C79 Metastaze, drugje M 6 – – – – – – – – – 1 – – 1 1 2 1 –Metastases of other sites Ž 7 – – – – – – – – – 1 – 1 1 2 – 1 1 Maligna neoplazma brez opredeljenega mesta M 48 – – – – – – – – 2 4 2 3 7 3 13 6 8 C80 Malignant neoplasm Ž 50 – – – – – – – – – 1 – 1 2 10 13 10 13 without specification of site C81 Hodgkinova bolezen M 7 – – – – 1 – – – – – – 1 2 2 1 – –Hodgkin's disease Ž 4 – – – – 1 – – – – – – – – 1 – – 2 Folikularni ne–Hodgkinov limfom M 8 – – – – – – – – – – 1 – 1 1 1 1 3C82 Follicular non–Hodgkin's Ž 8 – – – – – – – – – 1 – – – – 1 2 4 lymphoma Difuzni ne–Hodgkinov limfom M 13 – – – 1 – – – – – – – – 1 – 2 5 4C83 Diffuse non–Hodgkin's Ž 13 – – – – – – – – – 1 1 – – 3 1 2 5 lymphoma Limfomi celic T in kožni limfom celic T M 2 – – – – – – – 1 – – – – – – 1 – –C84 Peripheral and cutaneous Ž 3 – – – – – – – – – – – – – – – 2 1 T–cell lymphomas Druge in neopredeljene vrste ne–Hodgkinovega C85 limfoma M 28 – – – – – – – – – 3 1 3 – 3 4 4 10Other and unspecified Ž 44 – – – – – – – – 1 1 1 1 4 – 8 11 17 types of non–Hodgkin's lymphoma Maligne imunoprolife– rativne bolezni M 2 – – – – – – – – – – – 1 1 – – – –C88 Malignant immunopro– Ž – – – – – – – – – – – – – – – – – – liferative diseases Difuzni plazmocitom in maligne neoplazme C90 plazmocitov M 38 – – – – – – – – – 1 2 6 1 8 8 4 8Multiple myeloma and Ž 46 – – – – – – – – – 1 1 2 7 6 8 10 11 malignant plasma cell neoplasms C91 Limfatična levkemija M 38 – – 1 – – – 1 – – – 2 3 5 8 4 5 9Lymphoid leukaemia Ž 22 – – – – – – – – – – 1 3 3 3 3 2 7 C92 Mieloična levkemija M 30 – – – 1 1 – – 1 1 – 2 1 2 6 4 3 8Myeloid leukaemia Ž 28 – – – – – – 1 – – 3 2 2 3 5 1 7 4 C93 Monocitna levkemija M 2 – – – – – – – – – – – – – – 1 – 1Monocytic leukaemia Ž – – – – – – – – – – – – – – – – – – Druge opredeljene levkemije M 1 – – – – – – – – – – – – – 1 – – –C94 Other leukaemias Ž – – – – – – – – – – – – – – – – – – of specified cells C95 Levkemija z neopredeljenim celičnim tipom M 8 – – – – – – – – – – – – – 2 2 1 3 Leukaemia, unspecified Ž 9 – – – 1 – – – – – – – – 1 1 2 1 3 cell type Druge in neopredeljene maligne neoplazme limfatičnega, krvotvornega in sorodnega tkiva M 3 – – – 1 – – – – – – 1 – 1 – – – –C96 Other & unspecified Ž 1 – – – – – – – – – – – – – – – – 1 malignant neoplasms of lymphoid, haemopoetic & related tissues C97 Maligne neoplazme na več neodvisnih (primarnih) mestih M 48 – – – 1 – – – – – – 5 3 2 3 12 11 11 Malignant neoplasms Ž 20 – – – – – – – – – 1 1 1 2 4 4 1 6 of independant (primary) multiple sites Tabela 11. – Table 11. Nadaljevanje – Continued Šifra Primarna Vse S t a r o s t i MKB lokacija Spol starosti A g e ICD Primary Sex All code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+ Zgoraj neupoštevani Not included above Meninge, benigna neoplazma M 2 – – – – – – – – – – – – – – – 1 1D32 Benign neoplasm Ž 9 – – – – – – – – – – 1 – – – 2 2 4 of meninges D33 CŽS, benigna neoplazma M – – – – – – – – – – – – – – – – – –Benign neoplasm of brain Ž 2 – – – – – – – – – – – – 1 – 1 – –and other parts of CNS D43 CŽS, neopredeljeno M 6 – – – 1 – – 1 – – 1 – 1 1 – – 1 –CNS, uncertain or unknown Ž 1 – – – – – – – – – – – – – 1 – – – * Vir: Inštitut za varovanje zdravja Source: Institute of Public Health 76 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo Cancer Incidence in Slovenia 2003 77 Institute of Oncology Ljubljana, Cancer Registry of Slovenia Tabela 12. Število vseh živih bolnikov z rakom po spolu in izbrani primarni lokaciji - Slovenija, 31. 12. 2003 Table 12. Prevalence of cancer patients by sex and selected primary site - Slovenia, December 31, 2003 Šifra Primarna MKB lokacija Skupaj Moški Ženske ICD Primary Total Males Females code site C00 – Vse lokacije Skupaj 57108 22382 34726 C96 All sites Total C00 Usta in žrelo 1699 1277 422 -C14 Mouth and pharynx C15 Požiralnik 133 105 28 Oesophagus C16 Želodec 1527 854 673 Stomach C18 Debelo črevo 2985 1496 1489 Colon C19 Rektum in rektosigmoidna zveza 2557 1379 1178 -C20 Rectum and rectosigmoid junction C22 Jetra in intrahepatični vodi 98 59 39 Liver and intrahepatic bile ducts C23 Žolčnik in žolčevodi 154 82 72 -C24 Gallbladder and billiary tract C25 Trebušna slinavka 151 79 72 Pancreas C32 Grlo 904 812 92 Larynx C33 Sapnik, sapnici in pljuča 1751 1340 411 -C34 Trachea, bronchus and lung C43 Maligni melanom kože 2330 913 1417 Malignant melanoma of skin C44 Druge maligne neoplazme kože 11778 5304 6474 Skin, other malignomas C48 Vezivno in mehko tkivo 523 250 273 -C49 Connective and soft tissue C50 Dojka 9442 63 9379 Breast C53 Maternični vrat 3457 – 3457 Cervix uteri C54 Maternično telo 3286 – 3286 Corpus uteri C56 Jajčnik 1259 – 1259 Ovary C61 Prostata 2518 2518 – Prostate C62 Modo 1285 1285 – Testis C64 Ledvica z ledvičnim mehom 1321 753 568 -C65 Kidney with renal pelvis C67 Sečni mehur 1070 806 264 Bladder C70 Centralni in avtonomni živčni sistem 492 269 223 -C72 Central and autonomic nervous system C73 Ščitnica 1026 223 803 Thyroid gland C81 Hodgkinova bolezen 734 389 345 Hodgkin's disease C82 ne-Hodgkinovi limfomi 1390 712 678 -C85 non-Hodgkin's lymphoma C90 Difuzni plazmocitom in maligne neoplazme plazmocitov 239 110 129 Multiple myeloma and malignant plasma cell neoplasms C91 Levkemije 975 510 465 -C95 Leukaemias 78 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo IZBOR PUBLIKACIJ, ki so jih sodelavci Epidemiologije in Registra raka objavili v zadnjih petih letih (tudi v sodelovanju z drugimi raziskovalci) SELECTION OF PUBLICATIONS, published by the members of Epidemiology and Cancer Registry in the last five years (also in cooperation with other researchers) 2001 - Boffetta P, Saellsten G, Pompe Kirn V et al. Mortality from car- diovascular diseases and exposure to inorganic mercury. Occup Environ Med 2001; 58(7): 461-6. - Capocaccia R, Gatta G, Magnani C, Stiller C, Coebergh JW, eds. Childhood cancer survival in Europe 1978-1992: the EURO- CARE Study. Milano: European School of Oncology, 2001. (Eur J Cancer 2001; 37 (6): 671-816. - Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet 2001; 358(9291): 1389-99. - Debeljak A, Triller N, Pompe Kirn V et al. Smernice za internistično obravnavo bolnika s pljučnim rakom: uradno stal- išče Združenja pulmologov Slovenije, ki bo sprejeto na letni konferenci decembra 2001. Zdrav Vestn 2001; 70(12): 751-70. - Ećimović P, Pompe Kirn V. Incidenca raka v Sloveniji 1998 – novo letno poročilo Registra raka za Slovenijo. Onkologija 2001; 5(1): 45. - Pompe Kirn V, Japelj B, Primic Žakelj M, Šircelj M. Kaj je vpliva- lo na incidenco raka dojk v Sloveniji in kako bo z zbolevnostjo v tem desetletju. Zdrav Vestn 2001; 70(6): 341-5. - Primic Žakelj M, Pompe Kirn V, Čeh F. Najpomembnejši dejavniki tveganja raka. In: Več znanja - manj raka: didaktični komplet za učitelje. Ljubljana: Zavod Republike Slovenije za šol- stvo, 2001: 11-6. - Primic Žakelj M, Pompe Kirn V, Škrlec F, Šelb J. Can we rely on cancer mortality data? Checking the validity of cervical can- cer mortality data for Slovenia. Radiol Oncol 2001; 35(4): 243-47. - Primic Žakelj M. Epidemiology of breast cancer in the XXI cen- tury. Evidence based management of breast cancer, Sarajevo 2001. Sarajevo: European School of Oncology, 2001. - Pompe Kirn V. Kajenje in rak pri ženskah. In: Štabuc B, ed. Kajenje in rak pri ženskah. 9. seminar »In memoriam dr.Dušana Reje«, Ljubljana 2001. Ljubljana: Zveza slovenskih društev za boj proti raku; Onkološki inštitut; Inštitut za varovanje zdravja RS; Rdeči križ Slovenije 2001: 16-20. - Robertson C, Van Den Donk M, Primic Žakelj M, MacFarlane T, Boyle P. The association between induced and spontaneous abortion and risk of breast cancer in Slovenian women aged 25-54. Breast 2001; 10(4): 291-4. - Sant M, Capocaccia R, Coleman MP et al. and the EUROCARE Working Group. Cancer survival increases in Europe, but inter- national differences remain wide. Eur J Cancer 2001; 37(13): 1659-67. - Uršič Vrščaj M, Bebar S, Primic Žakelj M. Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival. Menopause 2001; 8(1): 70-5. 2002 - Capocaccia R, Colonna M, Corazziari I et al. and the EURO- PREVAL Working Group. Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol 2002; 13(6): 831-9. - Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002; 360(9328): 187-95. - Debeljak A, Triller N, Pompe Kirn V et al. Strokovna izhodišča za internistično obravnavo bolnika s pljučnim rakom. Zdrav Vestn 2002; 71(6): 385-90. - Ećimović P, Pompe Kirn V. Second primary cancers in laryn- geal cancer patients in Slovenia, 1961-1996. Eur J Cancer 2002; 38(9): 1254-60. - Lambert R, Guilloux A, Pompe Kirn V et al. Incidence and mor- tality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer 2002; 97(6): 811-8. - Micheli A, Mugno E, Krogh V et al. and the EUROPREVAL Working Group. Cancer prevalence in European registry areas. Ann Oncol 2002; 13(6): 840-65. - Pompe Kirn V. Epidemiological features of laryngeal cancer in Slovenia. Zdrav Vestn 2002; 71: Suppl 3: 59-63. - Pompe Kirn V. Rak v Sloveniji - število in preživetje bolnikov. In: Frankič D, ed. Prepoznavanje in zdravljenje raka. Strokovno izpopolnjevanje magistrov farmacije v letu 2002, Ljubljana 2002. Ljubljana: Lekarniška zbornica Slovenije, 2002: 5-8. - Pompe Kirn V.: Preživetje bolnikov z rakom v Sloveniji - novosti iz Registra raka za Slovenijo za obdobje 1988-1997. Onkologija 2002; 6(1): 28-31. - Primic Žakelj M. Rak danes in rak šest desetletij nazaj. In: Skela Savič B, ed. Razvoj onkologije in onkološke zdravstvene nege. Kakovost v zdravstveni negi. 29. strokovni seminar, Ljubljana 2002. Zbornik. Ljubljana: Sekcija medicinskih sester v onkologi- ji pri Zbornici zdravstvene nege Slovenije - Zvezi društev medi- cinskih sester in zdravstvenih tehnikov Slovenije, 2002: 19-24. - Uršič Vrščaj M, Primic Žakelj M, Kirar Fazarinc I. Epidemiologija raka materničnega vratu v Sloveniji in v svetu ter nacionalni program ZORA. In: Možina A, ed. Zgodnja detekcija raka materničnega vratu : kolposkopski tečaj, Ljubljana 2002. Zbornik predavanj. Ljubljana: Klinični center - Ginekološka klini- ka, 2002: 5-7. 2003 - Benedičič Pilih A. Trend incidence in preživetja bolnikov s kožnim malignim melanomom v Sloveniji v obdobju 1980-1999 glede na izbrane napovedne dejavnike preživetja. Magistrsko delo. Ljubljana: Univerza v Ljubljani, 2003. - Benedičič Pilih A, Pompe Kirn V, Kokol P, Povalej P, Arzenšek J. Kožni melanom v Sloveniji in potreba po preventivi. In: Miljković J, ed. Dermatološki dnevi. Strokovno izpopolnjevanje iz der- matologije z mednarodno udeležbo, Maribor 2003. Maribor: Splošna bolnišnica, 2003: 27-37. - Berrino F, Capocaccia R, Gatta G et al, eds. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003: 14(Suppl 5). - Lutz JM, Francisci S, Pompe Kirn V et al and EUROPREVAL Working Group. Cancer prevalence in Central Europe: the EUROPREVAL study. Ann Oncol 2003; 14(2): 313-22. Cancer Incidence in Slovenia 2003 79 Institute of Oncology Ljubljana, Cancer Registry of Slovenia - Pompe Kirn V. Rak v številkah: da bi ga bolje razumeli in lažje obvladovali. Okno 2003; 17(1): 27-9. - Pompe-Kirn V, Zakotnik B, Zadnik V. Preživetje bolnikov z rakom v Sloveniji 1983-1997. Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2003. - Primic Žakelj M, Arko D, Rener M, Žgajnar J. Rak dojk v Sloveniji: epidemiologija in presejanje. Zdrav Vestn 2003; 72: Suppl 2: ,II- 179-II-181. - Primic Žakelj M, Zadnik V. Epidemiologija raka dojk. In: Takač I, Arko D, eds. 30 let Centra za bolezni dojk v Mariboru. Simpozij z mednarodno udeležbo, Maribor 2003. Zbornik predavanj. Maribor: Splošna bolnišnica, 2003, 15-27. - Primic Žakelj M, Zadnik V. Rak dojk: razširjenost in nevarnostni dejavniki.In: Štabuc B, ed. Več znanja o raku, manj smrti. Seminar, Strunjan 2003. Ljubljana; Koper: Zveza slovenskih društev za boj proti raku; Obalno društvo za boj proti raku, 2003: 55-63. - Primic Žakelj M, Zadnik V. Staranje prebivalstva in rak. In: Skela Savič B, ed. Starost in rak. 30 strokovni seminar, Ljubljana 2003. Ljubljana: Sekcija medicinskih sester v onkologiji pri Zbornici zdravstvene nege - Zvezi društev medicinskih sester in zdravstvenih tehnikov Slovenije, 2003: 5-11. - Uršič Vrščaj M, Primic Žakelj M, Kirar Fazarinc I. Epidemiologija raka materničnega vratu v Sloveniji in v svetu ter nacionalni program ZORA. In: Možina A, ed. Zgodnja detekcija raka materničnega vratu in kolposkopski tečaj in Praktična kol- poskopija in ambulantno zdravljenje prekanceroze, Ljubljana 2003. Zbornik predavanj. Ljubljana: Klinični center; Ginekološka klinika; Združenje za ginekološko onkologijo, kolposkopijo in cervikalno patologijo, 2003: 92-5. - Zadnik V, Šelb J. Osnovni vzroki smrti s kazalniki umrljivosti v Sloveniji v letu 2001. - Zdrav Vestn 2003; 72(7-8): 429-4. 2004 - Benedičič Pilih A, Pompe Kirn V, Kokol P, Povalej P. Kožni melanom v Sloveniji in potreba po preventivi. In: Bešić N, Anderluh F, Benedik J et al, eds. Novosti v onkologiji in smernice za obravnavo bolnic z rakom dojk in bolnikov z malignim melanomom. 17. onkološki vikend. Laško: Kancerološko združenje Slovenskega zdravniškega društva, 2004: 107-9. - de Vries E, Boniol M, Dore JF, Coebergh JW, Pompe Kirn V and Eurocare Working Group. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. Eur J Cancer 2004; 40: 1045-52. - Ećimović P. Drugi primarni raki pri bolnikih s kadilskimi raki v Sloveniji v obdobju 1961-2000 ter njihov vpliv na preživetje. Doktorsko delo. Ljubljana: Univerza v Ljubljani, 2004. - Jazbec J, Ećimović P, Jereb B. Second neoplasms after treat- ment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004; 42: 574-81. - Kirar Fazarinc I, Primic Žakelj M. Stanje na področju presejanja raka dojk in vzpostavitev organiziranega programa v Sloveniji. Radiol Oncol 2004; 38: Suppl 1: S21-5. - Kirar Fazarinc I, Primic Žakelj M. Izvajanje Državnega programa ZORA in kazalci organiziranega presejanja raka materničnega vratu v Sloveniji. In: Bešić N, Anderluh F, Benedik J et al, eds. Novosti v onkologiji in smernice za obravnavo bolnic z rakom dojk in bolnikov z malignim melanomom. 17. onkološki vikend. Laško: Kancerološko združenje Slovenskega zdravniškega društva, 2004: 105-6. - Noričič G, Repše S, Pompe-Kirn V. Rezultati zdravljenja raka debelega črevesa in danke v Sloveniji - analiza leta 1997. Gastroenterolog 2004; 8: Suppl 2: 287-9. - Pompe-Kirn V, Zadnik V. Analiza incidence raka na območju UE Idrija. In: Osredkar J. Vpliv elementarnega živega srebra na peroksidacijo lipidov in funkcijsko sposobnost posameznih tarčnih organov pri prebivalcih mesta Idrije in delavcih rudni- ka. Zaključno poročilo o rezultatih raziskovalnega projekta v letu 2004. Ljubljana, 2004. - Primic Žakelj M. Smernice za zgodnje odkrivanje raka. In: Skela Savič B, Logonder M, Lokar K, eds. Ukrepajmo danes, da bomo živeli jutri. 31. strokovni seminar Sekcije medicinskih sester v onkologiji. Moravske toplice: Zbornica zdravstvene nege Slovenije-ZDMSZTS, 2004: 28-33. - Primic Žakelj M, Kirar Fazarinc I. Cervical cancer screening – a Slovenian experience. In: Better health outcomes through pub- lic health approaches in primary health care. Fourth interna- tional forum on common access to health care. Brdo pri Kranju: Ministry of Health, 2004: 1-5. - Primic Žakelj M, Ravnihar B and Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and abor- tion: collaborative reanalysis of data from 53 epidemiological studies, including 83000 women with breast cancer from 16 countries. Lancet 2004; 363: 1007-16. - Primic Žakelj M, Zadnik V. Kajenje in rak v Sloveniji. In: Štabuc B, Primic Žakelj M, Zdešar A, eds. Kajenje in rak. 12. seminar »In memoriam dr. Dušana Reje«. Ljubljana: Zveza slovenskih društev za boj proti raku, Onkološki inštitut, Inštitut za varovanje zdravja RS, Rdeči križ Slovenije, 2004: 36-42. - Primic Žakelj M, Zadnik V. Epidemiologija raka dojk v svetu in v Sloveniji. Radiol Oncol 2004; 38: Suppl 1: S1-S7. - Primic Žakelj M, Zadnik V, Škrlec F. Nekaj osnovnih podatkov in zanimivosti iz novega letnega poročila Registra raka za Slovenijo. Onkologija 2004; 8: 22-4. - Tyczynski JE, Bray F, Pompe Kirn V et al. Lung cancer mortality patterns in selected Central Eastern and Southern European countries. Int J Cancer 2004; 109: 598-610. - Tyczynski JE, Pleško I, Primic Žakelj M et al. Breast cancer mor- tality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer 2004; 112: 1056-64. - Zadnik V, Primic Žakelj M. Vpliv dejavnikov tveganja in genetske nagnjenosti na pojavljanje raka dojk pri mladih ženskah. In: Bešić N, Anderluh F, Benedik J et al, eds. Novosti v onkologiji in smernice za obravnavo bolnic z rakom dojk in bol- nikov z malignim melanomom. 17. onkološki vikend. Laško: Kancerološko združenje Slovenskega zdravniškega društva, 2004: 114-5. 2005 - Bray F, Carstensen B, Moller H, Zappa M, Žakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005; 14:2191-9. - Brennan P, Scelo G, Hemminki K, Mellemkjaer L, Tracey E, Pompe-Kirn V, et al. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005; 93:159-66. - Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M; EUROCARE Working Group. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 2005; 23: 3742-51. - Kobal AB, Horvat M, Prezelj M, Pompe-Kirn V, Zadnik V, Osredkar J, et al. Vpliv elementarnega živega srebra na peroksidacijo lipidov in funkcijsko sposobnost posameznih tarčnih organov pri prebivalcih mesta Idrija in delavcih rudnika : zaključno poročilo raziskovalnega projekta (skrajšana verzija). Idrij Razgl 2005; 50: 20-30. - Pompe Kirn V. Podrobnejši pregled trenda incidence raka ščitnice v obdobju 1983-2002 v Sloveniji. Onkologija 2005; 9:12-4. - Primic Žakelj M. Epidemiology of breast cancer: incidence and mortality trends, prevention and control. 3rd Sarajevo breast cancer conference. Sarajevo: ESO, 2005: 15-27. - Primic Žakelj M. Evropske smernice za presejanje žensk za raka materničnega vratu. In: Možina A, ed. HPV in preprečevanje raka materničnega vratu - Kje smo in kako naprej? HPV infection and cervical cancer prevention -Where are now, what to do next? Mednarodni znanstveni simpozij. Ljubljana: Združenje za ginekološko onkologijo, kolposkopijo in cervikalno patologijo, 2005: 9-13. - Primic Žakelj M. Prenovljeni evropski kodeks proti raku. In: Štabuc B, ed. Poročilo Zveze in regijskih društev za boj proti raku Slovenije: leto 2004. Ljubljana: Zveza društev za boj proti raku Slovenije, 2005: 6-11. - Primic Žakelj M. Zgodnje odkrivanje pogostejših rakov pri starejših. In: Turk J, ed. Zdrava poznejša leta. Ljubljana: Društvo za zdravje srca in ožilja Slovenije, 2005: 97-110. - Primic Žakelj M, Zadnik V. Epidemiologija raka dojk v Sloveniji in v svetu. In: Štabuc B, ed. Poročilo Zveze in regijskih društev za boj proti raku Slovenije: leto 2004. Ljubljana: Zveza društev za boj proti raku Slovenije, 2005: 13-6. - Primic Žakelj M, Zadnik V. Presejanje in zgodnje odkrivanje raka. In: Štabuc B, ed. Zgodnje odkrivanje raka - izzivi za pri- hodnost. XIII. seminar "In memoriam dr. Dušana Reje", Zbornik. Ljubljana: Zveza slovenskih društev za boj proti raku, 2005: 8-13. - Primic Žakelj, Zadnik V. Raziskovalno delo službe epidemi- ologija in registri raka na Onkološkem inštitutu. In: Bilban M, ed. Cvahtetovi dnevi javnega zdravja 2005. Ljubljana: Medicinska fakulteta, 2005: 125-34. - Primic Žakelj, Zadnik V, Žagar T. Epidemiološki podatki o raku materničnega vratu v Sloveniji. In: Takač I, ed. 50 let laboratorija za ginekološko citologijo v Mariboru. Mednarodni znanstveni simpozij. Maribor: Splošna bolnišnica, 2005: 151-60. - Primic-Žakelj M, Zadnik V, Žagar T. Is cancer epidemiology different in Western Europe to that in Eastern Europe? Ann Oncol 2005; 16 Suppl 2:ii27-9. - Quaglia A, Vercelli M, Lillini R, Mugno E, Coebergh JW, Quinn M, Martinez-Garcia C, Capocaccia R, Micheli A; ELDCARE Working Group. Socio-economic factors and health care sys- tem characteristics related to cancer survival in the elderly. A population-based analysis in 16 European countries (ELDCARE project).Crit Rev Oncol Hematol. 2005 May;54(2):117-28. - Zadnik V: Evropska raziskava vplivov dejavnikov tveganja na zbolevanje za rakom dojk pri mladih ženskah: podatki za Slovenijo. In: Bilban M, ed. Cvahtetovi dnevi javnega zdravja 2005. Ljubljana: Medicinska fakulteta, 2005: 135-49. - Zadnik V, Primic Žakelj M. Epidemiologija želodčnega raka. In: Omejc M, Repše S, eds: Kirurgija želodca - standardi in novosti. Simpozij. Ljubljana: Klinični oddelek za abdominalno kirurgijo, SPS Kirurška klinika, Klinični center, 2005: 122-7. - Žagar T, Primic Žakelj, Zadnik V. Povezovanje Registra raka za Slovenijo s sorodnimi državnimi podatkovnimi zbirkami. In: Tkačik B, Urbas M, eds. Komuniciranje z dajalci in uporabniki statističnih podatkov ter podpora EMU in Lizbonski strategiji. 15. statistični dnevi. Ljubljana: Statistični urad Republike Slovenije, Statistično društvo Slovenije, 2005: 268-77. 80 Incidenca raka v Sloveniji 2003 Onkološki inštitut Ljubljana, Register raka za Slovenijo